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essential for promoting normal host physiology. While the majority of commensal bacteria are found in
the intestinal lumen, many species have also adapted to colonize different anatomical locations in the
intestine including the surface of intestinal epithelial cells (IECs) and the interior of gut-associated
lymphoid tissues. Distinct tissue localization of commensal bacteria permits unique interactions between
these microbes and the mammalian immune system and collectively influences intestinal immune cell
homeostasis. Conversely, dysregulated localization of commensal bacteria can lead to inappropriate
activation of the immune system and is associated with numerous chronic infectious, inflammatory and
metabolic diseases. Therefore, regulatory mechanisms that control proper anatomical containment of
commensal bacteria are essential to maintain tissue homeostasis and limit pathology. Although the roles
of luminal and epithelial-associated commensal bacteria on immune cell homeostasis have been
extensively studied, how lymphoid tissue-resident commensals (LRC) modulate host immune responses
is not well understood. Data in Chapter 2 will describe interactions between a genetically related family of
LRCs that can colonize dendritic cells and induces lymphoid tissue-specific immune responses. Further,
Chapter 3 will provide evidence that LRC-induced immune responses are mutually beneficial for itself and
the host. Specifically, LRC-induced interleukin (IL)-22 enhances its own microbial colonization and LRCinduced IL-10 limits tissue inflammation during intestinal injury.
Dysregulated anatomical localization of commensal bacteria during chronic inflammatory conditions is
typically associated with extra-intestinal complications including anemia or dysregulated iron
homeostasis. Results in Chapter 4 support a role for the iron-regulatory hormone hepcidin in modulating
LRC colonization of DCs and identify hepcidin as a critical regulator of immune cell homeostasis and
tissue repair following intestinal injury. Collectively, studies presented in this thesis define mutually
beneficial interactions between mammalian hosts and commensal bacteria in intestinal-associated
lymphoid tissues that regulate immune cell homeostasis and host responses to tissue inflammation or
injury.
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ABSTRACT

DEFINING INTERACTIONS BETWEEN LYMPHOID TISSUE-RESIDENT
COMMENSAL BACTERIA AND THE HOST IMMUNE SYSTEM

Thomas Chia Ting Fung

Gregory F. Sonnenberg
David Artis

The mammalian gastro-intestinal tract is colonized by trillions of beneficial
commensal bacteria that are essential for promoting normal host physiology.
While the majority of commensal bacteria are found in the intestinal lumen, many
species have also adapted to colonize different anatomical locations in the
intestine including the surface of intestinal epithelial cells (IECs) and the interior
of gut-associated lymphoid tissues. Distinct tissue localization of commensal
bacteria permits unique interactions between these microbes and the mammalian
immune system and collectively influences intestinal immune cell homeostasis.
Conversely, dysregulated localization of commensal bacteria can lead to
inappropriate activation of the immune system and is associated with numerous
chronic infectious, inflammatory and metabolic diseases. Therefore, regulatory
mechanisms that control proper anatomical containment of commensal bacteria
iv

are essential to maintain tissue homeostasis and limit pathology. Although the
roles of luminal and epithelial-associated commensal bacteria on immune cell
homeostasis have been extensively studied, how lymphoid tissue-resident
commensals (LRC) modulate host immune responses is not well understood.
Data in Chapter 2 will describe interactions between a genetically related family
of LRCs that can colonize dendritic cells and induces lymphoid tissue-specific
immune responses. Further, Chapter 3 will provide evidence that LRC-induced
immune responses are mutually beneficial for itself and the host. Specifically,
LRC-induced interleukin (IL)-22 enhances its own microbial colonization and
LRC-induced IL-10 limits tissue inflammation during intestinal injury.
Dysregulated anatomical localization of commensal bacteria during
chronic inflammatory conditions is typically associated with extra-intestinal
complications including anemia or dysregulated iron homeostasis. Results in
Chapter 4 support a role for the iron-regulatory hormone hepcidin in modulating
LRC colonization of DCs and identify hepcidin as a critical regulator of immune
cell homeostasis and tissue repair following intestinal injury. Collectively, studies
presented in this thesis define mutually beneficial interactions between
mammalian hosts and commensal bacteria in intestinal-associated lymphoid
tissues that regulate immune cell homeostasis and host responses to tissue
inflammation or injury.
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Chapter 1
Introduction

Trillions of commensal microorganisms collectively termed the microbiota
colonize the mammalian gastrointestinal tract (GI). Most of these microbes
belong to three bacteria phyla: Bacteroidetes, Firmicutes and Proteobacteria.
Recent work has demonstrated a critical role for commensal bacteria in host
nutrient metabolism, colonization resistance against invading pathogens and
development and maturation of the immune system. Maintenance of proper hostcommensal interactions is essential for host health as dysregulated interactions
are often associated with and contribute to chronic inflammatory diseases.
Despite recent findings describing the molecular and cellular mechanisms that
promote healthy host-commensal bacteria interactions, our understanding of 1)
the anatomical localization of commensal bacteria in health and disease, 2) the
role of distinct commensal bacteria communities on immune cell homeostasis
and 3) the functional consequences of commensal bacteria colonization for the
host, is incomplete and requires further investigation.
Most commensal bacteria in mammalian hosts are found in the lumen of
the GI tract and are physically separated from the intestinal epithelium. However,
some bacteria are able to bypass this physical barrier to colonize the surface of
intestinal epithelial cells (IECs). More recently, commensal bacteria signatures
were detected in the interior of intestinal-associated lymphoid tissues such as
1

Peyer’s patches and the mesenteric lymph node, suggesting that commensals
colonize these immune cell-rich sites previously thought to be devoid of bacteria.
Based on these findings, commensal bacteria can be classified by their
anatomical localization as i) luminal, ii) epithelial-associated or iii) lymphoid
tissue-resident. Most studies in the past decade have focused on how the host
pathways recognize and interact with luminal and epithelial-associated
commensal bacteria. However, much less is known about how lymphoid tissueresident commensal bacteria (LRC) colonize and interact with the host. The aim
of this thesis is to comprehensively investigate and define interactions between
LRCs and the host immune system. This Chapter will introduce our current
understanding of intestinal commensal bacteria anatomical localization in the
context of a healthy mammalian GI tract and during chronic inflammation. The
end of this Chapter will also introduce the role of iron homeostasis in hostmicrobe interactions and immune cell function. Chapter 2 will highlight the
cellular mechanisms by which LRCs gain access to and colonize intestinalassociated lymphoid tissues and characterize the immunological consequences
of LRC colonization. Further, Chapter 3 will investigate the role of LRC-induced
immune pathways on commensal bacteria colonization and tissue protection
during intestinal injury. Finally, Chapter 4 will explore the role of iron
homeostasis and the iron-regulatory hormone hepcidin in LRC colonization and
immune cell homeostasis.

2

1.1 Anatomical localization of intestinal commensal bacteria in the healthy
mammalian GI tract
The mammalian GI tract is colonized by trillions of beneficial microbes including
bacteria, fungi and viruses, which collectively influence host intestinal physiology.
Levels of commensal bacteria in the GI tract have been reported to be as high as
1014 organisms, with over 1000 different bacterial species represented (Backhed
et al., 2005; Ley et al., 2008; Ley et al., 2006; Turnbaugh et al., 2007; Xu et al.,
2007). Some of the most well characterized roles of commensal bacteria include
promoting efficient host nutrient absorption and protection from pathogen
colonization (Brestoff and Artis, 2013; Buffie and Pamer, 2013; Cani, 2014; Flint
et al., 2012; Kamada et al., 2013a; Musso et al., 2011). In addition, an expanding
body of literature has identified critical roles for commensal bacteria in the
development of the host immune system and maintenance of immune cell
homeostasis (Hooper et al., 2012; Ivanov and Honda, 2012).
In contrast to the ability of commensal bacteria to confer host-beneficial
properties, dysregulated interactions between commensal bacteria and the host
are associated with many chronic infectious, inflammatory and metabolic
diseases such as inflammatory bowel disease (IBD), chronic viral infection,
obesity, cancer and cardiovascular disease (Hooper et al., 2012; Kamada et al.,
2013b). Progression of disease in these settings has been proposed to occur
either by changes in the composition of the microbiota known as dysbiosis and/or
bacterial translocation (Blumberg and Powrie, 2012; Brenchley and Douek, 2012;
3

Brenchley et al., 2006; Henao-Mejia et al., 2012; Hooper et al., 2012; Kamada et
al., 2013b; Loh and Blaut, 2012; Manichanh et al., 2012; Wang et al., 2011).
Although many studies have identified and characterized dysbiosis during
disease, much less is known about the role of commensal bacteria localization in
disease development and pathogenesis.
The majority of our current knowledge on the role of the microbiota in
health and disease is derived from studies describing luminal commensal
bacteria. However, emerging studies suggest that, in the steady state, specific
commensal populations colonize distinct compartments of the intestine and
selectively alter immune cell homeostasis to provide host tissue protection. For
example, the Firmicutes phylum member Clostridium spp. was demonstrated to
colonize the lumen of the colon while the Bacteroidetes phylum member
Bacteroides fragilis was shown to colonize both the lumen and crypts of the colon
(Atarashi et al., 2013; Atarashi et al., 2011; Lee et al., 2013; Round et al., 2011;
Round and Mazmanian, 2010). In contrast, the gram-positive segmented
filamentous bacteria (SFB) colonize the intestine by adhering tightly to epithelial
cells of the terminal ileum in mice (Gaboriau-Routhiau et al., 2009; Ivanov et al.,
2009). These studies highlight that the anatomical localization of commensal
bacteria in the intestine can be categorized into at least two groups: (i) luminal
and (ii) epithelial-associated. More recently, additional studies have described
gut-associated lymphoid tissues as a novel and unexpected site for commensal
bacterial colonization in healthy mammals. These commensal species, herein
4

referred to as lymphoid tissue-resident commensal bacteria (LRC), were shown
to colonize the interior of Peyer’s patches (PPs) of healthy mice, primates and
humans (Kunisawa and Kiyono, 2012; Obata et al., 2010; Sato et al., 2013;
Sonnenberg et al., 2012). Despite our growing understanding of host-commensal
bacteria relationships, how these interactions are influenced by commensal
bacteria colonization in different compartments of the intestine is not well
understood. This Chapter will discuss how anatomically distinct commensal
populations, including (i) luminal, (ii) epithelial-associated or (iii) lymphoid tissueresident (Figure 1), are recognized by the immune system, influence immune cell
function and are anatomically restricted via host and bacterial intrinsic
mechanisms. Furthermore, this Chapter will review current literature on how
dysregulated commensal bacteria localization in mice and humans may
contribute to a variety of chronic inflammatory diseases.

1.1.1 Luminal commensal bacteria
Analyses of commensal bacteria composition in the mammalian GI tract have
mainly focused on 16S rDNA sequencing of luminal contents from the intestine.
In healthy mice, luminal commensal bacteria are largely represented by three
phyla: Bacteroidetes, Firmicutes and Proteobacteria. Within these groups,
approximately 70% are Bacteroidetes, 20% are Firmicutes and less than 2% are
Proteobacteria (Eckburg et al., 2005; Hill et al., 2010; Ley et al., 2005; Ley et al.,
2006). Consistent with the intestine being a hypoxic environment, most luminal
5

commensal bacteria, especially Bacteroidetes and Firmicutes members, are
obligate anaerobes (Colgan and Taylor, 2010; Glover and Colgan, 2011).
Furthermore, many of these bacteria are not culturable using current techniques
and have only been identified through 16S rDNA sequencing (2012; Salzman et
al., 2002). Using this technique to interrogate interactions between the host and
luminal commensal bacteria, an increasing body of data has revealed that
members of both Bacteroidetes and Firmicutes have profound roles in shaping
the host immune system.
The Bacteroidetes phylum is comprised predominantly of gram-negative,
rod-shaped, anaerobic bacteria. Within this phylum, the genus Bacteroides is
highly represented along the mammalian GI tract and has been reported to reach
as high as 1010 – 1011 organisms per gram of human feces (Wexler, 2007). Many
members of the Bacteroides genus including B. thetaiotaomicron and B. fragilis
are well adapted to thrive in the GI tract (Wexler, 2007) and have been described
to aid in host metabolism by processing complex polysaccharides into smaller
compounds for host absorption (Comstock, 2009). Studies interrogating the
interactions between Bacteroides and the host immune system have focused
primarily on one species, B. fragilis (Figure 2). An identifying feature of this
bacterium is the presence of a capsular polysaccharide complex composed of
eight capsular polysaccharides, of which polysaccharide A (PSA) is the most
highly expressed (Surana and Kasper, 2012). While PSA can elicit proinflammatory responses such as production of interleukin (IL)-12, tumor necrosis
6

factor alpha (TNFα) and interferon gamma (IFNγ) through recognition by
dendritic cells (DCs) (Surana and Kasper, 2012), it also has potent antiinflammatory properties and can stimulate interleukin (IL)-10-producing CD4+
Foxp3+ Tregs in the colon (Round and Mazmanian, 2010). Surprisingly, this
response was independent of antigen presenting cells (APCs) but dependent on
T cell recognition of PSA by Toll-like receptor (TLR) 2 (Round et al., 2011). In
mice, this immunomodulatory response was required for intestinal colonization by
B. fragilis and was associated with protection from experimental colitis (Round
and Mazmanian, 2010). B. fragilis could also produce glycosphingolipids that
inhibit invariant natural killer T (iNKT) cell proliferation, likely by interfering with
lipid loading on CD1d molecules (An et al., 2014). Functionally, modulation of
iNKT cell homeostasis in the colon by B. fragilis glycosphingolipids protected
mice from iNKT cell-mediated intestinal inflammation. In a separate report, it was
demonstrated that B. fragilis could produce immunostimulatory glycolipids that
bind CD1d and activate iNKT cells in mice and humans (Wieland Brown et al.,
2013), suggesting a dual role for Bacteroides glycolipids in regulating immune
cell homeostasis.
Patients with autism spectrum disorder (ASD) often present with GI
symptoms (Adams et al., 2011; Buie et al., 2010; Coury et al., 2012; Kohane et
al., 2012). In recent findings, B. fragilis was demonstrated to correct behavioral
abnormalities and restore increased intestinal permeability and altered luminal
commensal bacteria composition in a mouse model of ASD (Hsiao et al., 2013).
7

Notably, oral treatment with PSA-deficient B. fragilis or wild-type B.
thetaiotaomicron but not Enterococcus faecalis also improved anxiety-like,
repetitive and communicative behavior of mice with ASD, suggesting that host
protection by Bacteroides is not specific to B. fragilis. Furthermore, it was
demonstrated that oral treatment of ASD mice with B. fragilis could limit elevated
levels of the neurotoxic, commensal bacteria-derived serum metabolite 4ethylphenylsulfate. These findings suggest that Bacteroides play important roles
in host physiology beyond the intestine by modulating the metabolic activity of
other commensal bacteria.
Within the Firmicutes phylum, which is comprised of gram-positive, spore
forming, obligate anaerobes, the most studied group of commensal bacteria in
regard to modulation of immune cell function is the class Clostridia (Figure 2).
Similar, to B. fragilis, Clostridium spp. isolated from mouse and human feces can
promote the differentiation and function of CD4+ Foxp3+ Tregs in the mouse colon
and are sufficient to protect mice from experimental colitis (Atarashi et al., 2013;
Atarashi et al., 2011). Colonization of germ-free mice, which have enlarged ceca,
by chloroform-resistant Clostridium spp. resulted in significantly reduced cecum
size due to Clostridium-dependent fermentation of dietary fiber and production of
short-chain fatty acids (SCFAs) as metabolic by-products (Furusawa et al.,
2013). Consistent with the hypothesis that gut metabolism and immune cell
homeostasis are two related processes, optimal induction of colonic Treg
responses by Clostridium spp. was dependent on metabolism of dietary fiber and
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subsequent production of SCFAs (Arpaia et al., 2013; Atarashi et al., 2013;
Furusawa et al., 2013; Smith et al., 2013b).
The cellular and molecular mechanisms by which SCFAs influence
immune cell function have begun to be elucidated. SCFAs could directly promote
Treg immune-suppressive function through Treg-intrinsic expression of the SCFA
receptor, GPR43 (Smith et al., 2013b). Butyrate also promoted acetylation at the
Foxp3 locus and the Foxp3 protein (Arpaia et al., 2013; Furusawa et al., 2013),
which have been previously shown to enhance Foxp3 stability and function (van
Loosdregt et al., 2010; Zhang et al., 2012). Alternatively, butyrate and propionate
could function independently of Tregs by suppressing DC production of proinflammatory cytokines and augmenting their ability to induce peripheral Treg
differentiation (Arpaia et al., 2013). Furthermore, the SCFA butyrate was shown
to promote Tregs at extra-intestinal tissues such as the spleen and peripheral
lymph nodes (Arpaia et al., 2013). More recently, it was demonstrated that
sensing of SCFAs by the metabolite receptors GPR43 on non-hematopoietic
cells promote activation of the NLRP3 inflammasome and is critical for SCFAinduced host protection from intestinal inflammation and injury (Macia et al.,
2015). Collectively, bacteria from the genus Clostridium are prominent members
of the luminal microbiota that induce tissue protective, immunoregulatory
responses through production of microbial-derived metabolites.
Anatomical restriction of B. fragilis and Clostridium spp. to the lumen of
the intestine is dependent on the presence of physical and biochemical barriers
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that limit interactions of commensal bacteria with IECs and potential translocation
to the underlying connective tissues of the intestinal lamina propria (Figure 2).
Mucus, which is secreted by specialized epithelial cells known as goblet cells,
forms a dense gel-like layer on the apical surface of the intestinal epithelium and
is composed of mucin glycoproteins including the highly glycosylated mucin
MUC2 (Johansson et al., 2011). In the colon, mucus is organized into an inner
mucus layer, which is approximately 50 µm thick in mice and is firmly attached to
the surface of epithelial cells, and an outer non-epithelial attached layer, which is
approximately 100 µm thick in mice (Johansson et al., 2011). Luminal
commensal bacteria in the colon are restricted to either the lumen or the outer
mucus layer whereas the inner mucus is mostly devoid of commensal bacteria
with the exception of some epithelial-associated species (Johansson et al.,
2011), which will be discussed in the following section. Although B. fragilis
colonizes the lumen, it could bind intestinal mucins and was found within the
colon mucus layer of gnotobiotic mice dual-colonized with E. coli and B. fragilis
(Huang et al., 2011). These data are supported by the finding that in the distal
colon, members of Bacteroidales are found near the inner mucus layer while
Firmicutes are found more evenly distributed throughout the lumen (Earle et al.,
2015). In studies interrogating how the microbiota regulates mucus production
and integrity, it was demonstrated that the colon inner mucus layer of germ-free
mice was penetrable to bacteria-sized beads and that colonization of these mice
with feces from conventional animals restored mucus integrity and anatomical
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segregation of commensal bacteria from the epithelium at 6 weeks postcolonization (Johansson et al., 2015).
In the small intestine, the mucus layer, although much less defined than in
the colon, is about 50 µm thick in mice and also promotes physical separation
between most luminal commensal bacteria and the epithelium (Johansson et al.,
2011). In mice deficient in the mucin glycoprotein MUC2, physical separation
between commensal bacteria and the intestinal epithelium was lost resulting in
the development of spontaneous colitis (Shan et al., 2013; Van der Sluis et al.,
2006). It was described that MUC2 in the mucus layer of the small intestine also
actively participated in promoting immune tolerance to luminal antigens by
conditioning intestinal DCs (Shan et al., 2013). Recognition and uptake of MUC2
by DCs enhanced their expression of the immunoregulatory cytokines Il10, Tgfb1
and limited their ability to induce T cell proliferation and production of the
proinflammatory cytokine IFNγ (Shan et al., 2013). These data indicate that
mucus secretion is an important mechanism that restricts dissemination of
luminal commensal bacteria and supports immunological tolerance to luminal
commensal antigens.
In addition to mucus, antimicrobial peptides (AMPs) are small molecular
weight proteins secreted into the lumen of the intestine that limit colonization of
commensal bacteria and promote physical separation between commensal
bacteria and the intestinal epithelium. AMPs are produced by virtually all IECs
but the expression of a subset of AMPs such as the C-type lectin regenerating
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islet-derived protein 3γ (REGIIIγ) is enriched in specialized IECs such as Paneth
cells in the small intestine (Hooper et al., 2012). AMPs are concentrated to the
epithelial surface to limit apical attachment of commensal bacteria normally
restricted to the lumen (Vaishnava et al., 2011). It was also demonstrated that
production of REGIIIγ could be induced by TLR signaling, as IEC-intrinsic
deletion of Myd88 resulted in loss of commensal-epithelium segregation
(Vaishnava et al., 2011). Collectively, these data suggest that recognition of
commensal bacteria by TLRs initiates regulatory pathways that promote
anatomical restriction. Recently, it was shown that the REGIII family proteins
recognize and target commensal bacteria by binding to surface carbohydrates
and forming an oligomeric membrane-permeabilizing pore (Mukherjee et al.,
2014). The gram-negative bacteria-derived component lipopolysaccharide (LPS)
inhibited REGIIIα pore-forming activity, providing a mechanism by which REGIII
family proteins are bactericidal to gram-positive but not gram-negative bacteria.
Other AMPs such as lipocalin 2 and calprotectin (S100A8/9), which limit
microbial access to micronutrients such as zinc, manganese and iron, are likely
candidates that control the gram-negative commensal populations in the
intestinal lumen (Behnsen et al., 2014; Corbin et al., 2008; Diaz-Ochoa et al.,
2014; Kehl-Fie et al., 2011; Liu et al., 2012).
A third mechanism by which the host limits commensal attachment to the
epithelium is through secretory IgA. IgA is the most abundant immunoglobulin
produced in mammals and play a critical role in immune defense at the intestinal
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barrier surface. Induction of IgA in the intestine occurs predominantly in the PPs
and isolated lymphoid follicles (ILFs) of the small intestine and, similar to mucins
and AMPs, is highly dependent on the microbiota (Cerutti and Rescigno, 2008;
Macpherson et al., 2012; Macpherson et al., 2008). IgA secreted by plasma cells
in these tissues is covalently bound to the polymeric immunoglobulin receptor
(pIgR) and transported through IECs via intracellular vesicles. Once released into
the lumen, IgA restricts commensal bacteria from associating with the epithelium
by binding to the surface of bacteria and neutralizing their ability to trigger
inflammation (Cerutti and Rescigno, 2008; Macpherson et al., 2012). Micedeficient in pIgR displayed increased penetration of commensal bacteria to the
mesenteric lymph node (mLN) and systemic antibody responses to commensal
bacteria. IgA can be induced by both T-dependent and T-independent
mechanisms. While high affinity IgA from T-dependent pathways is important for
protection from mucosal pathogen colonization, low-affinity, polyreactive IgA from
T-independent pathways is generally necessary for confining commensal
bacteria to the intestinal lumen (Cerutti and Rescigno, 2008; Macpherson et al.,
2008). In support of a role for IgA in anatomical containment of commensal
bacteria to the intestinal lumen, it was shown that IgA selectively labels
colitogenic bacteria in the intestine such as members of Prevotellaceae,
Helicobacter and SFB and likely limits their ability to stimulate the host immune
system (Bunker et al., 2015; Palm et al., 2014). Interactions between the luminal
microbiota and IgA are likely reciprocal as varying IgA levels in the gut is in part a
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function of microbiota composition (Moon et al., 2015). Taken together, mucus,
AMPs and secretory IgA are three of the main host mechanisms that
cooperatively serve as important regulators that restrict commensal bacteria to
the lumen of the GI tract.

1.1.2 Epithelial-associated commensal bacteria
Although most commensal bacteria are restricted to the intestinal lumen, a small
fraction can penetrate the mucus layer and colonize the surface of IECs.
Sequencing of 16S rDNA on the surface of the intestinal epithelium has revealed
the presence of epithelial-associated commensal bacteria that include members
of the Bacteroidetes and Firmicutes phyla at levels of about 2-3 logs less than
those observed for luminal bacteria (Hill et al., 2010; Vaishnava et al., 2011). The
most notable example in mice is SFB, a member of the Firmicutes phylum, which
colonizes and attaches to IECs of the terminal ileum (Gaboriau-Routhiau et al.,
2009; Ivanov et al., 2009). Colonization of mice with SFB results in elevated
Th17 cell responses in the small intestine lamina propria, which are associated
with both intestinal tissue protection from mucosal pathogen infection and
susceptibility to mouse models of autoimmune arthritis and multiple sclerosis
(Lee et al., 2011; Wu et al., 2010). Recent studies addressing the mechanisms
by which SFB induces Th17 cells demonstrated that a diverse array of cellular
and molecular pathways are involved. Host-specific attachment to IECs by SFB
was necessary for the generation of Th17 cell responses as they were induced in
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mice only following colonization with mouse but not rat SFB (Atarashi et al.,
2015). In additional studies, it was demonstrated that local induction of Th17
responses in the lamina propria was dependent on epithelial cell production of
serum amyloid proteins 1 and 2 (SAA1/2) (Ivanov et al., 2009; Sano et al., 2015).
SFB stimulated production of IL-22 by innate lymphoid cells (ILCs), which
activates epithelial STAT3 to promote SAA1/2 (Sano et al., 2015). Therefore,
SFB is an epithelial-associated commensal bacterium that elicits selective
immune responses beneath the intestinal epithelium.
Direct recognition of SFB is likely mediated by lamina propria
mononuclear phagocytes (MNPs) that actively sample bacteria in the intestinal
lumen (Figure 3). Subsets of lamina propria MNPs that express the fractalkine
receptor CX3CR1 have been shown to sample antigens by extending
transepithelial dendrites across the intestinal epithelium (Niess et al., 2005;
Rescigno et al., 2001). Although these phagocytes are believed to be nonmigratory and only stimulate local mucosal immune responses, one report
suggests that they could carry commensal bacteria antigens to the mLN to
stimulate both T cell and IgA responses (Diehl et al., 2013). Migration of
CX3CR1-expressing cells to the mLN and subsequent mucosal immune
responses were regulated by MYD88-dependent recognition of commensal
bacteria (Diehl et al., 2013). In contrast, it was recently demonstrated that
CX3CR1+ cells in the small intestine can acquire and transfer soluble antigens via
the gap junction protein Connexin 43 to CD103+ DCs, which then migrate to
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draining lymph nodes to induce antigen-specific T cell responses (Mazzini et al.,
2014). In recent studies, however, it was recently shown that intestinal CX3CR1+
but not CD103+ mononuclear phagocytes are responsible for antigen-specific
Th17 cell induction by SFB (Panea et al., 2015). Although further investigation is
necessary to delineate the precise contribution of MNPs to recognition of
epithelial-associated commensal bacteria, it can be concluded that generation of
immune cell responses by these bacteria collectively requires lamina propria
phagocytes that actively sample bacteria attached to the intestinal epithelium.
Similar to their functions in regulating luminal commensal bacteria, host
mechanisms such as AMPs and IgA are critical regulators of epithelialassociated commensal bacteria. Consistent with the specificity of REGIIIγ for
gram-positive

bacteria,

REGIIIγ

downstream

of

MYD88

signaling

was

demonstrated to restrict expansion of SFB on the epithelial surface as Reg3gdeficient mice had increased epithelial colonization of SFB and another epithelialassociated bacterium Eubacterium rectale in the small intestine (Vaishnava et al.,
2011). Increased commensal colonization at intestinal epithelial surfaces due to
loss of REGIIIγ resulted in increased frequencies of lamina propria T helper 1
(Th1) but not Th17 cells. Since total levels of SFB were not altered in Reg3gdeficient mice, these data suggest that dysregulated epithelial colonization by
SFB may skew CD4 T cells towards a Th1 cell response. A role for AMPs in
restricting colonization of epithelial-associated commensal bacteria was also
demonstrated in mice ectopically expressing the human α-defensin gene Defa5
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(Salzman et al., 2010). Analyses of the microbiota composition in the distal small
intestine of these mice demonstrated that while the amount of total bacteria was
similar to littermate controls, Defa5-transgenic (Defa5-Tg) mice had significantly
reduced colonization of SFB. In support of a role for AMPs in regulating
epithelial-associated bacterial species, cytokine responses that promote AMP
expression, such as IL-22, were recently demonstrated to suppress SFB
colonization (Qiu et al., 2013; Upadhyay et al., 2012). In addition, pathways and
molecules associated with IL-22 production in the intestine, such as the aryl
hydrocarbon receptor (Ahr) and RORγt+ ILC responses also direct commensal
colonization of the intestinal epithelial surface (Qiu et al., 2013). Ahr-deficient
mice, which have reduced RORγt+ ILCs, demonstrated expansion of SFB and
increased small intestine Th17 cells (Qiu et al., 2013). Finally, IgA is also
involved in restricting colonization by SFB as demonstrated by expansion of this
commensal bacterium in the feces of Iga-deficient mice (Suzuki et al., 2004).
Collectively, these data highlight a critical role for these biochemical and cellular
mechanisms in regulating colonization of SFB on the intestinal epithelial surface.
Commensal bacteria that are found in the lumen of the intestine can also
be epithelial-associated. Electron microscopy (EM) and immunofluorescence
revealed that B. fragilis could penetrate the inner mucus layer and colonize the
crypts of the large intestine. This was demonstrated to be dependent on both
host-derived and bacterial-intrinsic factors. Colonic crypt colonization by B.
fragilis was dependent on induction of Tregs by PSA (Round et al., 2011). In a
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follow-up study by the same group, it was shown that expression of commensal
(ccf) genes by B. fragilis could promote colonization of the bacteria at colonic
crypts (Lee et al., 2013). It was hypothesized that host-derived glycan structures
could induce the expression of ccf genes, consistent with the dependence of
Bacteroides spp. on host-derived carbohydrates for intestinal colonization and
survival (Wexler, 2007). It has also been reported that B. fragilis, although an
anaerobe, can tolerate and benefit from nanomolar concentrations of oxygen,
which is higher at the epithelial surface relative to the lumen of the intestine
(Baughn and Malamy, 2004). Additionally, although Clostridium spp. typically
reside in the intestinal lumen, EM analysis of the colon of Clostridium spp.
colonized mice also demonstrated their presence on the epithelial surface
(Atarashi et al., 2013). In support of a role for Clostridium spp. in modulating
epithelial cell responses, cecal extracts from Clostridium-colonized mice could
induce primary IECs to produce the Treg-inducing cytokine TGF-β (Atarashi et
al., 2013). Taken together, these data suggest that commensal bacteria-elicited
immune responses and commensal bacteria-intrinsic factors cooperatively permit
stable intestinal colonization by epithelial-associated commensal bacteria.
Further analyses are required to determine whether the immune cell responses
promoted by Bacteroides and Clostridia members are associated with their
localization in either the lumen or the epithelial surface. Chapter 2 of this thesis
will compare tissue-specific immune responses induced by epithelial-associated
commensal bacteria versus LRCs.
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1.1.3 Lymphoid tissue-resident commensal bacteria
Tissues beyond the intestinal epithelium are not typically thought of as sites for
commensal bacteria colonization. Although pathogens can penetrate the
intestinal epithelium, evade macrophage killing and in some cases thrive in
intestinal tissues, commensal bacteria that breach the intestinal barrier are
typically phagocytosed and cleared by lamina propria macrophages (Macpherson
and Harris, 2004; Smith et al., 2011; Varol et al., 2010). However, recent data
provided evidence that some commensal species could stably colonize the
interior of gut-associated lymphoid tissues such as PPs and mLN of healthy mice
and humans (Obata et al., 2010; Sonnenberg et al., 2012) (Figure 4). In a
seminal study by Kiyono and colleagues, sequencing of 16S rDNA in the interior
of intestinal lymphoid tissues revealed the presence of specific groups of
commensal bacteria including Alcaligenes spp., Ochrobactrum spp., Serratia
spp. and Burkholderia spp. Alcaligenes spp. represented the most abundant
lymphoid tissue-resident commensal in the PPs. It was observed that 16S rDNA
of some of these bacteria were detected in the PP DCs of healthy mice,
suggesting the possibility of intracellular survival in DCs. These data support a
hypothesis

in

which

lymphoid

tissue-resident

commensal

bacteria

can

preferentially access host lymphoid tissues and evade clearance by host immune
cells. Indeed, Alcaligenes spp. can be transcytosed by specialized IECs known
as M cells from the lumen of the small intestine to PPs (Sato et al., 2013).
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It is interesting to note that all of the lymphoid tissue-resident species
identified so far are also aerobic, environmental microbes, resistant to a broad
spectrum of antibiotics and associated with opportunistic nosocomial infections,
particularly in the respiratory tract (Amoureux et al., 2013; Chain et al., 2011;
Davies and Rubin, 2007; Mahenthiralingam et al., 2008). Some of these species,
such as Burkholderia spp. and Serratia spp. are well adapted to survive on
inanimate surfaces and also in host cells (Fedrigo et al., 2011; Valvano et al.,
2005). Whether these features are related to their unique colonization pattern in
the intestine is not well understood and requires further investigation. However,
analyses in Alcaligenes-colonized mice demonstrated that Alcaligenes spp. is
sufficient to promote robust Alcaligenes-specific and non-Alcaligenes-specific IgA
(Obata et al., 2010). Furthermore, B cell-deficient CBA/N xid and Iga-deficient
mice had reduced numbers of Alcaligenes spp. in the PP. These data suggest
that in contrast to luminal and epithelial-associated commensal bacteria, which
are restricted by IgA, optimal colonization by Alcaligenes spp. is dependent on
IgA-producing B cells (Obata et al., 2010). Consistent with the notion that
mucosal DCs are restricted from migrating beyond the mLN to systemic lymphoid
tissues (Macpherson and Uhr, 2004), Alcaligenes-specific IgG responses were
not detected in the periphery of Alcaligenes-colonized mice (Obata et al., 2010).
Recently, anatomical containment of the lymphoid tissue-residentcommensal

bacteria

Alcaligenes

xylosoxidans

(also

referred

to

as

Achromobacter xylosoxidans) was demonstrated to be dependent on IL-22
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produced by RORγt+ ILCs (Sonnenberg et al., 2012) (Figure 4). Rag1-deficient
mice depleted of ILCs experienced low-grade systemic inflammation that was
associated with dissemination of Alcaligenes spp. to the liver, spleen and blood
(Sonnenberg et al., 2012). Administration of IL-22 or the AMP calprotectin to ILCdepleted Rag1-deficient mice partially restored anatomical containment of
Alcaligenes xyloxidans, suggesting a role for IL-22-induced factors such as
AMPs in restricting Alcaligenes to intestinal lymphoid tissues (Sonnenberg et al.,
2012). More recently, it was revealed that secretory IgA from breast milk could
restrict translocation of Ochrobactrum anthropi from the neonatal gut to the
draining lymph node (Rogier et al., 2014), suggesting a role for IgA in anatomical
containment of other lymphoid tissue-resident commensal bacteria. These data
provide potential mechanisms for anatomical containment of LRCs and also
highlight that dysregulated localization of normally beneficial commensal bacteria
can promote pathological inflammation, a condition often associated with human
chronic inflammatory diseases. This idea will be discussed further in the following
section. However, despite these advances, lymphoid tissue-resident commensal
bacteria are still the least understood class of bacteria that colonize the intestine.
Studies in Chapter 2 and 3 will interrogate the functional significance of LRC
colonization in the context of immune cell homeostasis and intestinal injury.
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1.2 Anatomical localization of intestinal commensal bacteria during chronic
inflammatory diseases
Analyses of the composition and localization of the human and mouse microbiota
have established that in some contexts, commensal bacteria can promote
chronic inflammatory disease through dysbiosis and/or bacterial translocation
(Hooper et al., 2012; Kamada et al., 2013b). Most studies thus far have focused
on how changes in the composition of the luminal microbiota can influence the
development of disease. For example, IBD and obesity were associated with a
dysbiotic microbiota that was sufficient to transfer disease to healthy hosts
following cohousing or fecal transfer (Garrett et al., 2007; Vijay-Kumar et al.,
2010). The role of dysbiosis in other chronic diseases such as AIDS and cancer
has been extensively reviewed elsewhere (Cho and Blaser, 2012; Elinav et al.,
2013; Ivanov and Honda, 2012; Kaur et al., 2011; Manichanh et al., 2012;
Pflughoeft and Versalovic, 2012; Schwabe and Jobin, 2013). Alternatively,
prebiotic and probiotic administration of beneficial microbes have been reported
to promote intestinal health and limit pathologic inflammation (Bron et al., 2012;
Lebeer et al., 2010). However, an emerging theme of the studies performed in
the last decade is that dysregulated localization, not just dysbiosis, of normally
beneficial commensal bacteria can be detrimental to the host and is often a major
contributing factor to the development and pathogenesis of chronic inflammatory
diseases. Chronic viral infections, IBD, metabolic syndromes and cancer have all
been associated with dysregulated localization of commensal bacteria. The
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following sections will highlight disease settings where anatomical restriction of
luminal, epithelial-associated and lymphoid tissue-resident commensal bacteria
is disrupted and may contribute to chronic inflammatory disease.

1.2.1 Chronic viral infections
Chronic viral infections are strongly associated with the loss of intestinal barrier
function, commensal bacteria translocation to peripheral tissues and induction of
systemic inflammation in humans (Ancuta et al., 2008; Balagopal et al., 2008;
Brenchley et al., 2006; Jiang et al., 2009; Redd et al., 2009). A seminal finding by
Douek and colleagues demonstrated that patients chronically infected with HIV,
and those that have progressed to AIDS, exhibit elevated plasma LPS levels,
suggesting that translocation of gram-negative bacteria components or whole
gram-negative bacteria occurs in these diseases (Ancuta et al., 2008; Brenchley
et al., 2006). Consistent with elevated plasma LPS, the peripheral blood of AIDS
patients exhibited signs of systemic immune activation such as the presence of
elevated serum IFNα, activated monocytes and activated circulating CD8+ T
cells, hallmarks that contribute to viral replication, dissemination and disease
progression (Ancuta et al., 2008; Brenchley et al., 2006; Marchetti et al., 2008).
Interestingly, SIV-infected sooty mangabeys, which are natural hosts of SIV that
do not develop AIDS, did not exhibit loss of intestinal barrier function, bacterial
translocation

or

systemic

inflammation

(Estes

et

al.,

2010).

Bacterial

translocation has been observed in other chronic viral infections such as HCV
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and HBV. Patients infected with HCV and HBV had elevated plasma LPS, which
was associated with parameters of systemic immune activation such as elevated
serum levels of the TLR4-co-receptor CD14 and IL-6 (Sandler et al., 2011).
Taken together, these data suggest that loss of anatomical restriction of gramnegative commensal bacteria-derived products contribute to the pathogenesis of
chronic viral infections.
Although it remains unclear whether whole commensal bacteria are found
in the periphery of these patients or which commensal species promote disease
progression, recent studies suggest that HIV and HCV-infected patients have
elevated serum IgG responses to the lymphoid tissue-resident commensal
bacteria Alcaligenes (Sonnenberg et al., 2012; Tatro et al., 2014). In support of a
role for these bacteria in disease pathogenesis and systemic inflammation, levels
of Alcaligenes/Achromobacter-specific IgG were associated with hallmarks of
AIDS such as reduced CD4+ T cell counts and increased proportion of activated
CD4+ T cells, and parameters of HCV progression including increased serum
bilirubin and decreased serum albumin and platelets. Potential translocation of
Achromobacter/Alcaligenes members in HIV-infected patients agrees with
previous reports that Burkholderiales 16S rDNA, which includes the genus
Achromobacter and Alcaligenes, was present in the peripheral blood of some
patients (Merlini et al., 2011). Other groups of bacteria such as members of the
orders Enterobacteriales, Lactobacillales and Pseudomonadales were also
identified in the serum of these patients. Altogether, these data suggest that HIV
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infection is strongly associated with dysregulated anatomical localization of
various commensal bacterial communities.
Loss of cellular pathways that promote intestinal epithelial barrier function
may also contribute to bacterial translocation observed in chronic HIV and HCV
infection. RORγt+ ILCs, which are potent sources of IL-17 and IL-22, and the
CD103+ immunoregulatory DCs were found to be dramatically reduced in SIV
infection (Klatt et al., 2012; Li and Reeves, 2012; Xu et al., 2012). More recently,
it was demonstrated that ILC3s are irreversibly depleted during acute HIV
infection (Kloverpris et al., 2016; Zhang et al., 2015). These data are consistent
with the role of RORγt+ ILCs in regulating the anatomical containment of SFB
and LRCs (Qiu et al., 2013; Sonnenberg et al., 2012). Given that antiretroviral
therapy is inadequate to completely control bacterial translocation (Merlini et al.,
2011), further work is required to define the pathways that regulate intestinal
barrier integrity and systemic inflammation in chronic viral infections. It is also
important to highlight that patients with chronic viral infections often exhibit
intestinal, metabolic and cardiovascular symptoms, which have all been
associated with dysregulated localization of commensal bacteria (Gandhi et al.,
2012; Keating et al., 1995; Samaras et al., 2007; Sheikh et al., 2008). Therefore,
it is possible that bacterial translocation observed in HIV and HCV patients may
be related to the onset of these diseases.
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1.2.2 Inflammatory bowel disease
IBD, which includes Crohn’s disease (CD) and ulcerative colitis (UC), is strongly
associated with dysregulated localization of commensal bacteria in humans. It is
well documented that dysregulated host-commensal bacteria interactions, as
indicated by parameters such as elevated serum LPS and bacterial DNA, play a
major role in the pathogenesis of IBD by promoting inappropriate immune
activation and chronic inflammation (Brenchley and Douek, 2012; Gardiner et al.,
1995; Gutierrez et al., 2009; Lakatos et al., 2011; Obermeier et al., 2005).
Changes in localization of commensal bacteria in IBD have been observed in the
form of both bacterial translocation and increased bacterial colonization on the
surface of the intestinal epithelium. Studies have implicated a role for increased
colonization of the ileum by an adherent-invasive strain of Escherichia coli
(AIEC). The predominance of AIEC epithelial colonization was demonstrated to
contribute to chronic inflammation and immunopathology in human IBD
(Darfeuille-Michaud et al., 2004; Lee et al., 2011; Small et al., 2013). To analyze
the composition of disseminated commensal bacteria in gut-associated lymphoid
tissues, one recent report identified that Escherichia and Shigella were enriched
in the mLN of CD patients (O'Brien et al., 2014; Small et al., 2013). Similar
findings were reported by a study that sequenced 16S rDNA from microdissected intestinal biopsies. Facultative anaerobes such as Enterobacteriaceae
were enriched in micro-dissected ulcer biopsies of CD patients (De Hertogh et
al., 2006). Collectively, these data suggest that increased epithelial and lymphoid
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tissue colonization by commensal bacteria are hallmarks of and may contribute
to the pathogenesis of IBD. To further investigate bacterial translocation to extraintestinal sites in IBD, one study identified the presence of Enterococcus faecalis,
a common member of the luminal flora, in the visceral fat of UC and CD patients
(Zulian et al., 2013). In addition, it was recently demonstrated that pediatric CD
patients exhibit increased serum IgG specific for Alcaligenes spp. (Sonnenberg
et al., 2012), suggesting that impaired localization and systemic dissemination of
LRCs is also associated with disease pathogenesis. Studies in Chapter 3 of this
thesis will directly interrogate the role of LRC colonization in a mouse model of
acute intestinal injury.
While it is unclear whether translocation of commensal bacteria is the
cause or effect of IBD, several genetic polymorphisms in genes involved in hostmicrobial interactions are strongly associated with IBD (Jostins et al., 2012).
Among these, the most prevalent are polymorphisms in Atg16l1, Il23r, Nod2 and
Il10r (Cho, 2008; Gutierrez et al., 2014). ATG16L1, a component of the
autophagy machinery, is involved in intracellular degradation of bacteria (Cadwell
et al., 2008). IL-23R is expressed on innate and adaptive immune cells that
promote immunity to intestinal pathogens and maintain intestinal barrier function
(Duerr et al., 2006). NOD2 is a pattern recognition receptor (PRR) that
recognizes peptidoglycan from bacteria and triggers anti-bacterial immune
responses (Cho and Abraham, 2007). IL-10 is a potent anti-inflammatory
cytokine produced by innate and adaptive immune cells that maintain tissue
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homeostasis by suppressing pro-inflammatory responses (Saraiva and O'Garra,
2010; Shah et al., 2012). Therefore, loss of function mutations in these genes
may contribute to enhanced bacterial translocation and intestinal inflammation.

1.2.3 Metabolic diseases
Diabetes and obesity were two of the first extra-intestinal diseases to be
associated with commensal bacteria-derived chronic inflammation (Ley et al.,
2005; Ley et al., 2006; Turnbaugh et al., 2006). In a mouse model of diet-induced
obesity, mice fed a high-fat diet (HFD) for four weeks had increased
concentrations of bacterial DNA and LPS in the blood, mesenteric adipose tissue
and mLN as well as increased adherence of commensal bacteria to the intestinal
epithelium (Amar et al., 2011; Cani et al., 2007). Analysis of translocated bacteria
species in the mesenteric adipose tissue identified members of the family
Enterobacteriaceae and Enterococcus spp. and Lactobacillus spp. (Amar et al.,
2011), which are commensal bacteria commonly found in the lumen of the
intestine. Translocation of commensal bacteria was associated with a loss of
intestinal barrier integrity (Amar et al., 2011), increased levels of IL-1, IL-6 and
TNFα in adipose depots and the onset of diabetes. Many of these parameters
were markedly reduced in HFD-fed mice lacking the intracellular PRR Nod1
(Amar et al., 2011; Shi et al., 2006), TLR4 (Shi et al., 2006) or the TLR4-coreceptor CD14 (Amar et al., 2011; Cani et al., 2007), suggesting that recognition
of translocated commensal bacteria can drive tissue inflammation and disease
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pathology. In support of these findings, repeated subcutaneous injections of LPS
to mice fed a normal chow (NC) was sufficient to recapitulate many of the
diabetic symptoms observed in mice fed a HFD (Cani et al., 2007). Altogether,
these findings indicate that impaired anatomical localization is a hallmark and
significant contributor of diet-induced obesity.
Obesity is associated with significant changes in the composition of the
luminal microbiota. For example, mice deficient in TLR5 are highly susceptible to
diet-induced obesity, which was associated with a dysbiotic microbiota that could
confer disease to wild-type germ-free mice following fecal transfer (Vijay-Kumar
et al., 2010). In contrast, mice deficient in lymphotoxin β signaling are resistant to
diet-induced obesity, and cecal contents from HFD-fed lymphotoxin β receptor
(Ltbr)-deficient mice were less efficient in promoting weight gain in wild-type
germ-free recipients compared to cecal contents from HFD-fed wild-type mice
(Upadhyay et al., 2012). Interestingly, normal chow diet (NCD)-fed Ltbr-deficient
mice, which lacked IL-23 and IL-22, demonstrated increased colonization by
SFB. Whereas SFB levels were reduced in HFD-fed wild-type, SFB levels in
HFD-fed Ltbr-deficient mice remained high relative to wild-type controls.
Furthermore, administration of IL-22 or IL-23-Ig restored HFD-induced changes
in SFB and obesity in Ltbr-deficient mice. Although bacterial translocation was
not analyzed in these studies, it is interesting to speculate that specific groups of
commensal bacteria that promote or limit disease are more or less likely,
respectively, to disseminate to adipose depots and subsequently trigger chronic
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inflammation. Nevertheless, these data support the hypothesis that specific
immune pathways and/or commensal bacteria communities can promote (e.g.
LTβ signaling, Enterobacteriaceae) or limit (e.g. TLR5, SFB) the development of
obesity.
Other metabolic diseases are also associated with dysbiosis and loss of
normal localization of commensal bacteria in the intestine. For example, plasma
LPS levels are significantly elevated in patients with chronic hepatitis, alcoholic
and non-alcoholic liver disease and have been associated with severe liver
dysfunction (Garcia-Alvarez et al., 2012; Lin et al., 1995; Wiest et al., 2014). In a
mouse model of non-alcoholic fatty liver disease (NAFLD), it was demonstrated
that a dysbiotic microbiota in inflammasome-deficient mice could promote hepatic
steatosis and Tnf expression due to translocation of TLR4 and TLR9 agonists
through the portal circulation to the liver (Henao-Mejia et al., 2012). Although
translocation of intact bacteria was not detected in the portal vein or liver, these
data suggest that translocation of commensal-derived products alone to extraintestinal sites can promote immune activation and tissue pathology in this
mouse model of liver disease. More recently, it was shown that emulsifiers
commonly found in processed foods disrupt the mucus barrier on the surface of
the intestinal epithelium and result in altered microbiota composition on the
surface of the intestinal epithelium (Chassaing et al., 2015). These changes were
associated with the development of metabolic disease, which could be
recapitulated by transfer of the altered microbiota to germ-free mice. Collectively,
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a disturbance of metabolic homeostasis is often associated with changes in
anatomical localization of commensal bacteria.

1.2.4 Cardiovascular diseases
An increasing body of literature has revealed that the inflammatory and metabolic
effects of the gut microbiota contribute to the development and pathogenesis of
cardiovascular diseases (Libby, 2002, 2006). Several studies have identified
changes in the composition of luminal commensal bacteria and investigated the
mechanisms by which commensal-dependent metabolic pathways can impact
disease. In one study, fecal microbiota analyses of healthy controls and
atherosclerosis patients demonstrated a selective enrichment of the genus
Collinsella and reduction in the genus Eubacterium and Roseburia in patients
(Karlsson et al., 2012). By measuring the metabolic activity of the luminal
microbiota, it was determined that the microbiota of healthy controls was
enriched for genes involved in the synthesis of anti-inflammatory and anti-oxidant
compounds whereas the microbiota of atherosclerosis patients was enriched for
genes in the peptidoglycan biosynthesis pathway. These data suggest that
changes in composition of luminal commensal bacteria can alter the
inflammatory and metabolic status of the host to promote atherosclerosis. In
addition, a separate study demonstrated that increased levels of the commensaldependent dietary metabolite, trimethylamine-N-oxide (TMAO), were associated
with an increased risk of adverse cardiovascular events (Tang et al., 2013). This
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is supported by studies in which metabolism of the dietary metabolite L-carnitine,
which is abundant in red meat, produces TMAO and accelerates onset of
atherosclerosis (Koeth et al., 2013). Taken together, these findings establish a
link between luminal commensal bacteria, metabolism and atherosclerosis.
Despite these findings, much less is known about the role of disrupted
anatomical localization of commensal bacteria in cardiovascular disease.
However, one study sequenced 16S rDNA from atherosclerotic plaques of
human patients and demonstrated the presence of bacteria that are normal
inhabitants of the intestinal lumen including members of the Bacteroidaceae,
Enterobacteriaceae and Lachnospiraceae families (Koren et al., 2011). These
data suggest that dissemination of commensal bacteria or commensal bacteriaderived products to the circulation may be associated with the development and
pathogenesis of atherosclerosis. However, additional studies are necessary to
interrogate the origin, cause and contribution of commensal bacteria in
atherosclerotic plaques.

1.2.5 Cancer
As previously discussed, translocation of commensal bacteria is commonly
observed in chronic liver diseases and can contribute to liver fibrosis and
cirrhosis (Garcia-Alvarez et al., 2012; Lin et al., 1995; Wiest et al., 2014).
Hepatocellular carcinoma (HCC) is a leading cause of death in patients who
develop fibrotic and cirrhotic livers due to chronic inflammation. In support of the
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hypothesis that bacterial translocation promotes liver tumor development, Tlr4deficient mice, germ-free mice and mice treated with oral antibiotics were
protected from hepatocarcinogenesis in a mouse model of chronic liver injury
(Dapito et al., 2012). This is consistent with a previous report demonstrating that
LPS-induced liver fibrosis was reduced in Myd88-deficient mice and that hepatic
satellite cells is the dominant target by which TLR4 ligands promote liver fibrosis
(Seki et al., 2007). Another cancer associated with dysregulated anatomical
localization of commensal bacteria is colorectal cancer (CRC). Bacterial
translocation has been observed in the mLN and serum of CRC patients (Chin et
al., 2007; Klein et al., 2013; Lescut et al., 1990). These patients also exhibited
cachexia and elevated serum pro-inflammatory cytokine levels and had a poor
prognosis. However, studies on specific groups of commensal bacteria that
disseminate in human colon cancer are limited. Fusobacterium nucleatum, a rare
member of the human intestinal microbiota, was demonstrated to be strongly
associated with human colorectal carcinoma and was found to be enriched in
human colonic adenomas (Kostic et al., 2013). In contrast to commensal bacteria
such as the enterotoxigenic B. fragilis and AIEC which promote colitis-associated
cancer (Arthur et al., 2012; Wu et al., 2009), F. nucleatum did not promote colitis
in mice, but rather increased tumor multiplicity, recruited tumor-promoting
myeloid cells and generated a pro-inflammatory environment that favored tumor
development. Since F. nucleatum was also enriched in the fecal microbiota of
CRC patients, it is likely that increased luminal burden of F. nucleatum
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contributes to the accumulation of this bacterium in colonic adenomas. Response
to chemotherapy and immunotherapy was recently demonstrated to be
dependent on anatomical localization of the microbiota. In contrast to the role for
F. nucleatum in promoting colon adenomas, cyclophosphamide chemotherapy
commonly used for solid malignancies injures the small intestine, which results in
bacterial translocation and activation of anti-tumor CD4 T cell responses (Viaud
et al., 2013). In a separate study, treatment with the chemotherapeutic agent
oxaliplatin activated the immune system that was dependent on microbiota
priming of myeloid cells and reactive oxygen species production (Iida et al.,
2013). More recently, two studies demonstrated that the efficacy of cancer
immunotherapy via checkpoint inhibitors required the presence of a complete
microbiota (Sivan et al., 2015; Vetizou et al., 2015). However, whether the
chemotherapeutic agent oxaliplatin and cancer immunotherapies promote antitumor immunity by altering localization of commensal microbes is not known.
Future investigations should determine how dysregulated commensal bacteria
localization can promote or limit cancer development.

1.3 Iron homeostasis in health and disease
Iron is an essential nutrient for the survival of all living organisms. In humans,
iron is absorbed from the diet through enterocytes in the duodenum, which is
then redistributed to the rest of the body in the form of intracellular and
extracellular iron stores. Because iron is a critical element for many human
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biological processes, its uptake, storage and transport are tightly regulated by
multiple molecular mechanisms. Central to this iron-regulatory network is the
hormone hepcidin (Figure 5). Hepcidin is a 25-amino acid peptide that is
expressed and secreted primarily by liver hepatocytes. It binds to and results in
the degradation of the iron exporter ferroportin, a membrane-bound protein that
is expressed on duodenal enterocytes and reticuloendothelial cells such as
macrophages (Nemeth et al., 2004b; Zhang et al., 2011). As a result, hepcidinferroportin interactions inhibit iron uptake through the intestine and promote iron
sequestration in macrophages (Figure 6). To maintain homeostatic levels of
intracellular and extracellular iron, hepcidin expression is regulated by numerous
factors including plasma iron levels, inflammatory signals and erythropoiesis
(Kautz et al., 2014; Nemeth et al., 2004a). Consistent with a role for iron in the
survival and proliferation of microorganisms including pathogens, multiple studies
support the hypothesis that hepcidin-mediated iron regulation is a critical host
pathway to limit pathogen infection (Cassat and Skaar, 2013; Drakesmith and
Prentice, 2012; Ganz and Nemeth, 2015). However, whether hepcidin-mediated
iron regulation controls host-commensal bacteria interactions and the immunity
system is not well understood. The following sections will explore the role of
hepcidin and iron homeostasis in the context of host-microbe interactions and
immune cell function.
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1.3.1 Role of iron homeostasis and hepcidin in host-pathogen interactions
During inflammation, hepcidin is upregulated and subsequent hepcidinferroportin interactions result in a reduction in plasma iron levels via inhibition of
iron uptake and sequestration of iron within reticuloendothelial cells (Nemeth et
al., 2004b). Since most microbial pathogens trigger inflammatory immune
responses and require iron for survival, hepcidin-mediated hypoferraemia has
been proposed to be a host-protective response to limit pathogen proliferation
(Cassat and Skaar, 2013; Drakesmith and Prentice, 2012; Ganz and Nemeth,
2015). Indeed, hepcidin-deficient mice are susceptible to infections caused by
Gram-negative bacteria such as Vibrio vulnificus and Yersina enterocolitica
(Arezes et al., 2015; Quenee et al., 2012). Hepcidin-deficient mice treated with
hepcidin agonists that induce hypoferraemia were rescued from infection-induced
mortality, suggesting that hepcidin alone is sufficient to provide host protection
(Arezes et al., 2015). Furthermore, sera from hepcidin-deficient mice supported
in vitro growth of V. vulnificus to a greater extent than sera from wild-type mice,
suggesting that the susceptibility of hepcidin-deficient mice to infection is due to
elevated systemic iron. Collectively, these data support the hypothesis that
hepcidin-mediated plasma iron reduction acts to limit the bioavailability of iron to
invading extracellular pathogens.
Since some pathogens infect the host by colonizing the intracellular
compartment

of

host

cells

such

as

macrophages,

hepcidin-mediated

sequestration of intracellular iron may actually promote infection by these
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intracellular pathogens (Figure 6). Indeed, studies in mouse models revealed that
macrophages from hepcidin-deficient mice are unable to support the growth of
intracellular microbes such as Mycobacteria tuberculosis and Salmonella
enterica serovar enterica Tyhimurium (Nairz et al., 2009; Olakanmi et al., 2007).
Therefore, although hepcidin may serve to restrict infection by extracellular
pathogens, re-distribution of intracellular versus extracellular iron by hepcidin
may promote the survival of pathogens that thrive within host cells. Collectively,
these data suggest that dysregulated iron homeostasis is associated with altered
susceptibility to infectious disease. However, more studies are necessary to
define the role of hepcidin-mediated iron regulation in host protection from
extracellular versus intracellular microbial pathogens. Chapter 4 of this thesis will
investigate the role of hepcidin in the generation of anti-microbial immune
responses by innate and adaptive immune cells.

1.3.2 Role of iron homeostasis in host-commensal bacteria interactions
The host GI tract is colonized with trillions of microbes that provide multiple
beneficial functions. Similar to humans and microbial pathogens, many of these
microbes depend on iron for their survival and persistence in the host. Therefore,
the iron-regulatory hormone hepcidin could be a critical regulator of hostcommensal bacteria relationships. In support of this hypothesis, a recent study
reported that regulation of liver hepcidin expression during acute intestinal
inflammation is dependent on the immune environment and composition of the
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intestinal microbiota (Shanmugam et al., 2014). During DSS-induced intestinal
injury, wild-type mice downregulated expression of liver hepcidin whereas Il10-/mice, which are susceptible to intestinal inflammation, upregulated expression of
liver hepcidin. Differential regulation of hepcidin in wild-type and Il10-/- mice was
dependent on the intestinal microbiota as co-housing Il10-/- mice with wild-type
mice abolished this effect. More recently, it was shown that commensal bacteriainduced IL-1β secreted by macrophages promotes hepcidin expression in
hepatocytes (Lee et al., 2005; Shanmugam et al., 2015). Collectively, these data
support the hypothesis that commensal bacteria communities modulate hepcidin
expression.
Lactobacillus is a common human commensal bacterium frequently used
as probiotics. Unlike most organisms many Lactobacillus species have little to no
requirement for iron and are rapidly outcompeted by other commensal bacteria
that thrive in the presence of elevated iron such as during dietary
supplementation and intestinal bleeding (Bailey et al., 2011). To determine the
effect

of

iron

supplementation

on

microbiota

composition,

one

study

demonstrated that anemic African children who received iron-fortified biscuits
had a high ratio of fecal enterobacteria to probiotic lactobacilli and bifidobacteria
(Zimmermann et al., 2010). These changes were associated with an increase in
calprotectin levels, a marker of intestinal inflammation. These data suggest that
that treatment of anemia using iron replacement therapy may have adverse
effects and result in a pathogenic and inflammatory gut microbiota. This is indeed
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supported by the poor efficacy of iron supplementation in the management of
anemia caused by inflammatory bowel diseases (Rogler and Vavricka, 2014;
Stein and Dignass, 2013). More studies are necessary to determine 1) the role of
iron homeostasis in regulating host-commensal relationships during a state of
health and disorders associated with iron deficiency and 2) whether the iron
regulatory hormone hepcidin influences iron-mediated changes to hostcommensal interactions. Chapter 4 of this thesis will explore the role of hepcidin
on host-LRC interactions.

1.3.3 Role of iron homeostasis and hepcidin in immune cell function
Dysregulated iron homeostasis in animals has been associated with changes in
innate immune function. In a mouse model of acute wounding, iron
supplementation skewed macrophage activation to a pro-inflammatory M1
phenotype and impaired wound healing (Sindrilaru et al., 2011). Treatment of
iron-supplemented animals with the iron chelator deferoxamine restored wound
healing, suggesting that iron is necessary and sufficient to promote M1
macrophage polarization. During infection, Hfe-/- mice, which have impaired
hepcidin expression and thus decreased intracellular iron stores, are highly
susceptible to Salmonella and Mycobacterium avium infection (Gomes-Pereira et
al., 2008; Wang et al., 2008). These data are in contrast to the previous reports
that hepcidin-deficient macrophages are unable to support intracellular bacteria
growth due to reduced intracellular iron levels (Nairz et al., 2009; Olakanmi et al.,
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2007). The authors hypothesized that susceptibility of Hfe-/- mice to intracellular
bacterial infection may be due to an inability of knockout animals to mount an
innate immune response to the pathogen, as Hfe-/- peritoneal macrophages
expressed lower levels of the pro-inflammatory cytokines IL-6 and TNFα
following LPS or Salmonella exposure (Wang et al., 2008). This defect was
restored in wild-type macrophages treated with a cell-permeable iron chelator or
overexpressing the iron exporter ferroportin, suggesting that reduced proinflammatory cytokine production is a result of low intracellular iron. Interestingly,
iron is selectively involved in the microbial sensing through the TLR4 but not the
TLR2 and TLR3 pathways (Wang et al., 2009). Altogether these data suggest
that high intracellular iron levels enhance pro-inflammatory cytokine production
by macrophages. Chapter 4 of this thesis will interrogate the role of hepcidinmediated iron homeostasis on cytokine production by innate and adaptive
immune cells.
Several studies in humans have demonstrated that impaired iron
homeostasis results in dysregulated immune responses. In children with irondeficient anemia, one study showed that serum IL-6 levels and the oxidative
burst capacity of neutrophils were significantly reduced compared to healthy
controls (Ekiz et al., 2005). In contrast, a separated study demonstrated that
monocytes in patients supplemented with iron produced less IL-6 in response to
IFNγ (Sonnweber et al., 2011). Although these results suggest that iron is a
critical regulator of innate immune cell function, it is likely that iron may have both
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direct effects on immune cell function and indirect effects potentially through
modulation of the endogenous microbiota. More studies are necessary to dissect
the interplay between iron homeostasis, the immune system and the gut
microbiota.

1.3.4 Regulation of hepcidin expression
Hepcidin expression is regulated at the level of transcription by three main cellextrinsic factors: inflammatory stimuli, erythropoiesis and plasma iron levels
(Figure 5). Cytokines that activate the STAT3 pathway including IL-6 and IL-22
are strong inducers of hepcidin production (Armitage et al., 2011; Nemeth et al.,
2004a; Smith et al., 2013a). Regulation of hepcidin expression by inflammation is
consistent with the fact that hepcidin is strongly upregulated in the context of
infection and tissue inflammation. While inflammatory signals upregulate
hepcidin, erythropoietic signals such as erythroferrone downregulate hepcidin to
increase iron availability for erythropoiesis (Kautz et al., 2014). In order to
maintain homeostatic levels of systemic iron, hepcidin expression is tightly
controlled by plasma iron levels. High plasma iron promotes hepcidin expression
to halt iron absorption through the intestine and inhibit its release from
intracellular stores (Ganz and Nemeth, 2015).
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1.4 Outline of thesis
Commensal bacteria colonize distinct sites along the mammalian GI tract. While
most commensal bacteria are found in the lumen or on the surface of the
intestinal epithelium, recent studies report the presence of commensal bacterial
signatures in the interior of intestinal-associated lymphoid tissues. The focus of
this thesis is to examine interactions between LRCs and the host immune
system. Chapter 2 will explore the cellular mechanisms by which LRCs colonize
intestinal-associated lymphoid tissues and the immunological consequences of
LRC colonization. Chapter 3 will investigate the role of LRC-induced immune
responses in the context of LRC colonization and intestinal injury. Finally,
Chapter 4 will define the role of iron homeostasis and the iron regulatory
hormone hepcidin on LRC colonization and immune cell homeostasis.
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Figure 1. Anatomical localization of commensal bacteria in the mammalian
gastrointestinal tract.

Figure 1. Commensal bacteria in the mammalian GI tract can be classified by their anatomical
localization as (i) luminal, (ii) epithelial-associated or (iii) lymphoid tissue-resident. Commensal
bacteria are important for promoting normal host physiology. In the healthy mammals, most
commensal bacteria occupy the lumen of the intestine while some are found associated with the
intestinal epithelium. Recent studies have identified that commensal bacteria can also inhabit gutassociated lymphoid tissues in the steady state.
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Figure 2. Interactions between the host immune system and luminal
commensal bacteria.

Figure 2. Luminal commensal bacteria comprise of the majority of commensal bacteria in the
mammalian intestine and are physically separated from immune cells. Colonization of the GI tract
by luminal commensal bacteria promotes tissue protective and inhibits pathological immune
responses. Anatomical containment of luminal commensal populations is mediated by physical
and biochemical barriers such as IECs, tight junctions, mucus, antimicrobial peptides (AMPs) and
secretory immunoglobulin A.
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Figure 3. Interactions between the host immune system and intestinal
epithelial-associated commensal bacteria.

Figure 3. Colonization of the mammalian GI tract by epithelial-associated commensal bacteria
promotes pro-inflammatory immune responses and is regulated by distinct host mechanisms.
SFB is a model epithelial-associated commensal bacterium that colonizes the small intestine by
adhering to IECs. SFB can promote pro-inflammatory immune responses that are associated with
both pathogen immunity and autoimmunity. Some members of the luminal commensal flora such
as B. fragilis and Clostridia can also colonize the epithelial surface of the colon and may interact
with IECs.
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Figure 4. Interactions between the host immune system and lymphoid
tissue-resident commensal bacteria.

Figure 4. Lymphoid-tissue resident commensal bacteria can colonize gut-associated lymphoid
tissues such as Peyer’s patches, isolated lymphoid follicles and mesenteric lymph nodes.
Lymphoid tissue-resident commensal bacteria share many properties: they are typically aerobic,
environmental microbes that are broadly resistant to antibiotics. One member of this group,
Alcaligenes spp., is a potent inducer of intestinal IgA responses. Anatomical containment of
+

Alcaligenes spp. is mediated by IL-22-producing RORγt innate lymphoid cells. Loss of this
pathway results in dissemination of Alcaligenes spp., systemic inflammation and tissue pathology.
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Figure 5. Regulation of iron homeostasis by the hormone hepcidin.
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Figure 5. Hepcidin is a iron-regulatory hormone that is expressed primarily by hepatocytes.
Hepcidin interacts with the membrane-bound iron exporter, ferroportin (FPN) expressed on
duodenal enterocytes, splenic macrophages and hepatocytes and results in its degradation.
Hepcidin-ferroportin interactions therefore regulate plasma iron levels by inhibiting dietary iron
absorption and iron release by splenic macrophages and hepatocytes. Expression of hepcidin is
upregulated by plasma iron and inflammatory cytokines and downregulated by erythropoiesis.
Figure modified from Ganz and Nemeth 2012 Biochimica et Biophysica Acta.
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Figure 6. Role of iron homeostasis in host-pathogen interactions.
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Figure 6. Iron is an essential nutrient for both mammals and microbial pathogens. Regulation of
systemic iron levels by hepcidin differentially influences the survival and growth of extracellular
and intracellular pathogens. In the absence of hepcidin expression where iron export by
ferroportin (FPN) is uninhibited, increase in extracellular iron levels favors the growth of
extracellular pathogens but may inhibit infection by intracellular pathogens. In the presence of
hepcidin expression where iron export by ferroportin is inhibited, an increase in intracellular iron
levels now favors growth of intracellular pathogens but inhibits infection by extracellular
pathogens.
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Chapter 2
Lymphoid tissue-resident commensal bacteria colonize DCs and promote
tissue-specific immune cell responses

2.1 Abstract
Dysregulated immune responses against commensal bacteria are associated
with the pathogenesis of chronic inflammatory diseases, and can be prevented
by maintaining physical separation between commensal bacteria and intestinal
immune cells. However, recent reports demonstrate that selective species of
commensal bacteria can reside within intestinal-associated lymphoid tissues of
healthy mammals. How this unique colonization occurs and functionally
influences the immune system is unclear. This Chapter will demonstrate that
lymphoid tissue-resident commensal bacteria (LRC) can colonize and persist in
murine dendritic cells and modulate their cytokine production. In germ-free and
antibiotic-treated (ABX) mice, LRCs colonize intestinal-associated lymphoid
tissues and induce multiple members of the IL-10 cytokine family, including
dendritic cell-derived IL-10 and group 3 innate lymphoid cell (ILC3)-derived IL-22.
Unlike SFB, which colonize the epithelial surface of the small intestine and
promote lamina propria Th17 cell responses, LRCs selectively promote Th17 cell
responses in the Peyer’s patch and mesenteric lymph nodes but not in the small
intestine lamina propria. Collectively, the data in this Chapter reveal a novel hostcommensal bacteria dialogue whereby LRCs colonize intestinal-associated
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lymphoid tissues and interact with dendritic cells to promote tissue-specific
immune responses.

2.2 Introduction
Trillions of microorganisms constitutively colonize the mammalian gastrointestinal
(GI) tract and are essential to establish and maintain a state of health (Belkaid
and Hand, 2014; Turnbaugh et al., 2007). These microorganisms include
commensal bacteria that aid in nutrient metabolism and resistance to pathogen
infection (Brestoff and Artis, 2013; Buffie and Pamer, 2013; Flint et al., 2012), as
well as the development and maturation of the immune system (Belkaid and
Hand, 2014; Honda and Littman, 2012; Hooper et al., 2012; Ivanov and Honda,
2012). In the healthy intestine, most commensal bacteria are restricted to the
lumen of the GI tract or found associated with the surface of the intestinal
epithelium and remain physically separated from the immune cells that populate
the lamina propria and intestinal-associated lymphoid tissues (Chow et al., 2010;
Chu and Mazmanian, 2013; Hooper et al., 2012; Hooper and Macpherson,
2010). Physical separation of commensal bacteria from immune cells is achieved
by multiple physical and biochemical mechanisms that include intestinal epithelial
cells, tight junction proteins, and secretion of anti-microbial peptides, mucus and
immunoglobulin A (Chow et al., 2010; Chu and Mazmanian, 2013; Hooper et al.,
2012; Hooper and Macpherson, 2010). Anatomical segregation of commensal
bacteria from the immune system, often referred to as the “demilitarized zone”, is
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essential to prevent pathologic immune responses against commensal bacteria
(Hooper et al., 2012; Hooper and Macpherson, 2010). Consistent with this,
translocation and dissemination of commensal bacteria across the intestinal
epithelium lead to the generation of pro-inflammatory immune cell responses and
are often associated with the pathogenesis of chronic infectious, inflammatory
and metabolic diseases (Brenchley and Douek, 2012; Brenchley et al., 2006;
Kamada et al., 2013; Loh and Blaut, 2012; Manichanh et al., 2012; Musso et al.,
2011; Zhao, 2013).
Several recent studies suggest that a subset of commensal bacteria can
colonize the interior of intestinal-associated lymphoid tissues of healthy
mammals (Fung et al., 2014; Kunisawa and Kiyono, 2012; Obata et al., 2010;
Sato et al., 2013; Sonnenberg et al., 2012). One report demonstrated by 16S
rDNA sequencing and fluorescence in situ hybridization (FISH) that the interior of
isolated lymphoid follicles (ILFs), Peyer’s patches (PPs) and mesenteric lymph
nodes (mLNs) from healthy mice, non-human primates and humans contain
multiple groups of bacteria (Obata et al., 2010). These bacteria include
Alcaligenes spp., Achromobacter spp., Bordetella spp. and Ochrobactrum spp.
16S rDNA for many of these lymphoid tissue-resident commensal bacteria
(LRCs) were found associated with CD11c+ dendritic cells (DCs), suggesting a
role for DCs in lymphoid tissue colonization. In a subsequent study, it was
demonstrated that IL-22 and group 3 innate lymphoid cells (ILC3) are important
in preventing systemic dissemination of one LRC, Alcaligenes xylosoxidans, and
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subsequent induction of systemic inflammation (Sonnenberg et al., 2012). These
data highlight that intestinal-associated lymphoid tissues are potential sites for
colonization by commensal bacteria and innate immune pathways maintain
anatomical segregation between LRCs and the systemic immune system.
Despite these findings, the mechanisms by which commensal bacteria colonize
immune cell-rich lymphoid compartments associated with the intestinal tract of
healthy mammals, and the functional significance of this colonization to the host,
remain undefined. This Chapter will demonstrate that lymphoid tissue-resident
commensal bacteria can colonize the intracellular compartment of murine DCs,
modulate DC cytokine production in a viability-dependent manner and promote
local Th17 cell and ILC3 responses in intestinal-associated lymphoid tissues in
vivo.

2.3 Methods

2.3.1 Mice
C57BL/6 and Rag1-/- mice were purchased from Jackson Laboratories and used
at 6-12 weeks of age. Conventional mice used as controls in gnotobiotic mice
experiments were purchased from Jackson Laboratories and co-housed with
mice bred in our conventional animal facility for at least 7 days before use.
C57BL/6 and Rag1-/- mice used as controls for knockout mice were either bred in
the same animal facility as the knockout mice, purchased from Jackson
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Laboratories and co-housed with mice bred in our SPF animal facility for at least
7 days or littermates as indicated to control for microbiota differences. All
conventional mice were maintained in specific pathogen-free facilities at the
University of Pennsylvania or Weill Cornell Medical College. Germ-free and
gnotobiotic C57BL/6 and Rag1-/- mice were maintained within sterile vinyl
isolators at the University of Pennsylvania or Weill Cornell Medical College
Gnotobiotic Mouse Facility and monitored for germ-free or gnotobiotic status by
aerobic and anaerobic culturing. Additional microbiology testing was performed
on feces from mice under experimentation and at the endpoint of the experiment
to confirm germ-free or monocolonization status. Germ-free C57BL/6 mice were
monocolonized with the mouse LRC isolate Bordetella spp., or SFB by oral
gavage or cohousing with soiled bedding from previously monocolonized mice for
at least 10 days. To establish LRC colonization in ABX-treated mice,
conventional mice were treated in the drinking water with a limited ABX cocktail
of ampicillin (1 mg/ml, Sigma) and gentamicin (1 mg/ml, Gemini Bio-Products) for
C57BL/6 mice or ampicillin (1 mg/ml), gentamicin (1 mg/ml) and neomycin (0.25
mg/ml, Sigma) for Rag1-/- for 3 days and then orally gavaged with the clinical
LRC isolate (LRCR), Achromobacter. Antibiotic cocktails were supplemented with
1 packet of artificial sweetener (Sweet’N Low) per 250 ml. All mice were used at
least 10 days post LRCR colonization. All experiments were performed according
to the guidelines of the University of Pennsylvania or Weill Cornell Medical
College Institutional Animal Care and Use Committee.
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2.3.2 Microbiology
The LRC strain, Bordetella spp., used to colonize BMDCs or monocolonize germfree mice was originally isolated from the spleen of an anti-CD90.2 mAb treated
conventional Rag1-/- mice using a previously defined protocol (Sonnenberg et al.,
2012). E. coli (human isolate) and Ochrobactrum spp. used to colonize BMDCs
and the ABX-resistant (ampicillin, gentamicin, neomycin) LRC (LRCR),
Achromobacter used to colonize antibiotic-treated mice were human clinical
isolates kindly provided by Kaede V. Sullivan (Children’s Hospital of
Philadelphia). Bacterial identities were determined by genomic sequencing
(Wellcome Trust Sanger Institute) and confirmed by genus-specific 16S rDNA
primers. E. coli R9 (ATCC 35328), Enterobacter cloacae (ATCC 13047) and
gentamicin-sensitive Achromobacter spp. (ATCC 31444) used to colonize
BMDCs were purchased from American Type Culture Collection. Feces from
SFB-monocolonized mice were obtained from Dr. Yoshinori Umesaki and Dr.
Tatsuichiro Shima (Yakult). All bacterial strains used to colonize germ-free mice
and for in vitro DC assays were grown in LB broth and incubated at 250 RPM,
37°C for 16-20 hours. For enumeration of tissue and fecal CFUs, the spleen,
liver, feces, mesenteric lymph nodes (mLN) and Peyer’s patches (PP) were
isolated, homogenized in sterile PBS and plated on Brain Heart Infusion (BHI)
agar supplemented with 5% defibrinated horse blood. When culturing LRCR from
tissues and feces, BHI blood agar plates were supplemented with 25 µg/ml
ampicillin.
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2.3.3 Bone marrow-derived and primary dendritic cell assays
Bone marrow-derived DCs were generated by culturing bone marrow cells from
C57BL/6, Myd88-/-, Tlr2-/- and Tlr4-/- mice in the presence of 20 ng/mL GM-CSF
for 8-10 days. Culture media was replaced with fresh media every 3 days.
Frequencies of CD11c+ cells were ≥ 95%. To prepare primary splenic and mLN
DCs, C57BL/6 mice were first injected subcutaneously in the right flank with 5 x
106 cells GM-CSF-expressing B16 melanoma (kindly provided by Jedd D.
Wolchok, MSKCC). 10 days later, CD11c+ cells were purified from Liberase TL
(Roche)-digested spleen and mLN using CD11c positive selection beads
(Miltenyi Biotec). Cell purities in the spleen were approximately 90% CD11c+
CD11b+ of non-T and B cells. For intracellular bacterial survival assays, BMDCs
were seeded on 6-well plates at 5 x 106 cells/well in antibiotic-free media and cocultured with bacteria at an MOI of 50 for 2 hours, harvested and washed 3 times
with sterile PBS. BMDCs were then plated in media containing gentamicin (100
µg/mL) at 200,000 cells/well on 48-well plates and lysed with sterile water every
48 hours to enumerate CFUs. For ELISA and qPCR, BMDCs were co-cultured
with bacteria at an MOI of 50 for 2 hours and then gentamicin-treated to kill
extracellular bacteria. Culture supernatants and cell lysates were harvested for
ELISA and qPCR, respectively, 24 hours later. Heat killing was performed by
incubating bacterial suspensions at 70°C for 60 min. For transmission electron
microscopy, BMDCs colonized with Bordetella spp. for 5 days were harvested,
processed for imaging by the University of Pennsylvania Electron Microscopy
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Resource Laboratory and imaged using the Jeol-1010 transmission electron
microscope. For microarray analysis, BMDCs were co-cultured with bacteria for 2
hours, washed extensively with PBS, incubated in media containing gentamicin
(100 µg/mL) and lysed in TRIzol on day 4. All cell incubations were performed at
37°C and 5% CO2.

2.3.4 Immunofluorescent detection of intracellular bacteria
BMDC-bacteria co-cultures were harvested on days 0, 2 and 5 and transferred to
glass slides via cytospin. BMDCs were fixed with 4% PFA for 30 minutes at room
temperature and stained with the Live/Dead BacLight Bacterial Viability Kit
according to the manufacturer’s instructions (Invitrogen). Cells were mounted
with VectaShield mounting medium containing DAPI (Vector Laboratories) and
imaged on the Nikon Eclipse Ti Fluorescence Inverted Microscope. PFA fixation
did not affect the ability of the bacterial viability kit to distinguish between live and
dead bacteria.

2.3.5 Gene expression profiling and quantitative real-time PCR
RNA was isolated using TRIzol reagent (Life Technologies) according to the
manufacturer’s instructions. cDNA was generated using Superscript reverse
transcriptase II (Invitrogen). Quantitative real-time PCR was performed using
SYBR green chemistry (Invitrogen) and QuantiTect Primer Assays (Qiagen) on
the ABI 7500 real-time PCR system (Applied Biosystems). Samples were
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normalized to β-actin and displayed as fold change over PBS-treated BMDCs or
antibiotic-treated mice. For microarray analysis, BMDCs colonized with the LRC,
Bordetella spp., for 4 days were lysed directly in TRIzol. RNA was isolated,
amplified, reverse-transcribed to cDNA and hybridized to an Affymetrix GeneChip
(Mouse Gene 1.0ST) by the University of Pennsylvania Molecular Profiling
Facility. Relative expression data was normalized by Z score transformation.

2.3.6 Flow cytometry
mLN and PP were harvested, and single-cell suspensions were prepared at
necropsy. For small intestine lamina propria preparations, intestines were
isolated, attached fat and PPs were removed and tissues were cut open
longitudinally. Luminal contents were removed by shaking in cold PBS. Epithelial
cells and intra-epithelial lymphocytes were removed by shaking tissue in stripping
buffer (1 mM EDTA, 1 mM DTT and 5% FCS) at 37°C for 30 minutes. The lamina
propria layer was isolated by digesting the remaining tissue in 1 mg/mL
collagenase/dispase (Roche) and 20 µg/mL DNase I (Sigma-Aldrich) for 30
minutes at 37°C. For flow cytometric analyses, cells were stained with antibodies
against the following markers: anti-NK1.1 (clone PK136, eBioscience), anti-CD3
(clone 145-2C11, eBioscience), anti-CD5 (clone 53-7.3, eBioscience), antiCD11c (clone N418, eBioscience), anti-CD4 (clone GK1.5, Abcam), anti-CD8α
(clone 53-6.7, eBioscience), anti-B220 (clone RA3-6B2, eBioscience), anti-CD45
(clone 30-F11, eBioscience) and anti-CD11b (clone M1/70, eBioscience). For
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intracellular staining of RORγt, cells were fixed and permeabilized with the Foxp3
intracellular staining buffer set (eBioscience) and stained with anti-RORγt (clone
B2D, eBioscience). For intracellular cytokine staining, cells were stimulated ex
vivo by incubation for 4 h with 50 ng/mL PMA, 750 ng/mL ionomycin, 10 µg/mL
Brefeldin A (all obtained from Sigma-Aldrich) and 50 ng/mL rmIL-23
(eBioscience) and permeabilized as indicated above and stained with anti-IL-17A
(clone

eBioTC11-18H10.1,

eBioscience),

anti-IFN-γ

(clone

XMG1.2,

eBioscience) and anti-IL22-02 (mouse cytokine detection antibody developed by
Pfizer). Dead cells were excluded from analysis using the Live/Dead Aqua
Viability Kit (Invitrogen). Flow cytometry data collection was performed on the
LSR II (BD Biosciences). Data were analyzed using FlowJo software (Tree Star
Inc.).

2.3.7 Histology
Tissues from the small and large intestines were fixed with 4% PFA, embedded
in paraffin, and 5 µm sections were cut and stained with H&E.

2.3.8 Bacterial genome sequencing, assembly, and annotation.
DNA was prepared and sequenced using the Illumina Hi-Seq platform with library
fragment sizes of 200-300 bp and a read length of 100 bp at the Wellcome Trust
Sanger Institute, as previously described (Harris et al., 2010). De novo assembly
of 32 genomes was performed with Velvet v. 1.2.10 (Zerbino and Birney, 2008),
58

SSPACE v. 2.0 (Boetzer et al., 2011) and GapFiller v 1.1 (Boetzer and Pirovano,
2012) using an in-house pipeline developed at the Wellcome Trust Sanger
Institute. De novo assemblies were annotated with Prokka v. 1.5-1 (Seemann,
2014) using an in-house pipeline developed at the Wellcome Trust Sanger
Institute, which is available on GitHub (https://github.com/sanger-pathogens/BioAutomatedAnnotation).

2.3.9 Phylogenetic analysis
The fetchMG v. 1.0 (http://www.bork.embl.de/software/mOTU/fetchMG.html) was
used to extract the protein information based on 40 universal single copy marker
genes (Ciccarelli et al., 2006; Sorek et al., 2007) from each of the studied
genome including 32 draft genomes and 15 reference genomes (Table S1). The
protein sequences were then concatenated and aligned with MAFFT v. 7.205
(Katoh and Standley, 2013), and a maximum-likelihood tree was constructed
using RAxML v. 7.8.6 (Stamatakis, 2006) with 100 bootstrap replicates under the
Gamma + WAG model. The tree was visualized using SplitsTree v. 4.13.1
(Huson and Bryant, 2006).

2.3.10 Statistical analyses
Results represent mean ± SEM and statistical analyses were performed by
unpaired student’s t-test, one- or two-way ANOVA with or without multiple
comparisons tests as indicated in figure legends.
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2.3.11 Data accessibility
Sequenced microbial genome data have been deposited in the European
Nucleotide Archive under study number ERP012121.

Array data have been

deposited in GEO under accession number GSE76731.

2.4 Results

2.4.1 Lymphoid tissue-resident commensal bacteria are phylogenetically
distinct from luminal commensal bacteria
16S rDNA for several groups of bacteria have been detected in the interior of
PPs and the mLN of healthy mice (Obata et al., 2010; Sonnenberg et al., 2012).
These LRCs, including Achromobacter spp., Alcaligenes spp., Bordetella spp.
and Ochrobactrum spp., belong exclusively to the α- and β-proteobacteria
groups, which are not highly represented in sequence analyses of the luminal
contents of the intestine (Eckburg et al., 2005; Hill et al., 2010; Ley et al., 2005;
Ley et al., 2006). We constructed a phylogenetic tree using in-house sequenced
and publically available reference genomes of α-, β-, γ-proteobacteria and
Bacteroidia members (Table 1). Phylogenetic analyses indicated that members
of the α-proteobacteria and β-proteobacteria LRCs form two distinct clades from
γ-proteobacteria and Bacteroidia members, which are typically found in the
lumen of the intestine and not associated with intestinal lymphoid tissues in
healthy mammals (Figure 7A).
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2.4.2

Lymphoid

tissue-resident

commensal

bacteria

colonize

the

intracellular compartment of murine dendritic cells in vitro
16S rDNA for LRCs have been detected in CD11c+ cells from PPs and the mLN
of healthy mice (Obata et al., 2010; Sonnenberg et al., 2012), suggesting LRCs
may colonize DCs. To test this, bone marrow-derived DCs (BMDCs) were cocultured with intestinal bacteria predicted to be LRCs or representative intestinal
microbes not predicted to be LRCs (non-LRCs), and the ability of each bacterium
to survive in DCs was determined using a gentamicin protection assay. LRCs
and non-LRCs were both internalized by DCs, but the numbers of viable nonLRCs declined rapidly within the first three days of culture, while viable LRCs
persisted at high levels on days 2 and 4 (Figure 7B). LRCs but not non-LRCs
were also able to colonize and persist in primary DCs isolated from the mLN and
spleen (Figure 7C and 7D). Transmission electron microscopy (TEM)
demonstrated intracellular colonization of DCs by LRCs as noted by the
presence of dense bacterial clusters within intracellular vesicles (Figure 8A). To
investigate the kinetics of intracellular survival of LRCs on a single-cell level, LRC
and non-LRC-colonized BMDCs were analyzed using an immunofluorescence
assay that distinguishes between live and dead bacteria. Both LRCs and nonLRCs were able to initially colonize BMDCs, however, the number of BMDCs
containing viable bacteria was significantly greater for LRC-colonized BMDCs on
days 2 and 5 (Figure 8B and 8C). Similar to the results using TEM, LRCs appear
to form dense clusters in BMDCs beginning at day 2 post-colonization. However,
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these clusters were not observed in non-LRC-colonized DCs (Figure 8B).
Together, these data suggest that, in contrast to luminal-resident commensal
bacteria, LRCs have the ability to efficiently colonize and persist in murine DCs.

2.4.3 Lymphoid tissue resident-commensal bacteria modulate dendritic cell
cytokine production in a viability- and TLR-dependent manner
Innate immune cells such as DCs and macrophages respond to microbial stimuli
by producing pro- and anti-inflammatory cytokines that shape subsequent
adaptive immune cell responses. In the intestine, these responses are critical in
regulating tissue homeostasis, immunity and inflammation (Bekiaris et al., 2014;
Coombes and Powrie, 2008; Rescigno, 2010). Furthermore, DCs and
macrophages can sense viability-associated molecular patterns in bacteria to
induce distinct cytokine responses (Sander et al., 2011). Based on the ability of
LRCs to colonize and persist in murine DCs, we sought to characterize DC
cytokine induction following exposure to live versus heat-killed LRCs. To begin to
test this, genome-wide transcriptional profiling was performed on DCs treated
with PBS, live or heat-killed Bordetella spp., a model LRC isolated from our
mouse colony, at 4 days post-exposure. Analysis of canonical DC-derived
cytokines revealed that DCs colonized with live LRCs expressed greater levels of
the pro- and anti-inflammatory cytokines Il6, Il23a, Il18, Il12a, Il12b, Il10 and
Tgfb2 compared to PBS-treated DCs (Figure 9A). Notably, the induction of
mRNA and protein for several of these cytokines, including IL-1β, IL-6, IL-10, IL62

12p40 and IL-23, by live LRCs was detected as early as 24 hours post co-culture
(Figure 9B and 9C), and the induction of IL-10 and IL-23 mRNA (Figure 9A and
9B) and secretion of IL-1β, IL-10 and IL-23 protein (Figure 9C) did not occur in
DCs exposed to only heat-killed LRCs, suggesting that viability-dependent
factors expressed by LRCs induce selective DC cytokine responses. Primary
splenic DCs exposed to live LRCs also produced IL-1β, IL-6, IL-10 and IL-12p40
(Figure 9D). Efficient induction of both viability- (IL-1β, IL-10, IL-23) and nonviability-dependent cytokines (IL-6, IL-12p40) required MYD88, suggesting a role
for Toll-like receptors (TLRs) in recognition of LRCs (Figure 10A). Consistent with
this, production of IL-1β and IL-23 was significantly reduced in Tlr4-/- but not Tlr2/-

BMDCs (Figure 10B). Collectively, these data indicate that LRCs can effectively

colonize murine DCs in vitro and promote distinct pro- and anti-inflammatory
cytokine responses by DCs in a viability- and TLR-dependent manner.

2.4.4 Lymphoid tissue-resident commensal bacteria colonize intestinalassociated lymphoid tissues in gnotobiotic mice
Most commensal bacteria found in the intestine are restricted to the lumen or the
surface of the intestinal epithelium (Chow et al., 2010; Chu and Mazmanian,
2013; Hooper et al., 2012; Hooper and Macpherson, 2010). However, 16S rDNA
for multiple groups of bacteria are enriched in the ILFs, PPs and mLN of healthy
mice (Obata et al., 2010; Sonnenberg et al., 2012). To test whether these LRCs
can stably colonize and survive in intestinal-associated lymphoid tissues, germ63

free mice were monocolonized with Bordetella spp., a model LRC isolated from
our mouse colony. At day 10 post-inoculation, viable LRCs were consistently
detected in the mLN (Figure 11A), PPs (Figure 11B) and fecal contents of the
small intestinal lumen (Figure 11C), but not the spleen and liver. However,
colonization by LRCs was not associated with macroscopic or microscopic
inflammation in the intestine at 2 weeks post colonization (Figure 11D). These
data support the hypothesis that LRCs can colonize and persist in intestinalassociated lymphoid tissues of healthy mammals.

2.4.5 Lymphoid tissue-resident commensal bacteria promote tissuespecific Th17 cell responses in gnotobiotic mice
Commensal bacteria modulate the innate and adaptive immune system in the GI
tract (Belkaid and Hand, 2014; Honda and Littman, 2012; Hooper et al., 2012;
Ivanov and Honda, 2012). Based on the ability of live LRCs to elicit IL-1β, IL-6,
IL-23 and TGFβ, which are potent enhancers of Th17 cell responses (Korn et al.,
2009), we hypothesized that LRCs may promote Th17 cell responses in
colonized lymphoid tissues. To test this, we analyzed CD4+ T cells in the PP,
mLN and small intestine lamina propria (SI LP) of conventionally-housed (CNV),
germ-free, LRC-monocolonized mice and mice monocolonized with segmented
filamentous bacteria (SFB), an epithelial-associated commensal bacterium which
has previously been shown to induce robust Th17 cell responses in the SI LP
(Gaboriau-Routhiau et al., 2009; Ivanov et al., 2009). Consistent with published
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reports, germ-free mice lacked Th17 cells in the mLN (Figure 12A), PP (Figure
12B) and SI LP (Figure 12C) compared to CNV mice, and SFB was sufficient to
promote robust Th17 cell responses in all three of these tissues. In contrast,
LRCs promoted Th17 cell responses in the mLN and PP (Figure 12A, 12B and
12D) but failed to promote Th17 cell responses in the SI LP (Figure 10C and
10D), suggesting tissue-specific modulation of the immune system. Analysis of
LRC-elicited Th17 cells in the PP revealed that a subset of these cells coexpressed the IL-10 family cytokine, IL-22 (Figure 13A and 13B). Accumulation
of Th17 cells was selective as compared to Th1 cells, since LRCs did not
significantly promote IFNγ-producing CD4+ T cell responses in the mLN, PP or SI
LP (Figure 13C). Collectively, these data indicate that LRCs selectively promote
Th17 cell responses at intestinal-associated lymphoid tissues.

2.4.6 Lymphoid tissue-resident commensal bacteria promote tissuespecific ILC3 responses in gnotobiotic mice
ILC3 also respond to the cytokines IL-1β, IL-6 and IL-23, express the
transcription factor RORγt, and have important functions in lymphoid tissue
organogenesis, immunity to pathogens and intestinal tissue homeostasis through
production of effectors cytokines IL-17A and IL-22 (Artis and Spits, 2015;
Diefenbach et al., 2014; McKenzie et al., 2014; Qiu and Zhou, 2013; Sonnenberg
and Artis, 2012, 2015). Based on the ability of live LRCs to elicit DC-derived IL1β, IL-6 and IL-23, we hypothesized that LRCs may promote ILC3 responses in
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intestinal-associated lymphoid tissues. To test this, we measured ILC3
frequencies in the PP, mLN and SI LP of CNV, germ-free, SFB-monocolonized
and LRC-monocolonized mice. Consistent with published reports, germ-free mice
have reduced frequencies of ILC3 in the SI LP as compared to CNV mice (Klose
et al., 2013; Satoh-Takayama et al., 2008). Monocolonization by SFB did not
significantly alter ILC3 frequencies in the PP, mLN and SI LP (Figure 14A-D). In
contrast, LRC-monocolonized mice revealed a significant increase in ILC3
frequencies in the PP and mLN (Figure 14A, 14B and 14D) but not in the SI LP
as compared to germ-free mice (Figure 14C and 14D). Notably, ILC3s in the PP
of LRC-monocolonized mice produced IL-22 (Figure 15A). However, frequencies
and total numbers of IL-22+ ILC3 were comparable between germ-free and LRCcolonized mice (Figure 15B). Collectively, these data suggest that LRCs
modulate tissue-specific ILC3 responses in the intestine.

2.4.7 Lymphoid tissue-resident commensal bacteria colonize intestinalassociated lymphoid tissues in antibiotic-treated mice
ILC3 and IL-22 responses induce anti-microbial proteins in the intestine (Artis
and Spits, 2015; Diefenbach et al., 2014; McKenzie et al., 2014; Rutz et al.,
2013; Sonnenberg and Artis, 2012, 2015; Sonnenberg et al., 2011), suggesting
that LRCs may induce immune responses that limit its own colonization or the
colonization of other bacteria. To investigate the role of LRC-elicited immune
responses in LRC-host interactions, we established a mouse model of LRC
66

colonization by treating conventional C57BL/6 mice with a limited cocktail of
antibiotics (ABX) followed by inoculation with an antibiotic-resistant LRC,
Achromobacter (LRCR). We confirmed that, similar to the results using LRCmonocolonized mice, LRCR could be cultured from the mLN and PPs of LRCRcolonized C57BL/6 mice in which LRCR was the dominant bacterial species in
the intestinal lumen (Figure 16A and 16B). Furthermore, analyses of ILC3
responses in LRCR-colonized C57BL/6 mice revealed a significant increase in IL22+ ILC3 frequencies as compared to ABX-treated controls (Figure 16D).
Collectively, these data suggest that LRCs can colonize intestinal-associated
lymphoid tissues not only in gnotobiotic but also in antibiotic mice.

2.4.8 Lymphoid tissue-resident commensal bacteria promote innate
immune cell responses in a tissue-specific manner in antibiotic-treated
mice
Live LRCR were also detected in the mLN of LRCR-colonized Rag1-/- mice (Figure
16C), suggesting that lymphoid tissue colonization does not require the adaptive
immune system and allowing us to interrogate interactions between LRCs and
the innate immune system. To investigate whether DC colonization and cytokine
modulation by LRCs occur in the absence an adaptive immune system in vivo,
we measured LRCR 16S rDNA and cytokine gene expression in CD11c+ cells
isolated from the mLN of LRCR-colonized Rag1-/- mice. LRCR 16S rDNA was
detected in CD11c+ cells from LRCR-colonized but not in control ABX-treated
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mice (Figure 16E), suggesting that in this model LRCs or LRC-derived nucleic
acids are associated with murine DCs isolated from lymphoid tissues of healthy
mice. Furthermore, CD11c+ cells from LRCR-colonized mice expressed increased
levels of Il1b, Il10 and Il23a as compared to CD11c+ cells from control ABXtreated mice (Figure 17A). Induction of Il1b and Il23a was associated with an
increase in Il17a and Il22 expression in the whole mLN but not the small intestine
of LRCR-colonized Rag1-/- mice (Figure 17B and 17C). Altogether, these data
demonstrate that LRCs modulate tissue-specific DC and ILC3 responses in
antibiotic-treated mice.

2.5 Discussion
The findings in this Chapter define a unique host-commensal bacteria dialogue
whereby direct interactions between LRCs and the mammalian immune system
orchestrate tissue-specific immune responses. While most studies interrogating
host-microbiota interactions to date have focused on populations of commensal
bacteria residing in the intestinal lumen or attached to the intestinal epithelium,
here we examine an under-appreciated class of commensal bacteria that has the
potential to reside closely associated with immune cells in the interior of intestineassociated lymphoid tissues. This colonization pattern is paradoxical to our
current understanding of interactions between the immune system and
commensal bacteria, which suggests that anatomical segregation must occur to
limit the development of pathologic immune responses (Brenchley and Douek,
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2012; Hooper et al., 2012; Hooper and Macpherson, 2010; Kamada et al., 2013;
Manichanh et al., 2012). The data from this Chapter identifying the
immunological role of commensal bacteria colonization in lymphoid tissues
represent a key advance in our understanding of host-commensal bacteria
interactions. Furthermore, these studies suggest that ongoing host-microbiota
studies should consider not only the composition of luminal and epithelial
commensals but also commensal bacteria communities that colonize organized
lymphoid tissues associated with the intestine such as the mLN, PPs and ILFs.
Interrogating interactions between the host immune system and several
species of LRCs revealed that LRCs but not luminal members of the microbiota
could colonize and persist within murine DCs and modulate selective DC
cytokine responses in a viability-dependent manner. Induction of IL-1β, IL-6, IL10 and IL-23 by non-LRCs such as E. coli has been demonstrated by other
groups (Hayashi et al., 2013; Manuzak et al., 2012; Sander et al., 2011),
suggesting that activation of DCs does not account for differences in intracellular
bacterial survival. Constitutive colonization of intestinal DCs by LRCs likely
maintains expression of viability-dependent cytokines, including IL-1β, IL-10 and
IL-23. This is in direct contrast to luminal-resident or epithelial-attached
commensal bacteria in which viable bacteria belonging to these groups are not
typically found beyond the intestinal epithelium (Hooper et al., 2012; Hooper and
Macpherson, 2010; Obata et al., 2010). Therefore, these commensal bacteria
predominantly influence immune cells through indirect interactions, for example
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via production of metabolites or modulation of intestinal epithelial cell responses
(Arpaia et al., 2013; Furusawa et al., 2013; Goto et al., 2014; Ivanov et al., 2009;
Pham et al., 2014; Pickard et al., 2014; Smith et al., 2013). It is likely that LRCs
may provide more direct and continuous stimulation to the immune system.
Furthermore, the data in this Chapter suggest that induction of tissue-specific
immune responses by commensal bacteria is linked to their anatomical
localization in the GI tract and associated lymphoid tissues. Consistent with this,
the epithelial-associated commensal SFB, induces potent SI LP Th17 cell
responses that are dependent primarily on physical attachment to intestinal
epithelial cells, production of epithelial cell-derived SAA1/2 and activation of the
IL-23R-IL-22 axis. (Atarashi et al., 2015; Gaboriau-Routhiau et al., 2009; Ivanov
et al., 2009; Sano et al., 2015). Similarly, Bacteroides fragilis predominantly
colonizes the colonic crypts in mice and promotes robust regulatory T cell
responses in the underlying colon lamina propria (Lee et al., 2013; Round and
Mazmanian, 2010). This Chapter demonstrates that LRCs colonize and activate
DCs to selectively promote Th17 cell and ILC3 responses within intestinalassociated lymphoid tissues.
Collectively, the findings in Chapter 2 demonstrate that colonization of
lymphoid tissues by commensal bacteria modulates the host immune system in a
tissue-specific manner. Further interrogation of LRC colonization in health and
disease will be critical to understand the complex microbial contexts where LRCs
influence tissue immunity and inflammation. Understanding the mechanisms by
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which LRCs modulate tissue-specific immune cell function may inform the
development the therapeutics for the treatment of chronic inflammatory diseases.

71

Figure 7. Lymphoid tissue-resident commensal bacteria are
phylogenetically distinct from luminal commensal bacteria and selectively
colonize murine dendritic cells.
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Figure 7. (A) Maximum-likelihood tree of 47 bacterial genomes based on 40 universal single copy
marker genes. Red symbols indicate published reference genomes. Blue symbols and text
indicate in-house sequenced genomes. Scale bar indicates number of substitutions per site. (B)
Bone marrow-derived dendritic cells (BMDCs) were co-cultured with representative LRCs or
luminal-resident commensals and bacterial survival was measured at 0, 48 and 96 hours. Data
are representative of at least 2 independent experiments. (C) Primary DCs isolated from the
mesenteric lymph node (mLN) and (D) spleen of C57BL/6 mice were co-cultured with the mousederived LRC, Bordetella spp. or luminal commensal, E. coli ATCC 35328, and bacterial survival
was measured at 0, 48 and 96 hours. l.o.d., limit of detection. Data are representative of 2
independent experiments.
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Figure 8. Lymphoid tissue-resident commensal bacteria colonize the
intracellular compartment of bone marrow-derived dendritic cells.
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Figure 8. (A) Bordetella-colonized BMDCs were analyzed at day 5 post co-culture by
transmission electron microscopy. Images are representative of 10 individual bacteria-containing
DCs. (B) Bordetella- and E. coli-colonized BMDCs were analyzed at day 0, 2 and 5 post-coculture by immunofluorescence. Scale bar – 5 µm. Data are representative of 2 independent
experiments. (C) Percentage of BMDCs containing live (green) bacteria was quantified across 716 distinct fields of view. Infection efficiency (BMDCs containing live or dead bacteria/total
BMDCs) on day 0 was approximately 15% for Bordetella spp. and 30% for E. coli. Data are
represented as mean ± SEM. Statistics were performed using unpaired, two-tailed, student’s t
test. ***, p < 0.0001. ND, not detectable.
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Figure 9. Lymphoid tissue-resident commensal bacteria modulate dendritic
cell cytokine responses in a viability-dependent manner.
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Figure 9. (A) Genome-wide transcriptional profiling was performed on BMDCs co-cultured with
live or heat-killed Bordetella spp. for 4 days. Numbers in colored legend represent Z scores. (B)
BMDCs co-cultured with live or heat-killed Bordetella spp. for 24 hours were analyzed for cytokine
gene expression by qPCR. (C) BMDCs co-cultured with live or heat-killed Bordetella spp. for 24
hours were analyzed for cytokine protein secretion by ELISA. (D) Production of IL-1β, IL-6, IL-10
and IL-12p40 was measured in supernatants from Bordetella- or E. coli-spleen DC co-cultures at
96 h post-co-culture. qPCR and ELISA data are representative of at least 2 independent
experiments. Data are represented as mean ± SEM. Statistics in B and C were performed using
unpaired, two-tailed, student’s t test. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.
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Figure 10. Lymphoid tissue-resident commensal bacteria modulate
dendritic cell cytokine production in a MYD88- and TLR-dependent manner.
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Bordetella spp. for 24 hours and production of IL-1β, IL-6, IL-10, IL-12p40 and IL-23 was
measured in the culture supernatant by ELISA. (B) C57BL/6, Tlr2
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Figure

11.

Lymphoid

tissue-resident

commensal

bacteria

colonize

intestinal-associated lymphoid tissues but do not cause pathological
inflammation in gnotobiotic mice.
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Figure 11. (A) Mesenteric lymph node (mLN), (B) Peyer’s patch (PP) homogenates and (C) small
intestinal lumen contents from GF and Bordetella spp. (LRC)-monocolonized mice were cultured
to determine bacterial CFUs. Data in (A) and (B) are representative of at least 2 independent
experiments. (D) H&E staining of the small intestine and colon of conventional (CNV), germ-free
(GF) and mice LRC-monocolonized mice.
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Figure 12. Lymphoid tissue-resident commensal bacteria promote tissuespecific Th17 cell responses in gnotobiotic mice.
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Figure 12. (A) mLN, (B) PP and (C) small intestine lamina propria (SI LP) of conventionallyhoused (CNV), GF, SFB-monocolonized and LRC-monocolonized mice were analyzed for
+

+

+

frequencies of IL-17A and IFNγ CD4 T cells by flow cytometry. (D) Frequencies of Th17 cells in
CNV, GF, SFB-monocolonized and LRC-monocolonized mice. Values represent frequencies of
+

+

IL-17A cells among CD4 T cells. One-way ANOVA, mLN and SI LP - ****p < 0.0001; PP - **p <
+

+

0.01. Cells in all flow cytometry plots are gated as live, Lineage and CD4 . Lineage cocktail
consists of CD3, CD5, CD8α, CD11b and NK1.1. Data are represented as mean ± SEM. Data
are pooled from 2 independent experiments for a total of 6-8 mice per group. Statistics in D were
performed using one-way ANOVA with unpaired, two-tailed, student’s t test with no correction for
multiple comparisons. *, p < 0.05; **, p < 0.01; ****, p < 0.0001.
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Figure 13. Lymphoid tissue-resident commensal bacteria promote tissuespecific IL-22-producing Th17 cell responses in gnotobiotic mice.
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Figure 13. (A and B) PPs of CNV, GF, SFB-monocolonized and LRC-monocolonized mice were
analyzed for frequencies of IL-22-producing Th17 cells by flow cytometry. Values represent
+

+

+

frequencies of IL-22 IL-17A CD4 T cells. One way ANOVA, mLN - ****p < 0.0001; PP - **p <
0.01; SI LP - *p < 0.05. Data are pooled from 2 independent experiments for a total of 6-8 mice
+

+

+

per group. (C) Frequencies of Th1 (IFNγ of Lineage CD4 ) cells in the mLN, PP and SI LP of
CNV, GF and LRC-monocolonized mice. Lineage cocktail consists of CD3, CD5, CD8α, CD11b
and NK1.1. One-way ANOVA, mLN - **p < 0.01; PP - ****p < 0.0001; SI LP - ***p < 0.001. Data
representative of 3 independent experiments. Statistics in panel B were performed using one-way
ANOVA with unpaired, two-tailed, student’s t test with no correction for multiple comparisons.
Statistics in panel C were performed using one-way ANOVA with uncorrected Fisher’s LSD test.
*, p < 0.05; **, p < 0.01; p < 0.001; ****, p < 0.0001.
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Figure 14. Lymphoid tissue-resident commensal bacteria promote tissue
specific ILC3 responses in gnotobiotic mice
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Figure 14. (A) mLN, (B) PP and (C) SI LP of CNV, GF, SFB-monocolonized and Bordetella
(LRC)-monocolonized mice were analyzed for frequencies of ILC3 cells by flow cytometry. Cells
-

-

-

-

-

-

in (A) were gated as live and lineage (CD3 , CD5 , CD8α, CD11b , B220 , NK1.1 ). Cells in (B)
+

-

and (C) were gated as live, CD45 and lineage . (D) Quantification of ILC3 frequencies in the
mLN, PP and SI LP of CNV, GF, SFB-monocolonized and LRC-monocolonized mice. mLN ILC3
+

+

-

values represent frequencies of CD45 RORγt of lineage cells. PP and SI LP ILC3 values
+

+

-

represent frequencies of CD90 RORγt of lineage cells. One-way ANOVA, mLN - ****p < 0.0001;
PP - *p < 0.05; SI LP - **p < 0.01. Data are pooled from 2 independent experiments for a total of
6-8 mice per group. Data are represented as mean ± SEM. Statistics in panel D were performed
using one-way ANOVA with uncorrected Fisher’s LSD test. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
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Figure 15. Lymphoid tissue-resident commensal bacteria do not elicit IL-22producing ILC3 in gnotobiotic mice.
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Figure 15. (A) PPs of CNV, GF, SFB-monocolonized and LRC-monocolonized mice were
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analyzed for frequencies of IL-22 ILC3 cells by flow cytometry. Cells are gated as live, lineage ,
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CD90 and RORγt . Data are pooled from 2 independent experiments for a total of 6-8 mice per
+

group. (B) Numbers of total or IL-22 ILC3 in the mLN of CNV, GF, SFB-monocolonized and
LRC-monocolonized mice. Data are representative of 2 independent experiments with 4-5 mice
per group. Data are represented as mean ± SEM.
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Figure 16. Lymphoid tissue-resident commensal bacteria colonize
antibiotic-treated mice.
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Figure 16. Bacterial CFUs were determined in antibiotic (ABX)-treated control and ABX-resistant
R

-/-

Achromobacter (LRC )-colonized C57BL/6 (A) PP and (B) mLN homogenates or (C) Rag1 mLN
homogenates. Data are representative of at least 2 independent experiments. (D) PP of CNV,
R

ABX-treated and ABX-resistant Achromobacter (LRC )-colonized C57BL/6 mice were analyzed
+

R

for frequencies of IL-22 ILC3. One-way ANOVA, *p < 0.01. (E) LRC 16S rDNA was measured
+

R

by PCR in sorted CD11c cells from ABX-treated control or LRC -colonized Rag1

-/-

mLN. Data

are representative of 2 independent experiments with 3 mice per group. Statistics in panel D were
performed using one-way ANOVA with uncorrected Fisher’s LSD test. **, p < 0.01.
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Figure 17. Lymphoid tissue resident-commensal bacteria promote tissue-
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Figure 17. (A) Expression of Il1b, Il10 and Il23a was measured in sorted CD11c cells from ABXR
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treated control or LRC -colonized Rag1 mLN. Data pooled from 2 independent experiments for
R

a total of 6 mice per group. (B) mLNs and (C) small intestines of CNV, ABX-treated and LRC colonized were analyzed for expression of Il17a and ll22. Data pooled from 2 independent
experiments for a total of 6-8 mice per group. One-way ANOVA, mLN Il17a – ****p < 0.0001;
mLN Il22 – **p < 0.01; SI Il17a – ***p < 0.001; SI Il22 – **p < 0.01. Statistics in panel A were
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performed using one-way ANOVA and uncorrected Fisher’s LSD test. **, p < 0.01; ***, p < 0.001;
****, p < 0.0001.
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Table 1. List of publically available reference genomes used in this thesis.
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Chapter 3
Lymphoid tissue-resident commensal bacteria-induced immune pathways
are required for bacterial colonization and host tissue protection

3.1 Abstract
Trillions of commensal bacteria colonize the gastrointestinal tract of mammals.
Although most commensal bacteria are found restricted to the luminal or
epithelial surface of the intestine, some commensals, referred to as lymphoid
tissue-resident commensal bacteria (LRC), can colonize the interior of intestinalassociated lymphoid tissues. Chapter 2 demonstrated that LRCs elicit members
of the IL-10 cytokine family, including DC-derived IL-10 and ILC3-derived IL-22,
within intestinal-associated lymphoid tissues but not the small intestine lamina
propria. This Chapter will explore the functional consequences of these LRCinduced immune pathways. IL-22 production enhances LRC colonization by
restricting the colonization of other commensal microbes. Furthermore, LRCinduced IL-10 and provides host protection from lethal intestinal damage by
limiting intestinal tissue injury and systemic inflammation. Collectively, these data
reveal a novel host-commensal bacteria dialogue whereby selective subsets of
commensal bacteria interact with DCs to induce tissue-specific responses that
are mutually beneficial for both the host and microbe.
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3.2 Introduction
Commensal microorganisms, such as bacteria, fungi and viruses that colonize
our gastrointestinal tract are essential for the maintenance of host health.
Animals that lack commensal microbes or are depleted of commensals through
the use of oral antibiotics are often highly susceptible to mouse models of
infectious, inflammatory and metabolic diseases. Germ-free animals are unable
to restrict colonization and infection by the bacterial pathogens Citrobacter
rodentium, Listeria monocytogenes, Salmonella serovar Typhimurium (Inagaki et
al., 1996; Kamada et al., 2012; Stecher et al., 2005). The mechanisms for
enhanced susceptibility to bacterial colonization is largely dependent on lack of
competition from the endogenous commensal microbiota, In the presence of a
complex microbiota, which often utilize the same nutrients as pathogens,
pathogenic bacteria are rapidly outcompeted. Collectively, the endogenous
microbiota protects the host from invasive microbes by providing colonization
resistance.
The endogenous microbiota stimulates the development of intestinal and
systemic immune responses against invading pathogens. For example, germfree mice colonized with the epithelial-associated commensal SFB generate
Th17 cell responses that are protective against colonization by Citrobacter
rodentium (Ivanov et al., 2009). On the other hand, the microbiota has also been
shown to prime regulatory T cell responses, which are responsible for limiting
pro-inflammatory and pathologic immune cell responses such as Th1 and Th17
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cells. For example, the luminal commensals Bacteroides fragilis and Clostridium
spp. promote Treg responses that are protective in multiple mouse models of
intestinal inflammation (Atarashi et al., 2011; Round and Mazmanian, 2010). On
the other hand, generation of pro-inflammatory immune responses by
commensal bacteria may be detrimental to the host. Indeed, SFB-colonized
animals, which have elevated intestinal and systemic Th17 responses, are more
susceptible to experimental autoimmune encephalitis and autoimmune arthritis
(Lee et al., 2011; Wu et al., 2010).
In contrast to the hypothesis that commensal bacteria drive tissue
inflammation in colitis, germ-free mice, antibiotic-treated mice and mice lacking
the bacterial recognition adaptor protein MYD88 are all highly susceptible to
DSS-induced colitis (Ayres et al., 2012; Kitajima et al., 2001; Rakoff-Nahoum et
al., 2004). These data support the hypothesis that recognition of the endogenous
microbiota and microbiota-dependent host physiological changes are protective
in the context of intestinal inflammation. These data also suggest that a defined
consortium of commensal bacteria offers intestinal tissue protection. Indeed,
colonization of germ-free mice with Bacteroides fragilis or Clostridium spp. as
previously discussed is host protective during colitis (Atarashi et al., 2011; Round
and Mazmanian, 2010). However, other commensals, such as Prevotella and
Helicobacter, do not provide host protection and instead drive disease
development (Palm et al., 2014). Despite these findings, the functional
significance of bacteria colonization by LRCs has not been explored.
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Host biological pathways are critical for the maintenance of healthy
interactions with commensal bacteria through modulation of intestinal barrier
functions including production of anti-microbial peptides, mucus and IgA. One
pathway that is critical for maintenance of intestinal barrier function is the
production of IL-22. IL-22 is an IL-10 cytokine family member that stimulates the
production of antimicrobial peptides and delivers pro-proliferative signals to cells
necessary for host tissue homeostasis (Rutz et al., 2013; Sonnenberg et al.,
2011). In support of a role for IL-22 in regulating the microbiota, Il22-/- mice have
a dysbiotic microbiota that is transmissible and colitogenic (Zenewicz et al.,
2013). Mice that lack molecular factors upstream of the IL-22 pathway such as
Rorc-/- and Ahr-/- mice also demonstrate expansion of the epithelial-associated
commensal SFB (Qiu et al., 2013; Upadhyay et al., 2012). Furthermore, IL-22
has been shown to suppress the luminal commensal E. coli in the context of
Salmonella infection. Collectively, it can be concluded that IL-22 is a critical
cytokine that restricts luminal and epithelial-associated commensal bacteria
colonization. Despite this, the role of IL-22 induced by LRCs is not known and will
be explored in this Chapter.
Chapter 2 demonstrated that LRCs can colonize the interior of DCs in
vitro and intestinal-associated lymphoid tissues in vivo to elicit tissue-specific
Th17 and IL-22 responses. This Chapter will demonstrate that, in contrast to
previously identified roles for IL-22 in limiting intestinal colonization by
commensal bacteria (Qiu et al., 2013; Rutz et al., 2013; Shih et al., 2014;
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Upadhyay et al., 2012), IL-22 enhances LRC colonization of intestinal-associated
lymphoid tissues. On the other hand, LRC-induced IL-10 limits pro-inflammatory
responses in the steady state and could protect mice in a model of intestinal
damage. These data collectively suggest that LRCs engage in a mutualistic
dialogue with mammalian hosts by eliciting members of the IL-10 cytokine family.

3.3 Methods

3.3.1 Mice
C57BL/6 and Rag1-/- mice were purchased from Jackson Laboratories and used
at 6-12 weeks of age. Conventional mice used as controls in gnotobiotic mice
experiments were purchased from Jackson Laboratories and co-housed with
mice bred in our conventional animal facility for at least 7 days before use.
C57BL/6 and Rag1-/- mice used as controls for knockout mice were either bred in
the same animal facility as the knockout mice, purchased from Jackson
Laboratories and co-housed with mice bred in our SPF animal facility for at least
7 days or littermates as indicated to normalize for microbiota differences. All
conventional mice were maintained in specific pathogen-free facilities at the
University of Pennsylvania or Weill Cornell Medical College. Germ-free and
gnotobiotic C57BL/6 and Rag1-/- mice were maintained within sterile vinyl
isolators at the University of Pennsylvania or Weill Cornell Medical College
Gnotobiotic Mouse Facility and monitored for germ-free or gnotobiotic status by
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weekly aerobic and anaerobic culturing. Germ-free and gnotobiotic Il10+/+ and
Il10-/- mice were maintained at the National Gnotobiotic Rodent Resource Center
(University of North Carolina, Chapel Hill). Additional microbiology testing was
performed on feces from mice under experimentation and at the endpoint of the
experiment to confirm germ free or monocolonization status. DSS experiments
using gnotobiotic mice were performed in a biosafety cabinet, and the gnotobiotic
status of mice was confirmed by microbiology testing. Germ-free C57BL/6 mice
were monocolonized with the mouse LRC isolate Bordetella spp., or SFB by oral
gavage or cohousing with soiled bedding from previously monocolonized mice for
at least 10 days. To establish LRC colonization in ABX-treated mice,
conventional mice were treated in the drinking water with a limited ABX cocktail
of ampicillin (1 mg/ml, Sigma) and gentamicin (1 mg/ml, Gemini Bio-Products) for
C57BL/6, Il22-/- and Il17a-/- mice or ampicillin (1 mg/ml), gentamicin (1 mg/ml) and
neomycin (0.25 mg/ml, Sigma) for Rag1-/- and Rag1-/- Il22-/- for 3 days and then
orally gavaged with the clinical LRC isolate (LRCR), Achromobacter. Neomycin
(0.25 mg/ml), metronidazole (0.5 mg/ml, Sigma) and vancomycin (0.25 mg/ml,
Chem-Impex International) were added to the limited ABX cocktail as indicated.
Antibiotic cocktails were supplemented with 1 packet of artificial sweetener
(Sweet’N Low) per 250 ml. For cytokine treatments in vivo, rmIL-22 or PBS
control (kindly provided by Pfizer) was injected i.p. at 25 µg/mouse every 2 days
for 1 week and control- or IL-22-Fc (kindly provided by Pfizer) was injected i.p. at
50 µg/mouse every 3 days for 1 week. First injections were administered 1 day
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prior to LRCR colonization. For quantification of Th17 cells in the absence of IL10, either LRC-monocolonized Il10-/- mice, or LRC-monocolonized GF C57BL/6
mice treated with 500 µg/mouse anti-IL-10R (clone 1B1.3A, Bio X Cell) i.p. every
3 days for 1 week, was used. All mice were used at least 10 days post LRCR
colonization. All animals used are on a C57BL/6 background with the exception
of Il10-/- and Il10+/+ germ free mice, which are on a 129S6/SvEv background. All
experiments were performed according to the guidelines of the University of
Pennsylvania or Weill Cornell Medical College Institutional Animal Care and Use
Committee.

3.3.2 Microbiology
The LRC strain, Bordetella spp., used to colonize BMDCs or monocolonize germfree mice was originally isolated from the spleen of an anti-CD90.2 mAb treated
conventional Rag1-/- mice using a previously defined protocol (Sonnenberg et al.,
2012). The ABX-resistant (ampicillin, gentamicin, neomycin) LRC (LRCR),
Achromobacter used to colonize antibiotic-treated mice were human clinical
isolates kindly provided by Kaede V. Sullivan (Children’s Hospital of
Philadelphia). Bacterial identities were determined by genomic sequencing
(Wellcome Trust Sanger Institute) and confirmed by genus-specific 16S rDNA
primers. All bacterial strains used to colonize GF mice and for in vitro DC assays
were grown in LB broth and incubated at 250 RPM, 37°C for 16-20 hours. For
enumeration of tissue and fecal CFUs, the spleen, liver, feces, mesenteric lymph
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nodes (mLN) and Peyer’s patches (PP) were isolated, homogenized in sterile
PBS and plated on Brain Heart Infusion agar supplemented with 5% defibrinated
horse blood. When culturing LRCR from tissues and feces, BHI blood agar plates
were supplemented with 25 µg/ml ampicillin.

3.3.3 Quantitative real-time PCR
RNA was isolated using TRIzol reagent (Life Technologies) according to the
manufacturer’s instructions. cDNA was generated using Superscript reverse
transcriptase II (Invitrogen). Quantitative real-time PCR was performed using
SYBR green chemistry (Invitrogen) and QuantiTect Primer Assays (Qiagen) on
the ABI 7500 real-time PCR system (Applied Biosystems). Samples were
normalized to β-actin and displayed as fold change over antibiotic-treated mice.

3.3.4 Flow cytometry
Peyer’s patches were harvested and single-cell suspensions were prepared at
necropsy. For flow cytometric analyses, cells were stained with antibodies
against the following markers: anti-NK1.1 (clone PK136, eBioscience), anti-CD3
(clone 145-2C11, eBioscience), anti-CD5 (clone 53-7.3, eBioscience), antiCD11c (clone N418, eBioscience), anti-CD4 (clone GK1.5, Abcam), anti-CD8α
(clone 53-6.7, eBioscience), anti-B220 (clone RA3-6B2, eBioscience), anti-CD45
(clone 30-F11, eBioscience) and anti-CD11b (clone M1/70, eBioscience). For
intracellular staining of RORγt, cells were fixed and permeabilized with the Foxp3
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intracellular staining buffer set (eBioscience) and stained with anti-RORγt (clone
B2D, eBioscience). For intracellular cytokine staining, cells were stimulated ex
vivo by incubation for 4 h with 50 ng/mL PMA, 750 ng/mL ionomycin, 10 µg/mL
Brefeldin A (all obtained from Sigma-Aldrich) and 50 ng/mL rmIL-23
(eBioscience) and permeabilized as indicated above and stained anti-IL22-02
(mouse cytokine detection antibody developed by Pfizer). Dead cells were
excluded from analysis using the Live/Dead Aqua Viability Kit (Invitrogen). Flow
cytometry data collection was performed on the LSR II (BD Biosciences). Data
were analyzed using FlowJo software (Tree Star Inc.).

3.3.5 DSS-induced intestinal damage
Mice were administered 2% DSS (MW 36,000-50,000, MP Biochemicals) in their
drinking water ad libitum for the number of days indicated and then placed on
regular drinking water. Disease severity was cumulatively scored based on rectal
bleeding (out of 2), fecal consistency (out of 2), general appearance (out of 4),
weight loss (out of 4) and rectal temperature (out of 4). For antibody treatments
during DSS, mice were administered i.p. 500 µg/mouse of rat IgG, anti-IL22-01
(mouse neutralizing antibody developed by Pfizer) or anti-IL-10R (clone 1B1.3A,
Bio X Cell) 1 day prior to DSS treatment, then on days 2, 5 and 7. Mice were
sacrificed on day 8.
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3.3.6 Histology
Tissues from the small and large intestines were fixed with 4% PFA, embedded
in paraffin, and 5 µm sections were cut and stained with H&E.

3.3.7 Statistical analyses
Results represent mean ± SEM and statistical analyses were performed by
unpaired student’s t-test, Mann-Whitney test, or one- or two-way ANOVA with or
without multiple comparisons tests as indicated in figure legends.

3.4 Results

3.4.1 Loss of IL-22 is associated with impaired colonization by lymphoid
tissue-resident commensal bacteria
Multiple reports suggest that IL-17A and IL-22 limit intestinal colonization of the
commensal bacterium SFB (Qiu et al., 2013; Rutz et al., 2013; Shih et al., 2014;
Upadhyay et al., 2012). Therefore, we hypothesized that induction of IL-17A and
IL-22 by LRCs would be important in limiting its own colonization in intestinalassociated lymphoid tissues. To examine the role for IL-17A and IL-22 in LRC
colonization, ABX-treated C57BL/6, Il17a-/- and Il22-/- mice were inoculated with
LRCR and lymphoid tissue colonization was assessed 10 days post-inoculation.
Based on the requirement for IL-22 in restricting Alcaligenes dissemination
(Sonnenberg et al., 2012), we also predicted that colonization of Il22-/- mice with
93

LRCR would result in systemic dissemination of LRCR. However, systemic
dissemination of LRCR was not observed in the absence of either IL-17A or IL-22
(Figure 18A). Furthermore, analysis of intestinal-associated lymphoid tissues
revealed an impaired ability of LRCR to colonize the mLN and PPs of Il22-/- but
not C57BL/6 or Il17a-/- mice (Figure 19A and 19B). These data suggest that IL-22
may also facilitate colonization of lymphoid tissues by commensal bacteria.
ILC3s are major producers of IL-22 in the intestine of healthy mammals (Artis
and Spits, 2015; Diefenbach et al., 2014; McKenzie et al., 2014; Sonnenberg and
Artis, 2012, 2015; Sonnenberg et al., 2012). To test whether innate cell-derived
IL-22 could impact lymphoid tissue colonization by commensal bacteria, we
inoculated ABX-treated Rag1-/- and Rag1-/-Il22-/- mice with LRCR and measured
lymphoid tissue colonization. Similar to the findings using lymphocyte-sufficient
Il22-/- mice, inoculation of Rag1-/-Il22-/- mice with LRCR did not result in systemic
dissemination of LRCR (Figure 18B), but resulted in impaired LRCR colonization
in the mLN (Figure 19C). Collectively, these results suggest that induction of ILCderived IL-22 by LRCs is important to facilitate its colonization of lymphoid
tissues.

3.4.2 Impaired lymphoid tissue-resident commensal bacteria colonization in
Il22-/- mice is dependent on a dominant and transmissible microbiota
Expression of the IL-22 receptor is restricted to non-hematopoietic cells and IL22-IL-22R signaling regulates antimicrobial responses in the intestinal lumen and
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the composition of the microbiota (Qiu et al., 2013; Shih et al., 2014; Sonnenberg
et al., 2011; Zenewicz et al., 2013). Therefore, rather than a direct effect on DCs,
we hypothesized that in the absence of IL-22 there may be an expansion of
commensal bacteria that outcompete and limit LRC entry and colonization. To
investigate this hypothesis, we measured luminal bacterial colonization in
C57BL/6, Il22-/-, Il17a-/-, Rag1-/- and Rag1-/-Il22-/- mice that were treated with a
limited ABX cocktail followed by LRCR inoculation. At 10 days post-inoculation,
we detected an absence of fecal LRCR in Il22-/- and Rag1-/-Il22-/- but not in
C57BL/6, Rag1-/- and Il17a-/- mice (Figure 20A and 20B). Il22+/+ littermates raised
under the same conditions as Il22-/- mice also have impaired ABX-mediated fecal
LRC colonization, and administration of additional antibiotics including neomycin,
metronidazole and vancomycin, restored fecal LRC colonization in Il22-/- mice
and Il22+/+ littermates (Figure 20C). Furthermore, cohousing Il22-/- mice with
C57BL/6 mice impaired fecal and lymphoid tissue LRC colonization in C57BL/6
mice (Figure 20D). Altogether, these data indicate that IL-22 promotes LRC
colonization by limiting competition with other commensal microbes.

3.4.3 Exogenous administration of IL-22 enhances lymphoid tissue-resident
commensal bacteria colonization
To further interrogate the role of IL-22 in regulating LRC colonization, we pursued
a gain-of-function approach. Consistent with a role for IL-22 in promoting
lymphoid tissue colonization by LRCs, exogenous administration of recombinant
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mouse IL-22 to LRCR-colonized Rag1-/- mice significantly enhanced LRCR levels
in the mLN (Figure 19D). These data suggest that IL-22 is sufficient to promote
lymphoid tissue colonization by LRCs.

3.4.4

IL-22

regulates

lymphoid

tissue-resident

commensal

bacteria

colonization in the presence of a complex microbiota
The LRCR colonization model requires the use of antibiotics that eliminate most
commensal bacteria in the intestine. To test the requirement for IL-22 in LRC
colonization in the presence of a complex microbiota, we measured levels of the
endogenous LRC, Alcaligenes by fluorescence in situ hybridization (FISH) in
conventional Il22-/- mice and littermate controls. Compared to Il22+/+ littermates,
conventional Il22-/- mice have reduced Alcaligenes puncta in the PP and mLN
(Figure 21A and 21B). These data demonstrate that IL-22 plays a critical role in
enhancing the colonization of intestinal-associated lymphoid tissues by LRCs in
the presence of a complex microbiota.

3.4.5 Loss of IL-10 results in elevated lymphoid tissue-resident commensal
bacteria-induced Th17 cell responses in gnotobiotic mice
Although induction of Th17 cell responses were observed in the PP and mLN of
LRC-monocolonized mice, the magnitude of these responses was lower than that
observed in SFB-monocolonized mice (Figure 12A-D), raising the possibility that
LRCs are less efficient at inducing Th17 cell responses or are actively limiting
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Th17 cell responses. Since LRCs could promote IL-10 by DCs (Figures 9A-D
and 17A) and IL-10 has been shown to suppress IL-17 responses (Liu et al.,
2011a; McGeachy et al., 2007; Ouyang et al., 2011), we hypothesized that IL-10
may restrain LRC-induced Th17 cell responses. Consistent with this hypothesis,
Th17 cells were significantly increased in the mLN (Figure 22A and 22B) and PP
(Figure 22C and 22D) of LRC-monocolonized Il10-/- mice compared to LRCmonocolonized wild type mice. Collectively, these data demonstrate that LRCs
selectively promote local Th17 cell responses in intestinal-associated lymphoid
tissues, and that the magnitude of these responses is limited by co-induction of
IL-10.

3.4.6 Lymphoid tissue-resident commensal bacteria colonization provides
host protection from DSS-induced intestinal inflammation and injury
IL-22 is important for regulating immune homeostasis and maintenance of the
intestinal barrier following infection or tissue damage (Ouyang et al., 2011; Rutz
et al., 2013; Sonnenberg et al., 2011). The finding that LRCs induce IL-22 raises
the possibility that LRCs may provide intestinal protection following tissue
damage. To test this, we employed a model of intestinal damage where
administration of the chemical, dextran sodium sulfate (DSS), induces significant
damage to the colonic epithelium. Compared to CNV mice, mice lacking
commensal bacteria or treated orally with a broad-spectrum cocktail of antibiotics
are highly sensitive to intestinal damage induced by DSS and succumb to
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disease (Ayres et al., 2012; Kitajima et al., 2001; Maslowski et al., 2009). To test
the functional significance of LRC colonization following DSS treatment, we
administered 2% DSS to CNV, ABX-treated alone and LRCR-colonized Rag1-/mice for 6-7 days, then removed DSS, re-administered normal drinking water and
monitored their survival, weight loss and parameters of inflammation. Compared
to CNV mice, which survived throughout the duration of the experiment (21
days), ABX-treated mice exhibited significant systemic and intestinal morbidity
and succumbed to disease by day 10 post DSS administration (Figure 23A, 23C
and 23D). In contrast, LRCR-colonized mice were largely protected from DSSinduced mortality, and demonstrated significantly reduced weight loss and
elevated red blood cell counts as compared to ABX-treated controls (Figure 23AD). Further, analysis of intestinal tissue damage on day 5 post DSS
administration revealed that although CNV mice did not exhibit significant
intestinal damage or inflammation in the colon at this low dose of DSS, the
colons of ABX-treated mice displayed severe loss of crypt architecture and
extensive inflammation (Figure 24). In contrast, LRCR-colonized mice had visible
but reduced intestinal tissue damage and inflammation (Figure 24). LRCRconferred protection from DSS-induced mortality was also observed in
gnotobiotic C57BL/6 (Figure 25A) and Rag1-/- (Figure 25B) mice monocolonized
with the mouse-derived LRC, Bordetella spp., suggesting that host protection can
occur in the absence of other commensal bacteria. Collectively, these data
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demonstrate that colonization of lymphoid tissues by selective commensal
bacteria is host beneficial in the context of intestinal damage and inflammation.

3.4.7 Lymphoid tissue-resident commensal bacteria-induced IL-10 provides
host

protection

from

DSS-induced

intestinal

injury

and

systemic

inflammation
To investigate whether LRC-induced IL-22 is providing host protection in LRCRcolonized mice, we administered anti-IL-22 neutralizing antibody to LRCRcolonized Rag1-/- mice during exposure to DSS. Anti-IL-22-treated mice exhibited
comparable weight loss to IgG-treated mice (Figure 26C), suggesting that IL-22
is not involved in LRC-mediated host protection from DSS. As the antiinflammatory cytokine IL-10 was also induced upon LRC colonization both in the
steady state and during DSS exposure (Figure 9, 17A and Figure 26A), we
interrogated whether innate cell-derived IL-10 is providing host protection in
LRCR-colonized mice. To test this, we administered anti-IL-10R neutralizing
antibody to LRCR-colonized Rag1-/- mice during exposure to DSS. Blockade of
IL-10-IL-10R interactions resulted in increased weight loss and colonic
inflammation as compared to IgG-treated controls (Figure 26D, 27). ABX-treated
Rag1-/- mice on DSS water display elevated levels of serum IFNγ, which was
significantly diminished in LRCR-colonized Rag1-/- mice (Figure 26B). Conversely,
IL-10R neutralization in LRCR-colonized mice partially restored serum IFNγ levels
observed in ABX-treated mice (Figure 26B). Treatment of ABX-only control Rag199

/-

animals with anti-IL-10R during DSS exposure did not result in further weight

loss or colon pathology compared to isotype-treated animals (Figure 28A-B).
Collectively, these data suggest that LRC colonization protects mice from acute
intestinal injury and systemic inflammatory responses through induction of innate
cell-derived IL-10.

3.5 Discussion
This Chapter explores the role of LRC-induced immune pathways in the steady
state and in the context of acute intestinal injury. The data suggest that LRCs
induce IL-10 and IL-22, members of the IL-10 cytokine family, to establish
beneficial host-commensal interactions (Figure 29).
Multiple reports suggest that induction of the ILC3-IL-22 pathway limits
host colonization by pathogenic attaching and effacing bacterial pathogens such
as Citrobacter rodentium or the commensal bacterium SFB (Qiu et al., 2013;
Rutz et al., 2013; Shih et al., 2014; Sonnenberg et al., 2011; Upadhyay et al.,
2012). In contrast, the data in this Chapter demonstrate that IL-22 facilitates
colonization of lymphoid tissues by LRCs. Il22-/- mice harbor intestinal microbes
that limit LRC colonization in the lumen likely through competition for space or
nutrients. This is consistent with IL-22-induced antimicrobial functions on grampositive commensal bacteria (Hooper and Macpherson, 2010; Rutz et al., 2013;
Sonnenberg et al., 2011). This also agrees with a report demonstrating a role for
IL-22-induced lipocalin and calprotectin in enhancing Salmonella infection by
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suppressing commensal Enterobactericeae (Behnsen et al., 2014). Critically,
recombinant IL-22 enhanced LRC colonization in Rag1-/- mice, and reduced
endogenous LRC colonization was observed in CNV Il22-/- compared to littermate
controls. Reduction of endogenous LRCs in CNV Il22-/- mice may be due to
dysbiosis as Il22-/- mice have an altered and a transmissible microbiota
(Zenewicz et al., 2013). These data collectively suggest that IL-22 indirectly
promotes LRC colonization in multiple contexts by restricting colonization of
competing intestinal microbes.
It was previously reported that ILC3-derived IL-22 is a critical pathway that
maintains anatomical containment of LRCs in intestinal-associated lymphoid
tissues in healthy mice and that transient loss of this pathway results in
dissemination of Alcaligenes to systemic lymphoid tissues (Sonnenberg et al.,
2012). In the current study, systemic dissemination of a distinct but related LRC,
Achromobacter was not observed in the absence of IL-22. Rather, Il22-/- and
Rag1-/- Il22-/- mice had impaired lymphoid tissue entry and colonization.
Therefore, the findings in this Chapter highlight a multifaceted role for IL-22 in
maintaining anatomical localization of LRCs, by both promoting lymphoid tissue
colonization and limiting systemic dissemination.
LRC colonization is sufficient to protect wild type and lymphocyte-deficient
mice from lethal intestinal damage, supporting the hypothesis that host
recognition of commensal bacteria provides beneficial microbial stimulation to
limit intestinal injury. It was previously demonstrated that mice lacking the pattern
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recognition receptors TLR2, TLR4 or the downstream adaptor molecule MYD88
are also susceptible to lethal DSS-induced intestinal damage (Rakoff-Nahoum et
al., 2004), suggesting that direct recognition of microbial signals is critical for
maintenance of the intestinal barrier. Despite our understanding of microbial
recognition pathways in host protection from intestinal injury, the downstream
signals induced are not fully understood. The data in this Chapter suggest that
MYD88-dependent IL-10 induction by LRCs is one pathway that provides tissue
protective functions in the context of intestinal injury and systemic inflammation.
These data are consistent with the anti-inflammatory and tissue protective roles
of IL-10 in the intestine (Asseman et al., 1999; Kuhn et al., 1993; Ouyang et al.,
2011) and that innate and adaptive IL-10 responses in the intestine are
dramatically driven by the microbiota (Atarashi et al., 2011; Chiu and Ching,
2014; Geuking et al., 2011; Liu et al., 2011b; Ueda et al., 2010). The data in this
Chapter support a model whereby, following LRC colonization, IL-10 produced by
DCs in intestinal-associated lymphoid tissues has local effects in limiting Th17
cell responses in lymphoid tissues in the steady state, as well as distal effects on
the intestinal epithelium and systemic circulation in the context of intestinal
damage.
Collectively, the findings in this Chapter demonstrate a previously
unrecognized and mutually beneficial dialogue between the host and lymphoid
tissue-resident commensal bacteria (Figure 29). Colonization of lymphoid tissues
by commensal bacteria modulates the host immune system in a tissue-specific
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manner and confers protective effects in the context of intestinal damage. From
an evolutionary perspective, there may be multiple beneficial functions for
permitting colonization of mammalian lymphoid tissues by commensal bacteria.
However, it is likely that a tightly regulated balance between beneficial and
pathologic commensal colonization must be maintained in order to prevent
pathologic inflammation.
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Figure 18. Colonization of IL-22-deficient animals by lymphoid tissueresident
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Figure 18. (A) Bacterial CFUs were determined in spleen homogenates of LRC -gavaged
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LRC -gavaged Rag1 and Rag1 Il22 mice. ND, not detectable.

104

Figure 19. Loss of IL-22 is associated with impaired colonization by
lymphoid tissue-resident commensal bacteria.
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Figure 19. (A and B) mLN and PP homogenates from LRC -colonized C57BL6, Il17a and Il22

-/-

mice were cultured to determine CFUs. Data are representative of at least 2 independent
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experiments (C) mLN homogenates from LRC -colonized Rag1

-/-

and Rag1
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Il22
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mice were

cultured to determine CFUs. Data pooled from 2 independent experiments for a total of 5-6 mice
per group. (D) mLN homogenates from control or recombinant mouse IL-22 (rIL-22)-treated Rag1
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-

mice were cultured to determine CFUs. Data representative of 2 independent experiments using

recombinant mouse IL-22 or IL-22-Fc. Data are represented as mean ± SEM. Statistics in panels
D were performed using unpaired, two-tailed, student’s t test. *, p < 0.05; ND, not detectable.
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Figure 20. (A and B) Fecal CFUs were determined in LRC -gavaged C57BL/6, Il17a , Il22 ,
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and Rag1 Il22
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mice following treatment with neomycin, metronidazole and vancomycin (NMV)

for 1 week. One-way ANOVA, ****, p < 0.0001. (D) Fecal and mLN CFUs were determined in AGR

treated, LRC -gavaged C57BL/6, C57BL/6 mice co-housed with Il22
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(C57BL/6 CH) and Il22
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mice. Data in B, C and D are representative of 2 independent experiments. Statistics in panel C
were performed using one-way ANOVA and the Tukey’s multiple comparisons test. **, p < 0.01;
***, p < 0.001; ****, p < 0.0001.
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Figure 21. IL-22 regulates lymphoid tissue-resident commensal bacteria
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Figure 21. (A) Whole PP and (B) mLN were stained with Alcaligenes-specific 16S FISH probes
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107

Figure 22. Loss of IL-10 results in elevated lymphoid tissue-resident
commensal bacteria-induced Th17 cell response in gnotobiotic mice.
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Figure 23. Lymphoid tissue-resident commensal bacteria colonization
provides host protection from DSS-induced mortality and weight loss.
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Figure 23. CNV, ABX-treated and ABX-resistant Achromobacter (LRC )-colonized-colonized
-/-

Rag1 mice were administered 2% DSS in their drinking water for 6 to 7 days and then placed on
regular drinking water. Mice were monitored for survival (A) and weight loss (B) for up to 21 days.
Data in panel A are pooled from 2 independent experiments for a total of 8-9 mice per group. (C)
R

Disease score for CNV, ABX and LRC -colonized Rag1

-/-

mice treated with 2% DSS in drinking
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water for 6 days. (D) Red blood cell (RBC) counts for ABX and LRC -colonized Rag1

-/-

mice

treated with 2% DSS in drinking water for 8 days. Data pooled from 2 independent experiments
for a total of 4-7 mice per group. Data are represented as mean ± SEM. Statistics in panels B, C
and D were performed using unpaired, two-tailed, student’s t test with no correction for multiple
comparisons. * p < 0.05; ***, p < 0.0001.
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Figure 24. Lymphoid tissue-resident commensal bacteria colonization
provides host protection from DSS-induced intestinal injury.
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Figure 24. CNV, ABX-treated and ABX-resistant Achromobacter (LRC )-colonized-colonized
-/-

Rag1 mice were administered 2% DSS in their drinking water for 6 to 7 days and then placed on
regular drinking water. Mice were monitored for survival. Mice were sacrificed on day 6 and
analyzed for colon tissue pathology and inflammatory infiltrate by H&E. Data are representative of
2 independent experiments. Scale bar – 100 µm.
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Figure 25. Lymphoid tissue-resident commensal bacteria provide host
protection from DSS-induced mortality in gnotobiotic mice.
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Figure 25. (A) CNV, GF and Bordetella-monocolonized C57BL/6 mice were administered 2%
DSS in the drinking water for 5 days and then placed on regular drinking water. CNV, n = 3; GF, n
= 7; Bordetella-monocolonized, n = 9. (B) GF and Bordetella-monocolonized Rag1
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administered 2% DSS in the drinking water for 7-9 days and then placed on regular drinking
water for the duration of the experiment. GF, n = 6; Bordetella-monocolonized, n = 6. Data in
panels A and B are pooled from 2 independent experiments.
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Figure 26. Lymphoid tissue-resident commensal bacteria-induced IL-10
provides host protection from DSS-induced weight loss and systemic
inflammation.
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Figure 26. (A) Analysis of Il10 expression in the colon of 2% DSS-treated CNV, ABX-treated or
R

LRC -colonized Rag1

-/-

mice at day 6 post-DSS treatment. Data in A are pooled from 2

independent experiments with a total of 5-7 mice per group. (B) Serum IFNγ on day 8 post-DSS
treatment. Data in panel B are pooled from 3 independent experiments for a total of 8-12 mice per
R

-/-

group. One-way ANOVA - **p < 0.01. (C and D) ABX and LRC -colonized Rag1 mice given rat
IgG, anti-IL-22 or anti-IL-10R were treated with 2% DSS in the drinking water for 8 days and
monitored for weight loss. Data in C are representative of 2 independent experiments. Data in D
represent pooled data from 3 independent experiments. Data are represented as mean ± SEM.
Statistics were performed using one-way ANOVA with uncorrected Fisher’s LSD test (B, D) or
Mann-Whitney test with no correction for multiple comparisons (A). *, p < 0.05; **, p < 0.01; ***, p
< 0.001.
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Figure 27. Lymphoid tissue-resident commensal bacteria-induced IL-10
provides host protection from DSS-induced intestinal injury.
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DSS
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R
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Figure 27. ABX, LRC -colonized Rag1 mice given rat IgG or anti-IL-10R were treated with 2%
DSS in the drinking water for 8 days and colon pathology was assessed on day 8. Scale bar –
100 µm. Data are representative of 2 independent experiments.
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Figure 28. Blockade of IL-10-IL-10R interactions in antibiotic-treated mice is
not associated with enhanced intestinal tissue damage induced by DSS.
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Figure 28. (A) Weight loss and (B) colon pathology of ABX-treated, rat IgG or anti-IL-10R-/-

injected Rag1 mice given 2% DSS for 9 days. Scale bar – 100 µm. Data are representative of 2
independent experiments.
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29.
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Figure 29. Lymphoid tissue-resident commensal bacteria (LRC) colonize DCs in host intestinalassociated lymphoid tissues to elicit pro- and anti-inflammatory cytokines. Colonization of
lymphoid tissues by LRCs is also associated with the induction of tissue-specific Th17 cell and
ILC3 responses. IL-22 enhances LRC colonization in lymphoid tissues by limiting colonization of
other commensal bacteria. LRC-induced IL-10 limits intestinal tissue damage and suppresses
systemic inflammation.
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Chapter 4
The iron-regulatory hormone hepcidin regulates host-microbe interactions
and immune cell homeostasis

4.1 Abstract
Chronic inflammatory diseases are often associated with altered iron
homeostasis. For example, patients with inflammatory bowel disease frequently
exhibit anemia that is dependent on increased expression of the iron-regulatory
hormone hepcidin. Hepcidin is expressed and secreted by hepatocytes and acts
to limits iron absorption in the intestine and iron release from intracellular stores.
Despite our understanding of hepcidin-mediated iron regulation, its role in
immune cell function and host-commensal bacteria relationships is not well
understood. This Chapter demonstrates that, in addition to hepatocytes, bone
marrow-derived dendritic cells (BMDC) can express hepcidin and upregulate its
expression following exposure to LRCs. Furthermore, dendritic cell (DC)-intrinsic
hepcidin is required for intracellular colonization by LRCs. Examination of
hepcidin-deficient mice also revealed elevated levels of the pro-inflammatory
cytokines Il1b and Il6 and increased frequencies of IL-17A- and IFNγ-producing
CD4 T cells in intestinal-associated lymphoid tissues. Consistent with a role for
Th17 and Th1 cells in the pathogenesis of intestinal inflammation, hepcidindeficient mice exhibit delayed recovery from acute intestinal injury. Altogether,
these results highlight a previously unrecognized role for hepcidin in immune
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homeostasis and host-commensal bacteria interactions at the steady state and
during intestinal inflammation.

4.2 Introduction
Iron is an essential nutrient for all living organisms. The uptake, transport and
storage of iron are tightly regulated biological processes that are coordinated by
multiple molecular components. In mammals, one critical pathway involves the
iron-regulatory hormone hepcidin. Hepcidin, a 25-amino acid peptide that is
secreted primarily by liver hepatocytes, binds to and results in the degradation of
the membrane-bound iron exporter ferroportin (Cassat and Skaar, 2013; Ganz
and Nemeth, 2015; Zhao et al., 2013). As a result, hepcidin-ferroportin
interactions control iron levels in the plasma and intracellular stores. Hepcidin
expression is regulated cell-extrinsically by three major factors: plasma iron
levels, inflammatory cytokines and erythropoiesis. Studies have demonstrated
that upregulation of hepcidin during inflammation functions as a host protective
pathway to prevent extracellular pathogen infection by limiting their access to
iron. For example, hepcidin-deficient mice are highly susceptible to infection by
the pathogens Vibrio vulnificus and Yersinia enterocolitica (Arezes et al., 2015;
Quenee et al., 2012). Conversely, hepcidin deficiency may be protective during
infection by obligate intracellular pathogens due to low intracellular iron, an
essential nutrient for these microbes. Mice with a mutation in HFE, an adaptor for
iron sensing, have reduced intracellular iron due to impaired expression of
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hepcidin (Wang et al., 2008). Hfe-/- mice displayed prolonged survival and
enhanced control of bacterial replication during septicemia from the intracellular
pathogen Salmonella Typhimurium (Nairz et al., 2009). Furthermore, Hfe-/macrophages had reduced bacterial load compared to wild-type macrophages
when

infected

with

Salmonella

Typhimurium.

Altogether,

these

results

demonstrate that hepcidin-regulated iron homeostasis is a critical pathway for the
maintenance of antibacterial host responses.
Although the interaction between hepcidin and ferroportin has been well
characterized, the role of hepcidin in regulating host-commensal relationships
and immune cell function is not well understood. This Chapter will demonstrate
that in addition to hepatocytes, DCs are a cellular source of hepcidin in vitro, and
in the absence of hepcidin, LRC colonization in DCs is impaired. In the absence
of hepcidin in vivo, mice exhibit elevated pro-inflammatory cytokine production
and IL-17A+ and IFNγ+ CD4 T cell responses in the gut draining lymph node.
Consistent with a role for Th1 and Th17 cells in the pathogenesis of intestinal
inflammation, loss of hepcidin is associated with exacerbated tissue damage and
delayed recovery from acute intestinal injury. These results define iron
homeostasis as a critical pathway regulating immune cell homeostasis and hostcommensal bacteria relationships in the intestine and associated lymphoid
tissues.
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4.3 Methods

4.3.1 Mice
C57BL/6 mice were purchased from Jackson Laboratories. Hamp1-/- mice on a
C57BL/6 background were generated by Sophie Vaulont (Lesbordes-Brion et al.,
2006) and kindly provided by Stefano Rivella (Children’s Hospital of
Philadelphia). Genome scanning for 153 SNPs confirmed that Hamp1-/- mice are
98.67% C57BL/6 (Jackson Laboratories). Age and gender matched C57BL/6
mice used as controls were purchased from Jackson Laboratories and cohoused
with Hamp1-/- mice for at least 3 weeks before use. Analysis of fecal 16S rDNA
qPCR for groups of common mouse commensal bacteria showed that microbiota
of Hamp1-/- mice did not differ significantly from wild-type mice at the phylum and
genus levels following cohousing. All experiments were performed according to
the guidelines of the Weill Cornell Medical College Institutional Animal Care and
Use Committee.

4.3.2 Bone marrow-derived dendritic cells
Bone marrow-derived DCs were generated by culturing bone marrow cells from
C57BL/6 and Hamp1-/- mice in the presence of 20 ng/mL GM-CSF for 8-10 days.
Culture media was replaced with fresh media every 3 days. Frequencies of
CD11c+ cells were ≥ 95%. For intracellular bacterial survival assays, BMDCs
were seeded on 6-well plates at 5 x 106 cells/well in antibiotic-free media and co	
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cultured with bacteria at an MOI of 50 for 2 hours, harvested and washed 3 times
with sterile PBS. BMDCs were then plated in media containing gentamicin (100
µg/mL) at 200,000 cells/well on 48-well plates and lysed with sterile water every
48 hours to enumerate CFUs. For gene expression analyses, BMDCs were cocultured with bacteria at an MOI of 50 for 2 hours and then gentamicin-treated to
kill extracellular bacteria. Cell lysates were prepared 24 hours later. All cell
incubations were performed at 37°C and 5% CO2.

4.3.3 Gene expression profiling and quantitative real-time PCR
RNA was isolated from BMDCs using the RNeasy Mini Kit (Qiagen) according to
the manufacturer’s instructions. cDNA was generated using Superscript reverse
transcriptase II (Invitrogen). Quantitative real-time PCR was performed using
SYBR green chemistry (Invitrogen) and QuantiTect Primer Assays (Qiagen) on
the ABI 7500 real-time PCR system (Applied Biosystems). Samples were
normalized to β-actin and displayed as fold change over PBS-treated BMDCs.
For microarray analysis, BMDCs colonized with the LRC, Bordetella spp., for 4
days were lysed directly in TRIzol. RNA was isolated, amplified, reversetranscribed to cDNA and hybridized to an Affymetrix GeneChip (Mouse Gene
1.0ST) by the University of Pennsylvania Molecular Profiling Facility. Relative
expression data was normalized by Z score transformation.
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4.3.4 DSS-induced intestinal damage
Mice were administered 2.5% DSS (MW 36,000-50,000, MP Biochemicals) in
their drinking water ad libitum for 7 days and then placed on regular drinking
water. Mice were monitored for weight loss throughout the course of the
experiment.

4.3.5 Flow cytometry
Mesenteric lymph nodes were excised and single-cell suspensions were
prepared at necropsy. For large intestine lamina propria preparations, intestines
were excised, attached fat and PPs were removed and tissues were cut open
longitudinally. Luminal contents were removed by shaking in cold PBS. Epithelial
cells and intra-epithelial lymphocytes were removed by shaking tissue in stripping
buffer (100 I.U./ml pencillin, 100 µg/ml streptomycin, 1 mM EDTA, 1 mM DTT
and 5% FCS) at 37°C for 30 minutes. The lamina propria layer was isolated by
digesting the remaining tissue in 1 mg/mL collagenase/dispase (Roche) and 20
µg/mL DNase I (Sigma-Aldrich) for 30 minutes at 37°C. For flow cytometric
analyses, cells were stained with antibodies against the following markers: antiCD3 (clone 145-2C11, eBioscience), anti-CD5 (clone 53-7.3, eBioscience), antiCD4 (clone GK1.5, Abcam), and anti-CD45 (clone 30-F11, eBioscience). For
intracellular staining of RORγt, cells were fixed and permeabilized with the Foxp3
intracellular staining buffer set (eBioscience) and stained with anti-RORγt (clone
B2D, eBioscience). For intracellular cytokine staining, cells were stimulated ex
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vivo by incubation for 4 h with 50 ng/mL PMA, 750 ng/mL ionomycin, 10 µg/mL
Brefeldin A (all obtained from Sigma-Aldrich) and permeabilized as indicated
above and stained with anti-IL-17A (clone eBioTC11-18H10.1, eBioscience),
anti-IFN-γ (clone XMG1.2, eBioscience) and anti-TNFα (clone MP6-XT22,
eBioscience). Dead cells were excluded from analysis using the Live/Dead Aqua
Viability Kit (Invitrogen). Flow cytometry data collection was performed on the
LSR Fortessa (BD Biosciences). Data were analyzed using FlowJo software
(Tree Star Inc.).

4.3.6 Histology
Tissues from the large intestines were fixed with 4% PFA, embedded in paraffin,
and 5 µm sections were cut and stained with H&E.

4.3.7 Statistical analyses
Results represent mean ± SEM and statistical analyses were performed by
unpaired student’s t-test, one- or two-way ANOVA with or without multiple
comparisons tests as indicated in figure legends.

4.3.8 Data accessibility
Array data have been deposited in GEO under accession number GSE76731.
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4.4 Results

4.4.1 Bone marrow-derived dendritic cells upregulate hepcidin expression
following exposure to lymphoid tissue-resident commensal bacteria
In Chapter 2, microarray-based gene expression profiling was performed on DCs
colonized with the mouse-derived LRC, Bordetella spp. compared to DCs treated
with PBS. Analysis of these results indicated that colonization of Bordetella
significantly altered the expression of genes associated with iron storage,
transport and uptake, which include those that encode for transferrin, transferrin
receptor, ferroportin, lipocalin 2 and hemoglobin beta-chain (Figure 30).
Hepcidin, encoded by Hamp1, was also highly upregulated in Bordetellacolonized DCs and is considered to be a master regulator of systemic iron
homeostasis. Upregulation of Hamp1 in bacterial-colonized DCs was confirmed
by real time PCR (Figure 31). To investigate whether bacterial-derived products
are sufficient to induce hepcidin, BMDCs were treated with various TLR ligands
for 24 hours and hepcidin expression was measured. Consistent with exposure
to whole bacteria, BMDCs exposed to LPS, Pam3CSK4 and CpG DNA
upregulated Hamp1 (Figure 31). Collectively, these data suggest that in addition
to hepatocytes, BMDCs are a cellular source of hepcidin and BMDCs can
upregulate hepcidin in response to bacteria in vitro.
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4.4.2 Loss of hepcidin in bone marrow-derived dendritic cells results in
impaired intracellular bacterial survival by lymphoid tissue-resident
commensal bacteria
Data from Chapter 2 demonstrated that LRCs could persist and survive in bone
marrow-derived and primary DCs (Figure 7B-D). Given the role of hepcidin in
modulating intracellular iron, an essential nutrient for most microbes, and that
hepcidin is upregulated in BMDCs following LRC colonization, one hypothesis is
that Hamp1-/- BMDCs will not support intracellular colonization by LRCs. To test
this, wild-type or Hamp1-/- BMDCs were exposed to the mouse LRC, Bordetella
spp. or the non-LRC, E. coli, and intracellular survival was assessed over time.
Although Bordetella spp. initially colonized Hamp1-/- BMDCs, the amount of live
Bordetella spp. that survived in Hamp1-/- BMDCs was significantly reduced at 48
and 96 hours post-colonization (Figure 32). In contrast, E. coli survival was not
affected by hepcidin deficiency. Collectively, these results suggest that DCintrinsic hepcidin is important for efficient intracellular colonization by LRCs.

4.4.3 Loss of hepcidin is associated with altered immune cell homeostasis
in vivo
Hepcidin is induced in vivo by inflammatory cytokines, such as IL-6, generated
during host exposure to microorganisms including fungi, bacteria and viruses
(Nemeth et al., 2004). In Hamp1-/- mice, levels of serum and liver iron are
significantly increased whereas splenic iron levels are significantly decreased
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(Lesbordes-Brion et al., 2006). Despite these data, the role of hepcidin in
immune cell homeostasis in vivo has not been well characterized. To test this,
Hamp1-/- mice were analyzed for expression of innate immune cytokines. Gene
expression analyses of innate cell-derived cytokines in the mLN of Hamp1-/- mice
indicated elevated expression of the pro-inflammatory cytokines Il1b and Il6 but
not Il10 and Il12b (Figure 33). Collectively, these data suggest that hepcidin or
hepcidin-regulated iron homeostasis controls innate immune function in vivo.
IL-1β and IL-6 are innate immune cytokines that promote CD4 T cell
responses, namely Th17 cells. We hypothesize enhanced Il1b and Il6 expression
in Hamp1-/- mice may lead to elevated Th17 cell responses. To test this, we
analyzed the frequency of IL-17A+ CD4 T cells in wild-type and Hamp1-/- mice.
CD4 T cells from the spleen, mLN and colon of Hamp1-/- mice had elevated
expression of IL-17A (Figure 34A). Notably, hepcidin-deficiency does not result in
selective induction of Th17 cells as IFNγ-producing Th1 cells were also induced
(Figure 34A). Consistent with elevated Th17 cells, frequencies of Foxp3+ or
Foxp3- RORγt+ CD4 T cells were increased in Hamp1-/- mice (Figure 34B).
Altogether, these results demonstrate that loss of hepcidin in vivo is associated
with elevated proinflammatory CD4 T cell responses.
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4.4.4 Altered immune cell homeostasis in hepcidin-deficient mice is not due
to intestinal dysbiosis
Since commensal bacteria regulate intestinal and systemic Th17 responses, we
tested whether elevated Th17 responses in Hamp1-/- are due to changes in the
composition of the microbiota. We compared Hamp1-/- mice to wild-type mice
cohoused with their knockout counterparts for at least 3 weeks. Analysis of fecal
16S rDNA from representative groups of the normal mouse microbiota indicated
that

levels

of

Bacteroides,

Firmicutes,

SFB,

Lactobacillus

and

Enterobacteriaceae in the intestine of Hamp1-/- mice did not significantly differ
from co-housed wild-type mice (Figure 35). Altogether, these results suggest that
dysregulated innate and adaptive immune cell homeostasis in Hamp1-/- is not
due to dysbiosis but more likely due to interactions between hepcidin itself or
hepcidin-mediated iron homeostasis and the host immune system.

4.4.5 Loss of hepcidin is associated with delayed intestinal repair from
DSS-induced intestinal injury
Th1 and Th17 cells can promote tissue pathology and inflammation in mouse
models of intestinal injury (Neurath, 2014; Weaver et al., 2013). We hypothesize
that elevated proinflammatory CD4 T cells in Hamp1-/- mice may predispose
them disease during intestinal inflammation. To test this, we administered DSS to
wild-type and Hamp1-/- mice. Although weight loss between wild-type and
Hamp1-/- mice were not significantly different during DSS treatment, Hamp1-/	
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mice demonstrated delayed recovery from DSS-induced weight loss (Figure
36A). Consistent with this, analysis of tissue pathology revealed that there were
increased inflammatory infiltrates and loss of crypt architecture in the colons of
Hamp1-/- mice compared to wild-type colons during recovery from DSS (Figure
36B). Analysis of immune cell function during recovery from DSS indicated that
frequencies of IL-17A+, IFNγ+ and TNFα+ CD4 T cells were significantly increased
in the colons and mLN of Hamp1-/- mice (Figure 37 and 38A). Furthermore,
Hamp1-/- mice had increased frequencies of neutrophils in the intestine (Figure
38B). Collectively, these results suggest that elevated pro-inflammatory immune
responses in Hamp1-/- are associated with exacerbated tissue damage and
delayed recovery from acute intestinal injury.

4.5 Discussion
This Chapter demonstrates that in addition to hepatocytes, BMDCs are a source
of hepcidin in vitro. This finding parallels a previous report, which provided
evidence that macrophages and neutrophils upregulate the expression of
hepcidin mRNA and protein in response to Mycobacteria tuberculosis,
Pseudomona aeruginosa and Streptococcus (Peyssonnaux et al., 2006; Sow et
al., 2007). Despite the fact that hepcidin gene expression is upregulated
however, further studies are necessary to determine whether hepcidin protein
production and secretion is also increased in bacteria-stimulated BMDCs. In vivo,
hepatocytes appear to be the primary source of hepcidin at the steady state. To
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address whether hepcidin is expressed by immune cells in vivo, hepcidin
expression should be measured in lymphoid organs and compared to the liver
during steady state and inflammation. Since DCs, macrophages and neutrophils
are some of the first cellular responders to sites of inflammation (Peyssonnaux et
al., 2006; Sow et al., 2007), it is interesting to speculate that these cells may
provide an early, localized source of hepcidin, which acts to limit iron available to
invading pathogens during infection or colonization with commensal bacteria. In
contrast, hepatocytes respond rapidly to systemic inflammation by upregulating
hepcidin and may act to control systemic sequestration of iron from invasive
pathogens. One hypothesis may be that there is a division of labor between
immune cells and hepatocytes for promoting localized versus systemic iron
sequestration. One approach to determine whether there are differential
functions for hepcidin derived from immune cells relative to hepatocytes is to
generate bone marrow chimeric animals that lack hepcidin either in the
hematopoietic or non-hematopoietic compartments. Models of local or systemic
bacterial infection can then be applied to these mice.
Hepcidin-deficient mice have elevated systemic iron levels (LesbordesBrion et al., 2006). The data in this Chapter examining immune cell function in
the gut-draining lymph nodes of Hamp1-/- mice reveal a previously unrecognized
role for hepcidin in immune cell homeostasis (Figure 39). Loss of hepcidin in vivo
was associated with elevated pro-inflammatory cytokines IL-1β, IL-6 and
enhanced Th1 and Th17 cell responses. Multiple factors could contribute to
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these effects. Expression of hepcidin by the liver at steady state results in
inhibition of iron release from macrophages and hepatocytes. Therefore,
changes in intracellular iron levels by hepcidin may lead to altered immune cell
homeostasis. Consistent with this idea, altered iron homeostasis is often
associated with dysregulated systemic immune responses in vivo (Balouchi et
al., 2014; Cunningham-Rundles et al., 2000; Ekiz et al., 2005). Although there is
no known role for hepcidin itself in regulating immune responses, it is possible
that it may directly control cytokine production by innate and adaptive immune
cells through a novel pathway. Further investigation using gain and loss of
function approaches such as iron supplementation and chelation is necessary to
determine whether hepcidin-mediated iron homeostasis plays a role in
modulating immune cell function at the steady state.
Given the result that loss of hepcidin is associated with elevated proinflammatory cytokine responses including IL-1β, IL-6 and IL-17A, which are
critical members of innate and adaptive anti-bacterial immunity, one would
predict that hepcidin-deficiency may actually confer protection against bacterial
pathogens. However, there are multiple reports suggesting that hepcidin
deficiency is associated with susceptibility to extracellular bacterial infections
primarily due to an increased bioavailability of iron to invading pathogens (Arezes
et al., 2015; Quenee et al., 2012). The relative contribution of immune versus iron
defects in the context of antibacterial immunity is not well understood and should
be the focus of investigation.
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Hepcidin-deficient mice exhibit delayed recovery from DSS-induced
intestinal inflammation. These data are consistent with a pathogenic role for the
pro-inflammatory cytokines IL-1β and IL-6 in this model. Furthermore, intestinal
inflammation is often associated with elevated Th17 cells (Weaver et al., 2013),
which is a feature of Hamp1-/- mice at the steady state. It appears that loss of
hepcidin does not influence disease outcome during DSS treatment but rather
results in delayed recovery and tissue repair. As a result, mechanisms of repair
in the host such as the production of IL-22, M2 macrophages and various growth
factors should be measured in Hamp1-/- mice.
This Chapter demonstrates that in addition to hepatocytes, DCs are a
potent source of hepcidin in vitro. In vivo, loss of hepcidin was associated with
elevated pro-inflammatory cytokine expression, elevated Th17 cell responses
and delayed repair from DSS-induced intestinal injury (Figure 39). These results
represent a key advance in our understanding of the interplay between iron
homeostasis and immune cell function and may inform future therapeutic
strategies for the treatment of anemia associated with chronic inflammation.
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Figure 30. BMDCs were treated with PBS or colonized with Bordetella spp. and analyzed for
gene expression by microarray on day 4. Numbers in colored legend represent Z scores.

	
  

131

Figure 31. Lymphoid tissue-resident commensal bacteria upregulate
hepcidin in bone marrow-derived dendritic cells.
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Figure 31. (A) BMDCs were stimulated with Bordetella spp. (MOI 50), LPS (100 ng/ml),
Pam3CSK4 (100 ng/ml) or CpG DNA (2 µg/ml) for 24 hours and Hamp1 expression was
analyzed by qPCR. Statistics were performed using one-way ANOVA and Sidak’s multiple
comparisons test. **** p < 0.0001.
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Figure 32. Hepcidin regulates intracellular survival of lymphoid tissueresident commensal bacteria in bone marrow-derived dendritic cells.
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Figure 32. Wild-type BMDCs were co-cultured with E. coli or Bordetella spp. for 2 hours and
levels of live intracellular bacteria was assessed by culturing. Data are representative of two
independent experiments. Statistics were performed using student’s t-test. l.o.d., limit of
detection. ***, p < 0.001; **** p < 0.0001.

	
  

133

Figure 33. Loss of hepcidin in vivo is associated with altered expression
pro-inflammatory cytokines in the mesenteric lymph node.
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Figure 34. Loss of hepcidin in vivo is associated with elevated pro-
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Figure 35. Altered immune cell homeostasis in Hamp1-/- mice is not due to
intestinal dysbiosis.
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Figure 36. Loss of hepcidin in vivo is associated with delayed recovery
from DSS-induced intestinal injury.
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Figure 36. Wild-type and Hamp1

-/-

Hamp1-/-

were treated with 2.5% DSS for 7 days and then placed on

regular drinking water. (A) Weight loss was measured throughout the course of the experiment
and (B) colon pathology was assessed on day 12. Scale bar – 200 µm. Data are representative of
two independent experiments. Statistics were performed using student’s t-test. **, p < 0.01.
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Figure 37. Loss of hepcidin in vivo is associated with elevated frequencies
of pro-inflammatory CD4 T cell responses during recovery from DSSinduced intestinal injury.
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Figure 37. CD4 T cells in the (A) mLN and (B) colon of DSS-treated (day 12) wild-type and
Hamp1

-/-

mice were analyzed for production of IL-17A and IFNγ following PMA and ionomycin
+

+

+

stimulation. Cells in flow cytometry plots are gated as live, CD45 , Lineage , CD4 . Lineage
cocktail consists of CD3, CD5, CD8α, CD19, NK1.1. Data are representative of two independent
experiments. Statistics were performed using student’s t-test. * p < 0.05; ***, p < 0.001.
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Figure 38. Loss of hepcidin in vivo is associated with elevated frequencies
of intestinal TNFα+ CD4 T cells and neutrophils during recovery from DSSinduced intestinal injury.
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(CD3 CD5 CD11b Ly6G ) were analyzed in the colon of DSS-treated mice (day 12) following
PMA and ionomycin stimulation. Data are representative of two independent experiments.
Statistics were performed using student’s t-test. ***, p < 0.001.
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Figure 39. Hepcidin and iron homeostasis regulate immune cell function.
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Figure 39. In wild-type mice, hepcidin controls systemic iron levels by inhibiting dietary iron intake
and iron release from macrophages. Data from Chapter 4 suggest that hepcidin expression and
the associated reduction in systemic iron levels act to suppress the production of the proinflammatory cytokines IL-1β, IL-6 by innate immune cells and IL-17A, IFNγ and TNFα by CD4 T
helper cells. Hepcidin may regulate the immune cell function independent of iron. In the mice that
lack hepcidin, systemic iron levels increase due to uninhibited iron absorption and iron release
from macrophages. Elevated systemic iron may lead to enhanced production of pro-inflammatory
cytokines due to the release of reactive oxygen species (ROS). Elevated pro-inflammatory
cytokine production in Hamp1

-/-

mice may be responsible for impaired tissue homeostasis

following acute intestinal injury.

	
  

140

Chapter 5
Summary, discussion and future directions

5.1 Lymphoid tissue-resident commensal bacteria belong exclusively to the
Proteobacteria phyla
The mammalian intestine is colonized trillions of bacteria that belong
predominantly to three phyla: Bacteroidetes, Firmicutes and Proteobacteria (Ley
et al., 2005; Turnbaugh et al., 2006). Chapter 2 of this thesis identified that LRCs
belong exclusively to the alpha- and beta-Proteobacteria classes. Collectively,
Proteobacteria are classified as gram-negative bacteria that differ from their
Bacteroidetes and Firmicutes counterparts in their requirement for oxygen. It is
therefore possible that the metabolic requirements for Proteobacteria may be
linked to their intestinal colonization pattern (Figure 40). In support of this,
several reports identified that there is a unique spatial segregation of
Proteobacteria versus Bacteroides and Firmicutes in the lumen of the intestine.
For example, Proteobacteria are typically found in close proximity to the intestinal
epithelial wall, where oxygen concentration is the highest compared to the center
of the intestinal lumen (Albenberg et al., 2014; Flint et al., 2012; Ringel et al.,
2015; Yasuda et al., 2015). Therefore, sampling of luminal contents by
phagocytic dendritic cells and macrophages that populate the intestinal lamina
propria may be biased towards Proteobacteria members. Further investigation is
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necessary

to

link

the

metabolic

requirements

of

commensal

bacteria

communities with their distinct colonization pattern in the host intestine.
Proteobacteria are found not only in the mammalian GI tract but also in
the environment. In fact, many of the strains predicted to be LRCs such as
Bordetella, Achromobacter and Ochrobactrum are the causative agents for
opportunistic infections in immunocompromised individuals (Hagiya et al., 2013;
Melvin et al., 2014; Spilker et al., 2013). Specifically, strains of Bordetella and
Achromobacter have been associated with respiratory tract infections in patients
with cystic fibrosis (Melvin et al., 2014; Spilker et al., 2013). These data support
the hypothesis that while LRCs inhabit mammals and maintain immune cell
homeostasis in the presence of an intact and otherwise healthy immune system,
their proximity to lymphocytes in immune cell-rich tissues can quickly alter their
interactions with the host to become pathogenic. Therefore, future studies
assessing the beneficial versus pathological functions of LRCs should do so in
the context of healthy and diseased animals or patients to clearly identify host
and microbial-specific factors that regulate a healthy host-LRC interaction.
Proteobacteria levels frequently bloom during intestinal inflammation and
have been associated with the pathogenesis of IBD (Melvin et al., 2014; Spilker
et al., 2013). In light of the data in Chapter 3 that LRCs, which are
Proteobacteria members, promote tissue protective properties in the context of
acute intestinal injury, one may hypothesize that Proteobacteria that colonize a
healthy GI tract are largely beneficial, especially those that colonize lymphoid
	
  

142

tissues. However, during loss of intestinal barrier function, the pathogenic
members of Proteobacteria such as adherent invasive E. coli strains and
Helicobacter pylori expand, become dominant members of the microbiota and
contribute to disease. Therefore, understanding the role of LRCs in the context of
other pathogenic Proteobacteria members is essential and should be a focus for
future

investigations.

The

biological

implications

of

studying

host-LRC

interactions in the context of a replete microbiota will be described in the
following section.

5.2 Understanding LRC colonization in the context of a complex microbiota
The results from Chapter 2 demonstrated that LRCs promote tissue-specific
immune responses in gnotobiotic and antibiotic-treated mice where LRCs are the
dominant bacterial population in the intestine. However, in nature, the
composition

of

the

gut

microbiota

reflects

a

complex

community

of

microorganisms that have a diverse array of biological properties and functions.
Further experimentation is necessary to investigate host-LRC interactions in the
presence of a complex microbiota. However, this approach may be met with
multiple challenges. Despite the fact that 16S rDNA for bacteria belonging to
LRCs can be detected in the interior of intestinal-associated lymphoid tissues,
live bacteria cannot be cultured from the gut-draining mesenteric lymph node of
conventional mice that LRCs are predicted to colonize. This may either reflect the
absence of live LRCs in conventional mice or that LRCs colonize lymphoid
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tissues but maintain a dormant state and thus cannot be cultured using
laboratory methods (Figure 41). The former hypothesis is supported by the
finding that commensal bacteria, through a MYD88-dependent mechanism,
inhibit trafficking of a specialized subset of CX3CR1-expressing phagocytic cells
that sample the intestinal lumen (Diehl et al., 2013). Depletion of the gut
microbiota using broad-spectrum antibiotics, similar to the experimental approach
used to colonize antibiotic-treated mice with LRCs resulted in translocation of a
non-virulent strain of Salmonella to the mLN and spleen. Developing a mouse
model whereby live LRCs selectively colonize lymphoid tissues in the presence
of other luminal and epithelial-associated commensal bacteria should take into
account these factors.
The infant GI tract is typically colonized with more Proteobacteria
compared to the adult microbiota (Arrieta et al., 2014; Shin et al., 2015). One
intriguing theory is that colonization with LRCs early in life may provide
heightened immune cell maturation in lymphoid tissues. Over time, colonization
by Bacteroidetes and Firmicutes may act to limit LRC colonization in lymphoid
tissues to prevent pathologic inflammation. This hypothesis is supported by data
demonstrating that early exposure to antibiotics may predispose humans to
chronic inflammatory diseases such as allergic airway inflammation and obesity
(Melvin et al., 2014; Spilker et al., 2013). Whether this reflects altered LRC
colonization early in life is unknown and should be a subject of future
investigation.
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5.3 Commensal bacteria communities modulate tissue-specific immune cell
function
The gut microbiota that colonize the mammalian GI tract collectively influences
the development and maturation of the host immune system (Hooper et al., 2012;
Ivanov and Honda, 2012). Over last the decade, many reports have shown that
commensal bacteria found in different sites of the intestine influence the local
tissue immune environment. Data from Chapter 2 demonstrated that a novel
class of commensal bacteria, lymphoid tissue-resident commensal bacteria
(LRC), colonizes the interior of intestinal-associated lymphoid tissues such as the
Peyer’s patch and mesenteric lymph node. Within these tissues, LRCs promote
local ILC3 and Th17 cell responses but do not promote small intestine lamina
propria responses despite detectable LRCs in the lumen. This is in contrast to
the epithelial-associated commensal segmented filamentous bacteria (SFB),
which promotes potent Th17 responses in both intestinal-associated lymphoid
tissues and the small intestine lamina propria (Atarashi et al., 2015; GaboriauRouthiau et al., 2009; Ivanov et al., 2009; Sano et al., 2015). Induction of tissuespecific immune responses is therefore consistent with the colonization pattern of
the commensal in the intestine, supporting the notion that commensal bacteria
influence local immune responses.
The data in Chapter 2 also revealed that LRCs promote IL-10 production
by DCs and that IL-10 acts to limit Th17 cell responses in LRC-monocolonized
mice. This may be an evolutionary conserved feature adopted by commensal
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bacteria, especially LRCs, in order to limit the development of pathologic
inflammation but simultaneously promote maturation of the host immune system.
The finding that LRCs induce DC-derived IL-10 parallels the discovery that
commensal populations promote regulatory T cell responses that limit pathologic
inflammation (Atarashi et al., 2013; Atarashi et al., 2011; Round et al., 2011;
Round and Mazmanian, 2010). The human commensal Bacteroides fragilis was
demonstrated to colonize colonic crypts and is associated with elevated colonic
Treg responses (Lee et al., 2013). Similarly, Gram-positive commensal bacteria
from the class Clostridia colonize the lumen of the large intestine and also
promote potent Treg responses in the underlying lamina propria (Atarashi et al.,
2013; Atarashi et al., 2011). Whether LRCs also promote Tregs has not been
investigated and warrants future investigation. However, given the ability of LRCs
to promote IL-6 and IL-23 in vitro, it is likely that LRCs can promote the subset of
Tregs that express RORγt as this subset is induced by these cytokines
(Ohnmacht et al., 2015; Sefik et al., 2015).
LRCs may have the capacity to bypass intestinal barrier functions to
colonize lymphoid tissues. Therefore, it can be hypothesized that LRCs have the
capacity to modulate immune responses beyond the intestine. Indeed,
neutralization of IL-22-producing ILC3 was demonstrated to result in systemic
dissemination of LRCs, which resulted in elevated IL-6 and TNFα (Sonnenberg et
al., 2012). Whether LRCs can modulate extra-intestinal immune responses, such
as in secondary lymphoid tissues beyond the intestine, at the steady state
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requires further experimentation. However, the cellular mechanisms by which
LRCs promote tissue-specific immune effects appear to be direct communication
between the bacteria and immune cells in the intestine (Figure 42). This is in
contrast to the mechanism by which the epithelial-associated commensal SFB
elicits Th17 cell responses. In the case of SFB, bacterial attachment is required
for and leads to production of SAA1/2 by the epithelium that then induces a Th17
cell response (Atarashi et al., 2015; Sano et al., 2015). Since LRCs do not elicit
small intestine lamina propria Th17 cell responses, it is possible that LRCs do not
have the ability to attach to intestinal cells and/or regulate their biology. LRCs
may be able to access intestinal-associated lymphoid tissues exclusively by
being recognized and captured by mononuclear phagocytes that sample
intestinal lumen contents. Further research is necessary to decipher the precise
molecular and cellular pathways by which LRCs promote tissue-specific immune
responses.

5.4 Beneficial properties of lymphoid tissue-resident commensal bacteria
colonization in the host intestine
Data from Chapter 3 demonstrated that IL-22 is required for the colonization of
LRCs in the mesenteric lymph node. The mechanism of this pathway may
involve the production of IL-22-dependent antimicrobial peptides such as the
REG3 proteins, which limit the growth of both competing Gram-positive and
Gram-negative commensals (Cash et al., 2006; Lehotzky et al., 2010; Mukherjee
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et al., 2014; Sonnenberg et al., 2011; Vaishnava et al., 2011). In addition,
Chapter 3 provided evidence that exogenous administration of IL-22 to LRCcolonized mice enhanced LRC colonization. The mechanism of this pathway may
also be due to upregulation of IL-22-dependent antimicrobial peptides and
suppression of competing commensal bacteria. However, given the role of the
iron-regulatory hormone hepcidin in intracellular survival of LRCs in vitro,
administration of IL-22 may lead to hepcidin-mediated changes in iron
homeostasis that favors LRC colonization in lymphoid tissues (Figure 43).
IL-10 but not IL-22 produced by LRC-colonized DCs provide host tissue
protection during acute intestinal injury. However, as IL-22 is known to have proproliferative functions on inflamed and damaged tissues (Sonnenberg et al.,
2011), whether LRC-induced IL-22 plays a role for LRC-induced recovery from
acute intestinal injury should be investigated. Therefore, the mechanism by which
LRCs protect mice from DSS may involve the coordination of both IL-10 and IL22, where IL-10 provides protection from acute tissue damage whereas IL-22
may provide signals that promote tissue homeostasis following acute injury.
Given the role for IL-22 in enhancing LRC colonization in lymphoid tissues and
the fact that IL-22 has tissue protective properties, it would also be interesting to
test the hypothesis that IL-22-induced effects may be dependent on LRC
colonization (Figure 43).
IL-10 is induced by LRCs both in the gut-draining lymph node and colon
lamina propria. In addition, IL-10 appears to function systemically as blockade of
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IL-10-IL-10R interactions result in elevated serum IFNγ. The key question of
whether lymphoid tissue colonization contributes to and is required for LRCmediated tissue protection is not well understood but requires further
experimentation using approaches that selectively deplete lymphoid colonization
by LRCs or mice that lack secondary lymphoid organs. It is likely that in the
presence of a complex microbiota, LRCs adopt a more strict lymphoid
colonization pattern whereas in antibiotic-treated mice, LRCs can exert its tissue
protective effects through interactions with immune cells in both the lamina
propria and lymphoid tissues. An alternative explanation for intestinal tissueprotective effects by LRCs may lie in the ability of LRC-primed immune cells to
traffic to the site of inflammation. Direct stimulation of immune cells in lymphoid
tissues by LRCs may provide a more rapid response by directing tissueprotective lymphocytes (such as those that produce IL-10 and IL-22) to the site of
injury. Mice that lack gut homing molecules or trafficking machinery will be able
to determine whether LRCs employ this pathway for host-protection.

5.5 Analysis of commensal bacteria in lymphoid tissues during chronic
inflammatory diseases
Although the data from Chapter 3 suggest that LRC have beneficial tissueprotective properties for the host, its unique colonization pattern in intestinalassociated lymphoid tissues may result in pathologic inflammation when
mechanisms of intestinal barrier function such as the production of mucus and
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antimicrobial peptides are impaired. This is supported by translocation of LRCs
and development of systemic inflammation in animals that are depleted of IL-22+
ILCs (Sonnenberg et al., 2012). In humans, this possibility was demonstrated in
HIV patients that have enhanced systemic immune responses to commensal
bacteria. One study showed that patients with HIV have elevated systemic IgG
specific for the LRC, Alcaligenes (Tatro et al., 2014). Whether systemic immune
responses to Alcaligenes is due to bacterial translocation from lymphoid tissues
is unclear and warrants further investigation. However, these data highlight the
dangers of commensal bacteria colonization in lymphoid tissues and thus more
research is necessary to understand the mechanisms by which the host
harnesses the beneficial but limits the pathological functions of LRCs.

5.6 Interplay between commensal bacteria, the host immune system and
iron homeostasis during health and disease
Iron is an essential nutrient for all living organisms including mammals,
pathogenic and commensal bacteria. Iron scavenging from the environment is
therefore of critical importance to all organisms. In the mammals, mechanisms
are present to sequester iron for host biological processes and limit their access
from pathogenic microbes. Microbes on the other hand have also evolved
molecular strategies to scavenge iron. Therefore, there is a constant “tug-of-war”
between pathogenic microbes, commensal microbes and mammals for iron. In
mammals, one pathway that acts to limit iron available to invading pathogens
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involves the iron-regulatory hormone hepcidin (Arezes et al., 2015; Quenee et
al., 2012). The receptor for hepcidin, ferroportin, is expressed on macrophages
and hepatocytes and functions to export iron from these intracellular stores.
Binding of hepcidin to ferroportin results in its degradation and therefore inhibition
of iron release into the extracellular space (Cassat and Skaar, 2013; Ganz and
Nemeth, 2015). Although there is substantial evidence for the role of hepcidin in
limiting iron availability to pathogenic microbes, its role in regulating hostcommensal bacteria interactions is much less understood. Chapter

4

demonstrated that loss of hepcidin in vivo was associated with elevated
expression of proinflammatory cytokines. Upregulation of the cytokines such as
IL-1β and IL-6 in hepcidin-deficient mice was associated with elevated Th17 cell
responses. The mechanism by which loss of hepcidin in vivo leads to
dysregulated cytokine production is unknown. However, one possibility is that
generation of a pro-inflammatory immune environment is due to expansion of
members of the microbiota in the presence of iron overload. As SFB is a potent
inducer of intestinal and systemic Th17 cell responses (Gaboriau-Routhiau et al.,
2009; Ivanov et al., 2009), fecal 16S rDNA for SFB was measured and the
results determined that SFB levels were comparable between hepcidin-deficient
and wild-type mice. One experiment to interrogate whether other members of the
microbiota may be responsible for elevated Th17 cells will involve the use of
broad-spectrum antibiotics or derivation of hepcidin-deficient animals under
germ-free conditions. Given the DC-intrinsic role for hepcidin in LRC colonization
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in vitro, one may also speculate whether altered Th17 cell responses are due to
dysregulated host-LRC interactions. One hypothesis is that in the absence of
hepcidin, levels of intracellular LRCs are reduced leading to less production of IL10 and unrestrained Th17 cell responses. Experiments measuring the level of
LRCs in lymphoid tissues of Hamp1-/- mice should address this possibility (Figure
44).
An

alternative

explanation

for

elevated

pro-inflammatory

immune

responses in hepcidin-deficient mice is due to elevated production of reactive
oxygen intermediates (Figure 39). Under the setting of iron overload, the redox
potential of iron generates reactive oxygen species and hydroxyl radicals that
can damage the lipids, DNA and protein of host tissues (Cassat and Skaar, 2013;
Ganz and Nemeth, 2015). Production of ROS and cellular toxicity has been
associated with increased expression of pro-inflammatory cytokines and
increased Th17 cell responses (Naik and Dixit, 2011; Zhi et al., 2012). Future
experiments using gain and loss of function approaches will be necessary to
determine whether ROS levels are elevated in Hamp1-/- mice and are involved in
hepcidin-mediated immune regulation.
The animals used in Chapter 4 as controls for hepcidin-deficient mice
were age and gender-matched mice that were purchased from Jackson
Laboratories. These mice were cohoused with hepcidin-deficient mice for at least
3 weeks prior to use to normalize their microbiota composition. Although the data
suggest that loss of hepcidin leads to significant immune abnormalities, future
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experiments should compare Hamp1-/- mice to littermate controls to rule out the
possibility that the phenotypes observed are due to animals that have been
reared under different environments. Experiments comparing littermates and
knockout mice generated from breeding Hamp1+/- mice are currently on going to
address this concern.

5.7 Concluding remarks
Commensal bacteria communities are essential inhabitants of the mammalian GI
tract. These bacteria aid in nutrient metabolism, prevent pathogen colonization
and promote maturation of the immune system. Our current understanding of
commensal bacteria colonization suggest that they colonize at least three distinct
anatomical sites: i) the intestinal lumen, ii) the intestinal epithelial surface and iii)
intestinal-associated lymphoid tissues. Commensal bacteria from each of these
three sites appear to interact with the host immune system in distinct manners.
Luminal commensal bacteria are physically separated from the mucosal surface
by antimicrobial peptides and mucus and influence host immune cell functions
primarily through production of bacterial metabolites. Epithelial-associated
commensal bacteria can colonize the surface of intestinal epithelial cells and
interact with the host by altering the function of intestinal epithelial cells. Data in
this thesis demonstrated that LRCs interact with the host via colonization of
lymphoid tissues and activate innate and adaptive immune cells such as DCs,
ILCs and CD4+ T cells. A comprehensive understanding of how these three
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commensal populations interact and coordinate immune cell homeostasis is an
area for future investigation and would involve the development of novel
gnotobiotic mouse models. Understanding the contexts by which anatomically
distinct commensal communities interact with the host may inform the
development of immunologic- and bacterial-based therapeutic strategies for the
treatment of chronic inflammatory diseases in people.
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Figure 40. Spatial segregation of commensal bacteria in the intestine based
on oxygen requirements.
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Figure 40. Lymphoid tissue-resident commensal bacteria are predominantly Proteobacteria,
while luminal commensals are predominantly Firmicutes or Bacteroidetes. Proteobacteria are
typically gram-negative obligate aerobes or facultative anaerobes and thus differ from luminal
microbes by their requirement for oxygen. Oxygen concentration is higher near the surface of the
intestinal epithelium compared to the center of the lumen. Therefore, Proteobacteria may be
preferentially localize to the intestinal epithelium and thus are more readily sampled by innate
immune cells in the mucosa and poised to colonize intestinal-associated lymphoid tissues.
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Figure 41. Understanding LRC colonization in the presence of a complex
microbiota.
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Figure 41. Chapters 2 and 3 demonstrate that LRCs regulate immune cell and tissue
homeostasis in gnotobiotic or antibiotic mice where LRCs are the dominant bacterial species in
the intestine. In order to fully define LRC colonization, future studies should investigate host-LRC
interactions in the presence of a complex microbiota in conventional mice. Specifically, whether
LRCs impact immune cell function in the same manner in gnotobiotic/antibiotic mice should be
assessed. Previous work demonstrated that LRCs could not be cultured from intestinalassociated lymphoid tissues of conventional mice. Future work should address whether this is
due to lack of bacterial viability or LRCs adopting a dormant metabolic state.
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Figure 42. Commensal bacterial communities regulate tissue-specific
immune cell homeostasis through distinct pathways.
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Figure 42. Epithelial-associated, lymphoid tissue-resident and luminal commensals regulate
immune cell homeostasis through distinct pathways. Epithelial-associated commensals such as
SFB physically attach to epithelial cells and promote the production of serum amyloid A (SAA).
SAA conditions dendritic cells (DCs) to drive Th17 cell responses. On the other hand, lymphoid
tissue-resident commensals colonize the intracellular compartment of DCs and promote DCderived IL-1β, IL-6 and IL-23. These cytokines are likely responsible for LRC-induced Th17 and
ILC3 responses. Luminal commensal bacteria regulate immune cell function likely through the
production of bacterial-derived metabolites such as short chain fatty acids (SCFAs). SCFAs
condition DCs and epithelial cells to promote regulatory T cell responses.
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Figure

43.
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Figure 43. Chapter 3 of this thesis demonstrated that IL-22 enhances host colonization by
lymphoid tissue-resident commensal bacteria. Given the role of IL-22 in hepcidin expression and
the role of hepcidin in LRC colonization, it is possible that IL-22-induced LRC colonization is
dependent on hepcidin upregulation. IL-22 has potent tissue-protective effects by modulating antimicrobial peptide production and tissue regeneration. Given the role of LRCs in host tissue
protection during acute intestinal injury, future experiments should test whether IL-22 regulates
tissue homeostasis in part through modulation of LRC colonization.
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Figure 44. Regulation of immune cell homeostasis by hepcidin through
modulation of lymphoid tissue-resident commensal bacteria colonization.
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Figure 44. Chapter 5 demonstrated that hepcidin promotes lymphoid tissue-resident commensal
bacteria colonization in vitro and limits proinflammatory cytokine production by CD4 T helper
cells. Given that LRCs promote IL-10, which restrains Th17 cell responses, hepcidin may regulate
CD4 T cell responses through modulation of LRC colonization. In the presence of hepcidin,
intracellular colonization by LRCs is favored and thus results in IL-10 production and suppression
of CD4 T cell responses. In the absence of hepcidin, intracellular LRC colonization and IL-10
production are impaired. As a result, proinflammatory cytokine production by CD4 T cells is
uninhibited.

	
  

159

Bibliography

The Human Microbiome Project Consortium. (2012). A framework for human microbiome
research. Nature 486, 215-221.

Adams, J.B., Johansen, L.J., Powell, L.D., Quig, D., and Rubin, R.A. (2011). Gastrointestinal flora
and gastrointestinal status in children with autism--comparisons to typical children and correlation
with autism severity. BMC gastroenterology 11, 22.

Albenberg, L., Esipova, T.V., Judge, C.P., Bittinger, K., Chen, J., Laughlin, A., Grunberg, S.,
Baldassano, R.N., Lewis, J.D., Li, H., et al. (2014). Correlation between intraluminal oxygen
gradient and radial partitioning of intestinal microbiota. Gastroenterology 147, 1055-1063.e1058.

Amar, J., Chabo, C., Waget, A., Klopp, P., Vachoux, C., Bermudez-Humaran, L.G., Smirnova, N.,
Berge, M., Sulpice, T., Lahtinen, S., et al. (2011). Intestinal mucosal adherence and translocation
of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic
treatment. EMBO molecular medicine 3, 559-572.

Amoureux, L., Bador, J., Fardeheb, S., Mabille, C., Couchot, C., Massip, C., Salignon, A.L.,
Berlie, G., Varin, V., and Neuwirth, C. (2013). Detection of Achromobacter xylosoxidans in
hospital, domestic, and outdoor environmental samples and comparison with human clinical
isolates. Applied and environmental microbiology 79, 7142-7149.

An, D., Oh, S.F., Olszak, T., Neves, J.F., Avci, F.Y., Erturk-Hasdemir, D., Lu, X., Zeissig, S.,
Blumberg, R.S., and Kasper, D.L. (2014). Sphingolipids from a symbiotic microbe regulate
homeostasis of host intestinal natural killer T cells. Cell 156, 123-133.

160

Ancuta, P., Kamat, A., Kunstman, K.J., Kim, E.Y., Autissier, P., Wurcel, A., Zaman, T., Stone, D.,
Mefford, M., Morgello, S., et al. (2008). Microbial translocation is associated with increased
monocyte activation and dementia in AIDS patients. PloS one 3, e2516.

Arezes, J., Jung, G., Gabayan, V., Valore, E., Ruchala, P., Gulig, P.A., Ganz, T., Nemeth, E., and
Bulut, Y. (2015). Hepcidin-induced hypoferremia is a critical host defense mechanism against the
siderophilic bacterium Vibrio vulnificus. Cell host & microbe 17, 47-57.

Armitage, A.E., Eddowes, L.A., Gileadi, U., Cole, S., Spottiswoode, N., Selvakumar, T.A., Ho,
L.P., Townsend, A.R., and Drakesmith, H. (2011). Hepcidin regulation by innate immune and
infectious stimuli. Blood 118, 4129-4139.

Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J.R.,
Pfeffer, K., Coffer, P.J., and Rudensky, A.Y. (2013). Metabolites produced by commensal
bacteria promote peripheral regulatory T-cell generation. Nature 504, 451-455.

Arrieta, M.C., Stiemsma, L.T., Amenyogbe, N., Brown, E.M., and Finlay, B. (2014). The intestinal
microbiome in early life: health and disease. Frontiers in immunology 5, 427.

Arthur, J.C., Perez-Chanona, E., Muhlbauer, M., Tomkovich, S., Uronis, J.M., Fan, T.J.,
Campbell, B.J., Abujamel, T., Dogan, B., Rogers, A.B., et al. (2012). Intestinal inflammation
targets cancer-inducing activity of the microbiota. Science 338, 120-123.

Artis, D., and Spits, H. (2015). The biology of innate lymphoid cells. Nature 517, 293-301.

161

Asseman, C., Mauze, S., Leach, M.W., Coffman, R.L., and Powrie, F. (1999). An essential role
for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. The
Journal of experimental medicine 190, 995-1004.

Atarashi, K., Tanoue, T., Ando, M., Kamada, N., Nagano, Y., Narushima, S., Suda, W., Imaoka,
A., Setoyama, H., Nagamori, T., et al. (2015). Th17 Cell Induction by Adhesion of Microbes to
Intestinal Epithelial Cells. Cell 163, 367-380.

Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T.,
Narushima, S., Hase, K., et al. (2013). Treg induction by a rationally selected mixture of Clostridia
strains from the human microbiota. Nature 500, 232-236.

Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G.,
Yamasaki, S., Saito, T., Ohba, Y., et al. (2011). Induction of colonic regulatory T cells by
indigenous Clostridium species. Science 331, 337-341.

Ayres, J.S., Trinidad, N.J., and Vance, R.E. (2012). Lethal inflammasome activation by a
multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nature medicine 18,
799-806.

Backhed, F., Ley, R.E., Sonnenburg, J.L., Peterson, D.A., and Gordon, J.I. (2005). Host-bacterial
mutualism in the human intestine. Science 307, 1915-1920.

Bailey, J.R., Probert, C.S., and Cogan, T.A. (2011). Identification and characterisation of an ironresponsive candidate probiotic. PloS one 6, e26507.

162

Balagopal, A., Philp, F.H., Astemborski, J., Block, T.M., Mehta, A., Long, R., Kirk, G.D., Mehta,
S.H., Cox, A.L., Thomas, D.L., and Ray, S.C. (2008). Human immunodeficiency virus-related
microbial translocation and progression of hepatitis C. Gastroenterology 135, 226-233.

Balouchi, S., Gharagozloo, M., Esmaeil, N., Mirmoghtadaei, M., and Moayedi, B. (2014). Serum
levels of TGFbeta, IL-10, IL-17, and IL-23 cytokines in beta-thalassemia major patients: the
impact of silymarin therapy. Immunopharmacology and immunotoxicology 36, 271-274.

Baughn, A.D., and Malamy, M.H. (2004). The strict anaerobe Bacteroides fragilis grows in and
benefits from nanomolar concentrations of oxygen. Nature 427, 441-444.

Behnsen, J., Jellbauer, S., Wong, C.P., Edwards, R.A., George, M.D., Ouyang, W., and
Raffatellu, M. (2014). The cytokine IL-22 promotes pathogen colonization by suppressing related
commensal bacteria. Immunity 40, 262-273.

Bekiaris, V., Persson, E.K., and Agace, W.W. (2014). Intestinal dendritic cells in the regulation of
mucosal immunity. Immunological reviews 260, 86-101.

Belkaid, Y., and Hand, T.W. (2014). Role of the microbiota in immunity and inflammation. Cell
157, 121-141.

Blumberg, R., and Powrie, F. (2012). Microbiota, disease, and back to health: a metastable
journey. Science translational medicine 4, 137rv7.

Boetzer, M., Henkel, C.V., Jansen, H.J., Butler, D., and Pirovano, W. (2011). Scaffolding preassembled contigs using SSPACE. Bioinformatics (Oxford, England) 27, 578-579.

163

Boetzer, M., and Pirovano, W. (2012). Toward almost closed genomes with GapFiller. Genome
biology 13, R56.

Brenchley, J.M., and Douek, D.C. (2012). Microbial translocation across the GI tract. Annual
review of immunology 30, 149-173.

Brenchley, J.M., Price, D.A., Schacker, T.W., Asher, T.E., Silvestri, G., Rao, S., Kazzaz, Z.,
Bornstein, E., Lambotte, O., Altmann, D., et al. (2006). Microbial translocation is a cause of
systemic immune activation in chronic HIV infection. Nature medicine 12, 1365-1371.

Brestoff, J.R., and Artis, D. (2013). Commensal bacteria at the interface of host metabolism and
the immune system. Nature immunology 14, 676-684.

Bron, P.A., van Baarlen, P., and Kleerebezem, M. (2012). Emerging molecular insights into the
interaction between probiotics and the host intestinal mucosa. Nature reviews. Microbiology 10,
66-78.

Buffie, C.G., and Pamer, E.G. (2013). Microbiota-mediated colonization resistance against
intestinal pathogens. Nature reviews. Immunology 13, 790-801.

Buie, T., Campbell, D.B., Fuchs, G.J., 3rd, Furuta, G.T., Levy, J., Vandewater, J., Whitaker, A.H.,
Atkins, D., Bauman, M.L., Beaudet, A.L., et al. (2010). Evaluation, diagnosis, and treatment of
gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 125 Suppl 1,
S1-18.

164

Bunker, J.J., Flynn, T.M., Koval, J.C., Shaw, D.G., Meisel, M., McDonald, B.D., Ishizuka, I.E.,
Dent, A.L., Wilson, P.C., Jabri, B., et al. (2015). Innate and Adaptive Humoral Responses Coat
Distinct Commensal Bacteria with Immunoglobulin A. Immunity 43, 541-553.

Cadwell, K., Liu, J.Y., Brown, S.L., Miyoshi, H., Loh, J., Lennerz, J.K., Kishi, C., Kc, W., Carrero,
J.A., Hunt, S., et al. (2008). A key role for autophagy and the autophagy gene Atg16l1 in mouse
and human intestinal Paneth cells. Nature 456, 259-263.

Cani, P.D. (2014). Metabolism in 2013: The gut microbiota manages host metabolism. Nature
reviews. Endocrinology 10, 74-76.

Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F.,
Tuohy, K.M., Chabo, C., et al. (2007). Metabolic endotoxemia initiates obesity and insulin
resistance. Diabetes 56, 1761-1772.

Cash, H.L., Whitham, C.V., Behrendt, C.L., and Hooper, L.V. (2006). Symbiotic bacteria direct
expression of an intestinal bactericidal lectin. Science 313, 1126-1130.

Cassat, J.E., and Skaar, E.P. (2013). Iron in infection and immunity. Cell host & microbe 13, 509519.

Cerutti, A., and Rescigno, M. (2008). The biology of intestinal immunoglobulin A responses.
Immunity 28, 740-750.

Chain, P.S., Lang, D.M., Comerci, D.J., Malfatti, S.A., Vergez, L.M., Shin, M., Ugalde, R.A.,
Garcia, E., and Tolmasky, M.E. (2011). Genome of Ochrobactrum anthropi ATCC 49188 T, a

165

versatile opportunistic pathogen and symbiont of several eukaryotic hosts. Journal of bacteriology
193, 4274-4275.

Chassaing, B., Koren, O., Goodrich, J.K., Poole, A.C., Srinivasan, S., Ley, R.E., and Gewirtz,
A.T. (2015). Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic
syndrome. Nature 519, 92-96.

Chin, K.F., Kallam, R., O'Boyle, C., and MacFie, J. (2007). Bacterial translocation may influence
the long-term survival in colorectal cancer patients. Diseases of the colon and rectum 50, 323330.

Chiu, C.C., and Ching, Y.H. (2014). Monocolonization of germ-free mice with Bacteroides fragilis
protects against dextran sulfate sodium-induced acute colitis. BioMed Research International
2014, 675786.

Cho, I., and Blaser, M.J. (2012). The human microbiome: at the interface of health and disease.
Nature reviews. Genetics 13, 260-270.

Cho, J.H. (2008). The genetics and immunopathogenesis of inflammatory bowel disease. Nature
reviews. Immunology 8, 458-466.

Cho, J.H., and Abraham, C. (2007). Inflammatory bowel disease genetics: Nod2. Annual review
of medicine 58, 401-416.

Chow, J., Lee, S.M., Shen, Y., Khosravi, A., and Mazmanian, S.K. (2010). Host-bacterial
symbiosis in health and disease. Advances in immunology 107, 243-274.

166

Chu, H., and Mazmanian, S.K. (2013). Innate immune recognition of the microbiota promotes
host-microbial symbiosis. Nature immunology 14, 668-675.

Ciccarelli, F.D., Doerks, T., von Mering, C., Creevey, C.J., Snel, B., and Bork, P. (2006). Toward
automatic reconstruction of a highly resolved tree of life. Science 311, 1283-1287.

Colgan, S.P., and Taylor, C.T. (2010). Hypoxia: an alarm signal during intestinal inflammation.
Nature reviews. Gastroenterology & hepatology 7, 281-287.

Comstock, L.E. (2009). Importance of glycans to the host-bacteroides mutualism in the
mammalian intestine. Cell host & microbe 5, 522-526.

Coombes, J.L., and Powrie, F. (2008). Dendritic cells in intestinal immune regulation. Nature
reviews. Immunology 8, 435-446.

Corbin, B.D., Seeley, E.H., Raab, A., Feldmann, J., Miller, M.R., Torres, V.J., Anderson, K.L.,
Dattilo, B.M., Dunman, P.M., Gerads, R., et al. (2008). Metal chelation and inhibition of bacterial
growth in tissue abscesses. Science 319, 962-965.

Coury, D.L., Ashwood, P., Fasano, A., Fuchs, G., Geraghty, M., Kaul, A., Mawe, G., Patterson,
P., and Jones, N.E. (2012). Gastrointestinal conditions in children with autism spectrum disorder:
developing a research agenda. Pediatrics 130 Suppl 2, S160-168.

Cunningham-Rundles, S., Giardina, P.J., Grady, R.W., Califano, C., McKenzie, P., and De
Sousa, M. (2000). Effect of transfusional iron overload on immune response. The Journal of
infectious diseases 182 Suppl 1, S115-121.

167

Dapito, D.H., Mencin, A., Gwak, G.Y., Pradere, J.P., Jang, M.K., Mederacke, I., Caviglia, J.M.,
Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012). Promotion of hepatocellular carcinoma by
the intestinal microbiota and TLR4. Cancer cell 21, 504-516.

Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A.L., Barnich, N., Bringer,
M.A., Swidsinski, A., Beaugerie, L., and Colombel, J.F. (2004). High prevalence of adherentinvasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127,
412-421.

Davies, J.C., and Rubin, B.K. (2007). Emerging and unusual gram-negative infections in cystic
fibrosis. Seminars in respiratory and critical care medicine 28, 312-321.

De Hertogh, G., Aerssens, J., de Hoogt, R., Peeters, P., Verhasselt, P., Van Eyken, P., Ectors,
N., Vermeire, S., Rutgeerts, P., Coulie, B., and Geboes, K. (2006). Validation of 16S rDNA
sequencing in microdissected bowel biopsies from Crohn's disease patients to assess bacterial
flora diversity. The Journal of pathology 209, 532-539.

Diaz-Ochoa, V.E., Jellbauer, S., Klaus, S., and Raffatellu, M. (2014). Transition metal ions at the
crossroads of mucosal immunity and microbial pathogenesis. Frontiers in cellular and infection
microbiology 4, 2.

Diefenbach, A., Colonna, M., and Koyasu, S. (2014). Development, differentiation, and diversity
of innate lymphoid cells. Immunity 41, 354-365.

Diehl, G.E., Longman, R.S., Zhang, J.X., Breart, B., Galan, C., Cuesta, A., Schwab, S.R., and
Littman, D.R. (2013). Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by
CX(3)CR1(hi) cells. Nature 494, 116-120.
168

Drakesmith, H., and Prentice, A.M. (2012). Hepcidin and the iron-infection axis. Science 338,
768-772.

Duerr, R.H., Taylor, K.D., Brant, S.R., Rioux, J.D., Silverberg, M.S., Daly, M.J., Steinhart, A.H.,
Abraham, C., Regueiro, M., Griffiths, A., et al. (2006). A genome-wide association study identifies
IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463.

Earle, K.A., Billings, G., Sigal, M., Lichtman, J.S., Hansson, G.C., Elias, J.E., Amieva, M.R.,
Huang, K.C., and Sonnenburg, J.L. (2015). Quantitative Imaging of Gut Microbiota Spatial
Organization. Cell host & microbe 18, 478-488.

Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R.,
Nelson, K.E., and Relman, D.A. (2005). Diversity of the human intestinal microbial flora. Science
308, 1635-1638.

Ekiz, C., Agaoglu, L., Karakas, Z., Gurel, N., and Yalcin, I. (2005). The effect of iron deficiency
anemia on the function of the immune system. The hematology journal : the official journal of the
European Haematology Association / EHA 5, 579-583.

Elinav, E., Nowarski, R., Thaiss, C.A., Hu, B., Jin, C., and Flavell, R.A. (2013). Inflammationinduced cancer: crosstalk between tumours, immune cells and microorganisms. Nature reviews.
Cancer 13, 759-771.

Estes, J.D., Harris, L.D., Klatt, N.R., Tabb, B., Pittaluga, S., Paiardini, M., Barclay, G.R., Smedley,
J., Pung, R., Oliveira, K.M., et al. (2010). Damaged intestinal epithelial integrity linked to microbial

169

translocation in pathogenic simian immunodeficiency virus infections. PLoS pathogens 6,
e1001052.

Fedrigo, G.V., Campoy, E.M., Di Venanzio, G., Colombo, M.I., and Garcia Vescovi, E. (2011).
Serratia marcescens is able to survive and proliferate in autophagic-like vacuoles inside nonphagocytic cells. PloS one 6, e24054.

Flint, H.J., Scott, K.P., Louis, P., and Duncan, S.H. (2012). The role of the gut microbiota in
nutrition and health. Nature reviews. Gastroenterology & hepatology 9, 577-589.

Fung, T.C., Artis, D., and Sonnenberg, G.F. (2014). Anatomical localization of commensal
bacteria in immune cell homeostasis and disease. Immunological reviews 260, 35-49.

Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., Nakanishi, Y.,
Uetake, C., Kato, K., Kato, T., et al. (2013). Commensal microbe-derived butyrate induces the
differentiation of colonic regulatory T cells. Nature 504, 446-450.

Gaboriau-Routhiau, V., Rakotobe, S., Lecuyer, E., Mulder, I., Lan, A., Bridonneau, C., Rochet, V.,
Pisi, A., De Paepe, M., Brandi, G., et al. (2009). The key role of segmented filamentous bacteria
in the coordinated maturation of gut helper T cell responses. Immunity 31, 677-689.

Gandhi, R.T., Sax, P.E., and Grinspoon, S.K. (2012). Metabolic and cardiovascular complications
in HIV-infected patients: new challenges for a new age. The Journal of infectious diseases 205
Suppl 3, S353-354.

Ganz, T., and Nemeth, E. (2012). Hepcidin and iron homeostasis. Biochim Biophys Acta 1823,
1434-1443.
170

Ganz, T., and Nemeth, E. (2015). Iron homeostasis in host defence and inflammation. Nature
reviews. Immunology 15, 500-510.

Garcia-Alvarez, M., Berenguer, J., Guzman-Fulgencio, M., Alvarez, E., Cosin, J., Micheloud, D.,
Jimenez-Sousa, M.A., Fernandez-Rodriguez, A., Aldamiz-Echevarria, T., Carrero, A., et al.
(2012). Bacterial DNA translocation and liver disease severity among HIV-infected patients with
chronic hepatitis C. Journal of acquired immune deficiency syndromes (1999) 61, 552-556.

Gardiner, K.R., Halliday, M.I., Barclay, G.R., Milne, L., Brown, D., Stephens, S., Maxwell, R.J.,
and Rowlands, B.J. (1995). Significance of systemic endotoxaemia in inflammatory bowel
disease. Gut 36, 897-901.

Garrett, W.S., Lord, G.M., Punit, S., Lugo-Villarino, G., Mazmanian, S.K., Ito, S., Glickman, J.N.,
and Glimcher, L.H. (2007). Communicable ulcerative colitis induced by T-bet deficiency in the
innate immune system. Cell 131, 33-45.

Geuking, M.B., Cahenzli, J., Lawson, M.A., Ng, D.C., Slack, E., Hapfelmeier, S., McCoy, K.D.,
and Macpherson, A.J. (2011). Intestinal bacterial colonization induces mutualistic regulatory T cell
responses. Immunity 34, 794-806.

Glover, L.E., and Colgan, S.P. (2011). Hypoxia and metabolic factors that influence inflammatory
bowel disease pathogenesis. Gastroenterology 140, 1748-1755.

Gomes-Pereira, S., Rodrigues, P.N., Appelberg, R., and Gomes, M.S. (2008). Increased
susceptibility to Mycobacterium avium in hemochromatosis protein HFE-deficient mice. Infection
and immunity 76, 4713-4719.

171

Goto, Y., Obata, T., Kunisawa, J., Sato, S., Ivanov, II, Lamichhane, A., Takeyama, N., Kamioka,
M., Sakamoto, M., Matsuki, T., et al. (2014). Innate lymphoid cells regulate intestinal epithelial cell
glycosylation. Science 345, 1254009.

Gutierrez, A., Frances, R., Amoros, A., Zapater, P., Garmendia, M., Ndongo, M., Cano, R., Jover,
R., Such, J., and Perez-Mateo, M. (2009). Cytokine association with bacterial DNA in serum of
patients with inflammatory bowel disease. Inflammatory bowel diseases 15, 508-514.

Gutierrez, A., Scharl, M., Sempere, L., Holler, E., Zapater, P., Almenta, I., Gonzalez-Navajas,
J.M., Such, J., Wiest, R., Rogler, G., and Frances, R. (2014). Genetic susceptibility to increased
bacterial translocation influences the response to biological therapy in patients with Crohn's
disease. Gut 63, 272-280.

Hagiya, H., Ohnishi, K., Maki, M., Watanabe, N., and Murase, T. (2013). Clinical characteristics of
Ochrobactrum anthropi bacteremia. Journal of clinical microbiology 51, 1330-1333.

Harris, S.R., Feil, E.J., Holden, M.T., Quail, M.A., Nickerson, E.K., Chantratita, N., Gardete, S.,
Tavares, A., Day, N., Lindsay, J.A., et al. (2010). Evolution of MRSA during hospital transmission
and intercontinental spread. Science 327, 469-474.

Hayashi, A., Sato, T., Kamada, N., Mikami, Y., Matsuoka, K., Hisamatsu, T., Hibi, T., Roers, A.,
Yagita, H., Ohteki, T., et al. (2013). A single strain of Clostridium butyricum induces intestinal IL10-producing macrophages to suppress acute experimental colitis in mice. Cell host & microbe
13, 711-722.

172

Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W.Z., Strowig, T., Thaiss, C.A., Kau, A.L.,
Eisenbarth, S.C., Jurczak, M.J., et al. (2012). Inflammasome-mediated dysbiosis regulates
progression of NAFLD and obesity. Nature 482, 179-185.

Hill, D.A., Hoffmann, C., Abt, M.C., Du, Y., Kobuley, D., Kirn, T.J., Bushman, F.D., and Artis, D.
(2010). Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in
intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal
immunology 3, 148-158.

Honda, K., and Littman, D.R. (2012). The microbiome in infectious disease and inflammation.
Annual review of immunology 30, 759-795.

Hooper, L.V., Littman, D.R., and Macpherson, A.J. (2012). Interactions between the microbiota
and the immune system. Science 336, 1268-1273.

Hooper, L.V., and Macpherson, A.J. (2010). Immune adaptations that maintain homeostasis with
the intestinal microbiota. Nature reviews. Immunology 10, 159-169.

Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., Codelli, J.A., Chow, J.,
Reisman, S.E., Petrosino, J.F., et al. (2013). Microbiota modulate behavioral and physiological
abnormalities associated with neurodevelopmental disorders. Cell 155, 1451-1463.

Huang, J.Y., Lee, S.M., and Mazmanian, S.K. (2011). The human commensal Bacteroides fragilis
binds intestinal mucin. Anaerobe 17, 137-141.

Huson, D.H., and Bryant, D. (2006). Application of phylogenetic networks in evolutionary studies.
Molecular biology and evolution 23, 254-267.
173

Iida, N., Dzutsev, A., Stewart, C.A., Smith, L., Bouladoux, N., Weingarten, R.A., Molina, D.A.,
Salcedo, R., Back, T., Cramer, S., et al. (2013). Commensal bacteria control cancer response to
therapy by modulating the tumor microenvironment. Science 342, 967-970.

Inagaki, H., Suzuki, T., Nomoto, K., and Yoshikai, Y. (1996). Increased susceptibility to primary
infection with Listeria monocytogenes in germfree mice may be due to lack of accumulation of Lselectin+ CD44+ T cells in sites of inflammation. Infection and immunity 64, 3280-3287.

Ivanov, II, Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K.C.,
Santee, C.A., Lynch, S.V., et al. (2009). Induction of intestinal Th17 cells by segmented
filamentous bacteria. Cell 139, 485-498.

Ivanov, II, and Honda, K. (2012). Intestinal commensal microbes as immune modulators. Cell
host & microbe 12, 496-508.

Jiang, W., Lederman, M.M., Hunt, P., Sieg, S.F., Haley, K., Rodriguez, B., Landay, A., Martin, J.,
Sinclair, E., Asher, A.I., et al. (2009). Plasma levels of bacterial DNA correlate with immune
activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV
infection. The Journal of infectious diseases 199, 1177-1185.

Johansson, M.E., Jakobsson, H.E., Holmen-Larsson, J., Schutte, A., Ermund, A., RodriguezPineiro, A.M., Arike, L., Wising, C., Svensson, F., Backhed, F., and Hansson, G.C. (2015).
Normalization of Host Intestinal Mucus Layers Requires Long-Term Microbial Colonization. Cell
host & microbe 18, 582-592.

Johansson, M.E., Larsson, J.M., and Hansson, G.C. (2011). The two mucus layers of colon are
organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial
174

interactions. Proceedings of the National Academy of Sciences of the United States of America
108 Suppl 1, 4659-4665.

Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y., Lee, J.C.,
Schumm, L.P., Sharma, Y., Anderson, C.A., et al. (2012). Host-microbe interactions have shaped
the genetic architecture of inflammatory bowel disease. Nature 491, 119-124.

Kamada, N., Chen, G.Y., Inohara, N., and Nunez, G. (2013a). Control of pathogens and
pathobionts by the gut microbiota. Nature immunology 14, 685-690.

Kamada, N., Kim, Y.G., Sham, H.P., Vallance, B.A., Puente, J.L., Martens, E.C., and Nunez, G.
(2012). Regulated virulence controls the ability of a pathogen to compete with the gut microbiota.
Science 336, 1325-1329.

Kamada, N., Seo, S.U., Chen, G.Y., and Nunez, G. (2013b). Role of the gut microbiota in
immunity and inflammatory disease. Nature reviews. Immunology 13, 321-335.

Karlsson, F.H., Fak, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., Backhed, F.,
and Nielsen, J. (2012). Symptomatic atherosclerosis is associated with an altered gut
metagenome. Nature communications 3, 1245.

Katoh, K., and Standley, D.M. (2013). MAFFT multiple sequence alignment software version 7:
improvements in performance and usability. Molecular biology and evolution 30, 772-780.

Kaur, N., Chen, C.C., Luther, J., and Kao, J.Y. (2011). Intestinal dysbiosis in inflammatory bowel
disease. Gut microbes 2, 211-216.

175

Kautz, L., Jung, G., Valore, E.V., Rivella, S., Nemeth, E., and Ganz, T. (2014). Identification of
erythroferrone as an erythroid regulator of iron metabolism. Nature genetics 46, 678-684.

Keating, J., Bjarnason, I., Somasundaram, S., Macpherson, A., Francis, N., Price, A.B.,
Sharpstone, D., Smithson, J., Menzies, I.S., and Gazzard, B.G. (1995). Intestinal absorptive
capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut
37, 623-629.

Kehl-Fie, T.E., Chitayat, S., Hood, M.I., Damo, S., Restrepo, N., Garcia, C., Munro, K.A., Chazin,
W.J., and Skaar, E.P. (2011). Nutrient metal sequestration by calprotectin inhibits bacterial
superoxide defense, enhancing neutrophil killing of Staphylococcus aureus. Cell host & microbe
10, 158-164.

Kitajima, S., Morimoto, M., Sagara, E., Shimizu, C., and Ikeda, Y. (2001). Dextran sodium sulfateinduced colitis in germ-free IQI/Jic mice. Experimental animals / Japanese Association for
Laboratory Animal Science 50, 387-395.

Klatt, N.R., Estes, J.D., Sun, X., Ortiz, A.M., Barber, J.S., Harris, L.D., Cervasi, B., Yokomizo,
L.K., Pan, L., Vinton, C.L., et al. (2012). Loss of mucosal CD103+ DCs and IL-17+ and IL-22+
lymphocytes is associated with mucosal damage in SIV infection. Mucosal immunology 5, 646657.

Klein, G.L., Petschow, B.W., Shaw, A.L., and Weaver, E. (2013). Gut barrier dysfunction and
microbial translocation in cancer cachexia: a new therapeutic target. Current opinion in supportive
and palliative care 7, 361-367.

176

Klose, C.S., Kiss, E.A., Schwierzeck, V., Ebert, K., Hoyler, T., d'Hargues, Y., Goppert, N.,
Croxford, A.L., Waisman, A., Tanriver, Y., and Diefenbach, A. (2013). A T-bet gradient controls
the fate and function of CCR6-RORgammat+ innate lymphoid cells. Nature 494, 261-265.

Kloverpris, H.N., Kazer, S.W., Mjosberg, J., Mabuka, J.M., Wellmann, A., Ndhlovu, Z., Yadon,
M.C., Nhamoyebonde, S., Muenchhoff, M., Simoni, Y., et al. (2016). Innate Lymphoid Cells Are
Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression. Immunity
44, 391-405.

Koeth, R.A., Wang, Z., Levison, B.S., Buffa, J.A., Org, E., Sheehy, B.T., Britt, E.B., Fu, X., Wu,
Y., Li, L., et al. (2013). Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat,
promotes atherosclerosis. Nature medicine 19, 576-585.

Kohane, I.S., McMurry, A., Weber, G., MacFadden, D., Rappaport, L., Kunkel, L., Bickel, J.,
Wattanasin, N., Spence, S., Murphy, S., and Churchill, S. (2012). The co-morbidity burden of
children and young adults with autism spectrum disorders. PloS one 7, e33224.

Koren, O., Spor, A., Felin, J., Fak, F., Stombaugh, J., Tremaroli, V., Behre, C.J., Knight, R.,
Fagerberg, B., Ley, R.E., and Backhed, F. (2011). Human oral, gut, and plaque microbiota in
patients with atherosclerosis. Proceedings of the National Academy of Sciences of the United
States of America 108 Suppl 1, 4592-4598.

Korn, T., Bettelli, E., Oukka, M., and Kuchroo, V.K. (2009). IL-17 and Th17 Cells. Annual review
of immunology 27, 485-517.

Kostic, A.D., Chun, E., Robertson, L., Glickman, J.N., Gallini, C.A., Michaud, M., Clancy, T.E.,
Chung, D.C., Lochhead, P., Hold, G.L., et al. (2013). Fusobacterium nucleatum potentiates
177

intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell host & microbe
14, 207-215.

Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W. (1993). Interleukin-10-deficient
mice develop chronic enterocolitis. Cell 75, 263-274.

Kunisawa, J., and Kiyono, H. (2012). Alcaligenes is Commensal Bacteria Habituating in the GutAssociated Lymphoid Tissue for the Regulation of Intestinal IgA Responses. Frontiers in
immunology 3, 65.

Lakatos, P.L., Kiss, L.S., Palatka, K., Altorjay, I., Antal-Szalmas, P., Palyu, E., Udvardy, M.,
Molnar, T., Farkas, K., Veres, G., et al. (2011). Serum lipopolysaccharide-binding protein and
soluble CD14 are markers of disease activity in patients with Crohn's disease. Inflammatory
bowel diseases 17, 767-777.

Lebeer, S., Vanderleyden, J., and De Keersmaecker, S.C. (2010). Host interactions of probiotic
bacterial surface molecules: comparison with commensals and pathogens. Nature reviews.
Microbiology 8, 171-184.

Lee, P., Peng, H., Gelbart, T., Wang, L., and Beutler, E. (2005). Regulation of hepcidin
transcription by interleukin-1 and interleukin-6. Proceedings of the National Academy of Sciences
of the United States of America 102, 1906-1910.

Lee, S.M., Donaldson, G.P., Mikulski, Z., Boyajian, S., Ley, K., and Mazmanian, S.K. (2013).
Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 501,
426-429.

178

Lee, Y.K., Menezes, J.S., Umesaki, Y., and Mazmanian, S.K. (2011). Proinflammatory T-cell
responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proceedings
of the National Academy of Sciences of the United States of America 108 Suppl 1, 4615-4622.

Lehotzky, R.E., Partch, C.L., Mukherjee, S., Cash, H.L., Goldman, W.E., Gardner, K.H., and
Hooper, L.V. (2010). Molecular basis for peptidoglycan recognition by a bactericidal lectin.
Proceedings of the National Academy of Sciences of the United States of America 107, 77227727.

Lesbordes-Brion, J.C., Viatte, L., Bennoun, M., Lou, D.Q., Ramey, G., Houbron, C., Hamard, G.,
Kahn, A., and Vaulont, S. (2006). Targeted disruption of the hepcidin 1 gene results in severe
hemochromatosis. Blood 108, 1402-1405.

Lescut, D., Colombel, J.F., Vincent, P., Cortot, A., Fournier, L., Quandalle, P., Vankemmel, M.,
Triboulet, J.P., Wurtz, A., Paris, J.C., and et al. (1990). Bacterial translocation in colorectal
cancers. Gastroenterologie clinique et biologique 14, 811-814.

Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., and Gordon, J.I. (2005).
Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the
United States of America 102, 11070-11075.

Ley, R.E., Lozupone, C.A., Hamady, M., Knight, R., and Gordon, J.I. (2008). Worlds within
worlds: evolution of the vertebrate gut microbiota. Nature reviews. Microbiology 6, 776-788.

Ley, R.E., Turnbaugh, P.J., Klein, S., and Gordon, J.I. (2006). Microbial ecology: human gut
microbes associated with obesity. Nature 444, 1022-1023.

179

Li, H., and Reeves, R.K. (2012). Functional perturbation of classical natural killer and innate
lymphoid cells in the oral mucosa during SIV infection. Frontiers in immunology 3, 417.

Libby, P. (2002). Inflammation in atherosclerosis. Nature 420, 868-874.

Libby, P. (2006). Inflammation and cardiovascular disease mechanisms. The American journal of
clinical nutrition 83, 456s-460s.

Lin, R.S., Lee, F.Y., Lee, S.D., Tsai, Y.T., Lin, H.C., Lu, R.H., Hsu, W.C., Huang, C.C., Wang,
S.S., and Lo, K.J. (1995). Endotoxemia in patients with chronic liver diseases: relationship to
severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. Journal
of hepatology 22, 165-172.

Liu, B., Tonkonogy, S.L., and Sartor, R.B. (2011a). Antigen-presenting cell production of IL-10
inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice. Gastroenterology 141,
653-662, 662.e651-654.

Liu, J.Y., Li, Y.P., Huang, Y.T., Chuang, H.L., Pils, M.C., Bleich, A., Prinz, I., Fasnacht, N., BollatiFogolin, M., Schippers, A., et al. (2011b). Commensal gut flora reduces susceptibility to
experimentally induced colitis via T-cell-derived interleukin-10. BioMed research international 17,
2038-2046.

Liu, J.Z., Jellbauer, S., Poe, A.J., Ton, V., Pesciaroli, M., Kehl-Fie, T.E., Restrepo, N.A., Hosking,
M.P., Edwards, R.A., Battistoni, A., et al. (2012). Zinc sequestration by the neutrophil protein
calprotectin enhances Salmonella growth in the inflamed gut. Cell host & microbe 11, 227-239.

180

Loh, G., and Blaut, M. (2012). Role of commensal gut bacteria in inflammatory bowel diseases.
Gut microbes 3, 544-555.

Macia, L., Tan, J., Vieira, A.T., Leach, K., Stanley, D., Luong, S., Maruya, M., Ian McKenzie, C.,
Hijikata, A., Wong, C., et al. (2015). Metabolite-sensing receptors GPR43 and GPR109A facilitate
dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nature
communications 6, 6734.

Macpherson, A.J., Geuking, M.B., and McCoy, K.D. (2012). Homeland security: IgA immunity at
the frontiers of the body. Trends in immunology 33, 160-167.

Macpherson, A.J., and Harris, N.L. (2004). Interactions between commensal intestinal bacteria
and the immune system. Nature reviews. Immunology 4, 478-485.

Macpherson, A.J., McCoy, K.D., Johansen, F.E., and Brandtzaeg, P. (2008). The immune
geography of IgA induction and function. Mucosal immunology 1, 11-22.

Macpherson, A.J., and Uhr, T. (2004). Induction of protective IgA by intestinal dendritic cells
carrying commensal bacteria. Science 303, 1662-1665.

Mahenthiralingam, E., Baldwin, A., and Dowson, C.G. (2008). Burkholderia cepacia complex
bacteria: opportunistic pathogens with important natural biology. Journal of applied microbiology
104, 1539-1551.

Manichanh, C., Borruel, N., Casellas, F., and Guarner, F. (2012). The gut microbiota in IBD.
Nature reviews. Gastroenterology & hepatology 9, 599-608.

181

Manuzak, J., Dillon, S., and Wilson, C. (2012). Differential interleukin-10 (IL-10) and IL-23
production by human blood monocytes and dendritic cells in response to commensal enteric
bacteria. Clinical and vaccine immunology : CVI 19, 1207-1217.

Marchetti, G., Bellistri, G.M., Borghi, E., Tincati, C., Ferramosca, S., La Francesca, M., Morace,
G., Gori, A., and Monforte, A.D. (2008). Microbial translocation is associated with sustained
failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active
antiretroviral therapy. AIDS (London, England) 22, 2035-2038.

Maslowski, K.M., Vieira, A.T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H.C., Rolph, M.S.,
Mackay, F., Artis, D., et al. (2009). Regulation of inflammatory responses by gut microbiota and
chemoattractant receptor GPR43. Nature 461, 1282-1286.

Mazzini, E., Massimiliano, L., Penna, G., and Rescigno, M. (2014). Oral Tolerance Can Be
Established via Gap Junction Transfer of Fed Antigens from CX3CR1(+) Macrophages to
CD103(+) Dendritic Cells. Immunity 40, 248-261.

McGeachy, M.J., Bak-Jensen, K.S., Chen, Y., Tato, C.M., Blumenschein, W., McClanahan, T.,
and Cua, D.J. (2007). TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and
restrain T(H)-17 cell-mediated pathology. Nature immunology 8, 1390-1397.

McKenzie, A.N., Spits, H., and Eberl, G. (2014). Innate Lymphoid Cells in Inflammation and
Immunity. Immunity 41, 366-374.

Melvin, J.A., Scheller, E.V., Miller, J.F., and Cotter, P.A. (2014). Bordetella pertussis
pathogenesis: current and future challenges. Nature reviews. Microbiology 12, 274-288.

182

Merlini, E., Bai, F., Bellistri, G.M., Tincati, C., d'Arminio Monforte, A., and Marchetti, G. (2011).
Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor
immune response to antiretroviral therapy. PloS one 6, e18580.

Moon, C., Baldridge, M.T., Wallace, M.A., Burnham, C.A., Virgin, H.W., and Stappenbeck, T.S.
(2015). Vertically transmitted faecal IgA levels determine extra-chromosomal phenotypic
variation. Nature 521, 90-93.

Mukherjee, S., Zheng, H., Derebe, M.G., Callenberg, K.M., Partch, C.L., Rollins, D., Propheter,
D.C., Rizo, J., Grabe, M., Jiang, Q.X., and Hooper, L.V. (2014). Antibacterial membrane attack by
a pore-forming intestinal C-type lectin. Nature 505, 103-107.

Musso, G., Gambino, R., and Cassader, M. (2011). Interactions between gut microbiota and host
metabolism predisposing to obesity and diabetes. Annual review of medicine 62, 361-380.

Naik, E., and Dixit, V.M. (2011). Mitochondrial reactive oxygen species drive proinflammatory
cytokine production. The Journal of experimental medicine 208, 417-420.

Nairz, M., Theurl, I., Schroll, A., Theurl, M., Fritsche, G., Lindner, E., Seifert, M., Crouch, M.L.,
Hantke, K., Akira, S., et al. (2009). Absence of functional Hfe protects mice from invasive
Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood 114, 36423651.

Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B.K., and Ganz, T.
(2004a). IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron
regulatory hormone hepcidin. The Journal of clinical investigation 113, 1271-1276.

183

Nemeth, E., Tuttle, M.S., Powelson, J., Vaughn, M.B., Donovan, A., Ward, D.M., Ganz, T., and
Kaplan, J. (2004b). Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its
internalization. Science 306, 2090-2093.

Neurath, M.F. (2014). Cytokines in inflammatory bowel disease. Nature reviews. Immunology 14,
329-342.

Niess, J.H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B.A., Vyas, J.M., Boes, M.,
Ploegh, H.L., Fox, J.G., et al. (2005). CX3CR1-mediated dendritic cell access to the intestinal
lumen and bacterial clearance. Science 307, 254-258.

O'Brien, C.L., Pavli, P., Gordon, D.M., and Allison, G.E. (2014). Detection of bacterial DNA in
lymph nodes of Crohn's disease patients using high throughput sequencing. Gut 63, 1596-606.

Obata, T., Goto, Y., Kunisawa, J., Sato, S., Sakamoto, M., Setoyama, H., Matsuki, T., Nonaka,
K., Shibata, N., Gohda, M., et al. (2010). Indigenous opportunistic bacteria inhabit mammalian
gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis. Proceedings
of the National Academy of Sciences of the United States of America 107, 7419-7424.

Obermeier, F., Dunger, N., Strauch, U.G., Hofmann, C., Bleich, A., Grunwald, N., Hedrich, H.J.,
Aschenbrenner, E., Schlegelberger, B., Rogler, G., et al. (2005). CpG motifs of bacterial DNA
essentially contribute to the perpetuation of chronic intestinal inflammation. Gastroenterology 129,
913-927.

Ohnmacht, C., Park, J.H., Cording, S., Wing, J.B., Atarashi, K., Obata, Y., Gaboriau-Routhiau, V.,
Marques, R., Dulauroy, S., Fedoseeva, M., et al. (2015). MUCOSAL IMMUNOLOGY. The
microbiota regulates type 2 immunity through RORgammat(+) T cells. Science 349, 989-993.
184

Olakanmi, O., Schlesinger, L.S., and Britigan, B.E. (2007). Hereditary hemochromatosis results in
decreased iron acquisition and growth by Mycobacterium tuberculosis within human
macrophages. Journal of leukocyte biology 81, 195-204.

Ouyang, W., Rutz, S., Crellin, N.K., Valdez, P.A., and Hymowitz, S.G. (2011). Regulation and
functions of the IL-10 family of cytokines in inflammation and disease. Annual review of
immunology 29, 71-109.

Palm, N.W., de Zoete, M.R., Cullen, T.W., Barry, N.A., Stefanowski, J., Hao, L., Degnan, P.H.,
Hu, J., Peter, I., Zhang, W., et al. (2014). Immunoglobulin A coating identifies colitogenic bacteria
in inflammatory bowel disease. Cell 158, 1000-1010.

Panea, C., Farkas, A.M., Goto, Y., Abdollahi-Roodsaz, S., Lee, C., Koscso, B., Gowda, K., Hohl,
T.M., Bogunovic, M., and Ivanov, II (2015). Intestinal Monocyte-Derived Macrophages Control
Commensal-Specific Th17 Responses. Cell reports 12, 1314-1324.

Peyssonnaux, C., Zinkernagel, A.S., Datta, V., Lauth, X., Johnson, R.S., and Nizet, V. (2006).
TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood
107, 3727-3732.

Pflughoeft, K.J., and Versalovic, J. (2012). Human microbiome in health and disease. Annual
review of pathology 7, 99-122.

Pham, T.A., Clare, S., Goulding, D., Arasteh, J.M., Stares, M.D., Browne, H.P., Keane, J.A.,
Page, A.J., Kumasaka, N., Kane, L., et al. (2014). Epithelial IL-22RA1-mediated fucosylation

185

promotes intestinal colonization resistance to an opportunistic pathogen. Cell host & microbe 16,
504-516.

Pickard, J.M., Maurice, C.F., Kinnebrew, M.A., Abt, M.C., Schenten, D., Golovkina, T.V.,
Bogatyrev, S.R., Ismagilov, R.F., Pamer, E.G., Turnbaugh, P.J., and Chervonsky, A.V. (2014).
Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness.
Nature 514, 638-641.

Qiu, J., Guo, X., Chen, Z.M., He, L., Sonnenberg, G.F., Artis, D., Fu, Y.X., and Zhou, L. (2013).
Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl
hydrocarbon receptor signaling and regulation of microflora. Immunity 39, 386-399.

Qiu, J., and Zhou, L. (2013). Aryl hydrocarbon receptor promotes RORgammat(+) group 3 ILCs
and controls intestinal immunity and inflammation. Seminars in immunopathology 35, 657-670.

Quenee, L.E., Hermanas, T.M., Ciletti, N., Louvel, H., Miller, N.C., Elli, D., Blaylock, B., Mitchell,
A., Schroeder, J., Krausz, T., et al. (2012). Hereditary hemochromatosis restores the virulence of
plague vaccine strains. The Journal of infectious diseases 206, 1050-1058.

Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and Medzhitov, R. (2004).
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.
Cell 118, 229-241.

Redd, A.D., Dabitao, D., Bream, J.H., Charvat, B., Laeyendecker, O., Kiwanuka, N., Lutalo, T.,
Kigozi, G., Tobian, A.A., Gamiel, J., et al. (2009). Microbial translocation, the innate cytokine
response, and HIV-1 disease progression in Africa. Proceedings of the National Academy of
Sciences of the United States of America 106, 6718-6723.
186

Rescigno, M. (2010). Intestinal dendritic cells. Advances in immunology 107, 109-138.

Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F.,
Kraehenbuhl, J.P., and Ricciardi-Castagnoli, P. (2001). Dendritic cells express tight junction
proteins and penetrate gut epithelial monolayers to sample bacteria. Nature immunology 2, 361367.

Ringel, Y., Maharshak, N., Ringel-Kulka, T., Wolber, E.A., Sartor, R.B., and Carroll, I.M. (2015).
High throughput sequencing reveals distinct microbial populations within the mucosal and luminal
niches in healthy individuals. Gut microbes 6, 173-181.

Rogier, E.W., Frantz, A.L., Bruno, M.E., Wedlund, L., Cohen, D.A., Stromberg, A.J., and Kaetzel,
C.S. (2014). Secretory antibodies in breast milk promote long-term intestinal homeostasis by
regulating the gut microbiota and host gene expression. Proceedings of the National Academy of
Sciences of the United States of America 111, 3074-3079.

Rogler, G., and Vavricka, S. (2014). Anemia in inflammatory bowel disease: an under-estimated
problem? Frontiers in medicine 1, 58.

Round, J.L., Lee, S.M., Li, J., Tran, G., Jabri, B., Chatila, T.A., and Mazmanian, S.K. (2011). The
Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota.
Science 332, 974-977.

Round, J.L., and Mazmanian, S.K. (2010). Inducible Foxp3+ regulatory T-cell development by a
commensal bacterium of the intestinal microbiota. Proceedings of the National Academy of
Sciences of the United States of America 107, 12204-12209.

187

Rutz, S., Eidenschenk, C., and Ouyang, W. (2013). IL-22, not simply a Th17 cytokine.
Immunological reviews 252, 116-132.

Salzman, N.H., de Jong, H., Paterson, Y., Harmsen, H.J., Welling, G.W., and Bos, N.A. (2002).
Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse
intestinal bacteria. Microbiology (Reading, England) 148, 3651-3660.

Salzman, N.H., Hung, K., Haribhai, D., Chu, H., Karlsson-Sjoberg, J., Amir, E., Teggatz, P.,
Barman, M., Hayward, M., Eastwood, D., et al. (2010). Enteric defensins are essential regulators
of intestinal microbial ecology. Nature immunology 11, 76-83.

Samaras, K., Wand, H., Law, M., Emery, S., Cooper, D., and Carr, A. (2007). Prevalence of
metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using
International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin
resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected]
hypoadiponectinemia. Diabetes care 30, 113-119.
Sander, L.E., Davis, M.J., Boekschoten, M.V., Amsen, D., Dascher, C.C., Ryffel, B., Swanson,
J.A., Muller, M., and Blander, J.M. (2011). Detection of prokaryotic mRNA signifies microbial
viability and promotes immunity. Nature 474, 385-389.

Sandler, N.G., Koh, C., Roque, A., Eccleston, J.L., Siegel, R.B., Demino, M., Kleiner, D.E.,
Deeks, S.G., Liang, T.J., Heller, T., and Douek, D.C. (2011). Host response to translocated
microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology
141, 1220-1230, 1230 e1221-1223.

188

Sano, T., Huang, W., Hall, J.A., Yang, Y., Chen, A., Gavzy, S.J., Lee, J.Y., Ziel, J.W., Miraldi,
E.R., Domingos, A.I., et al. (2015). An IL-23R/IL-22 Circuit Regulates Epithelial Serum Amyloid A
to Promote Local Effector Th17 Responses. Cell 163, 381-393.

Saraiva, M., and O'Garra, A. (2010). The regulation of IL-10 production by immune cells. Nature
reviews. Immunology 10, 170-181.

Sato, S., Kaneto, S., Shibata, N., Takahashi, Y., Okura, H., Yuki, Y., Kunisawa, J., and Kiyono, H.
(2013). Transcription factor Spi-B-dependent and -independent pathways for the development of
Peyer's patch M cells. Mucosal immunology 6, 838-846.

Satoh-Takayama, N., Vosshenrich, C.A., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F.,
Mention, J.J., Thiam, K., Cerf-Bensussan, N., Mandelboim, O., et al. (2008). Microbial flora drives
interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.
Immunity 29, 958-970.

Schwabe, R.F., and Jobin, C. (2013). The microbiome and cancer. Nature reviews. Cancer 13,
800-812.

Seemann, T. (2014). Prokka: rapid prokaryotic genome annotation. Bioinformatics (Oxford,
England) 30, 2068-2069.

Sefik, E., Geva-Zatorsky, N., Oh, S., Konnikova, L., Zemmour, D., McGuire, A.M., Burzyn, D.,
Ortiz-Lopez, A., Lobera, M., Yang, J., et al. (2015). MUCOSAL IMMUNOLOGY. Individual
intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells. Science
349, 993-997.

189

Seki, E., De Minicis, S., Osterreicher, C.H., Kluwe, J., Osawa, Y., Brenner, D.A., and Schwabe,
R.F. (2007). TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nature medicine 13, 13241332.

Shah, N., Kammermeier, J., Elawad, M., and Glocker, E.O. (2012). Interleukin-10 and interleukin10-receptor defects in inflammatory bowel disease. Current allergy and asthma reports 12, 373379.

Shan, M., Gentile, M., Yeiser, J.R., Walland, A.C., Bornstein, V.U., Chen, K., He, B., Cassis, L.,
Bigas, A., Cols, M., et al. (2013). Mucus enhances gut homeostasis and oral tolerance by
delivering immunoregulatory signals. Science 342, 447-453.

Shanmugam, N.K., Chen, K., and Cherayil, B.J. (2015). Commensal Bacteria-induced Interleukin
1beta (IL-1beta) Secreted by Macrophages Up-regulates Hepcidin Expression in Hepatocytes by
Activating the Bone Morphogenetic Protein Signaling Pathway. The Journal of biological
chemistry 290, 30637-30647.

Shanmugam, N.K., Trebicka, E., Fu, L.L., Shi, H.N., and Cherayil, B.J. (2014). Intestinal
inflammation modulates expression of the iron-regulating hormone hepcidin depending on
erythropoietic activity and the commensal microbiota. Journal of immunology (Baltimore, Md. :
1950) 193, 1398-1407.

Sheikh, M.Y., Choi, J., Qadri, I., Friedman, J.E., and Sanyal, A.J. (2008). Hepatitis C virus
infection: molecular pathways to metabolic syndrome. Hepatology (Baltimore, Md.) 47, 21272133.

190

Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H., and Flier, J.S. (2006). TLR4 links innate
immunity and fatty acid-induced insulin resistance. The Journal of clinical investigation 116, 30153025.

Shih, V.F., Cox, J., Kljavin, N.M., Dengler, H.S., Reichelt, M., Kumar, P., Rangell, L., Kolls, J.K.,
Diehl, L., Ouyang, W., and Ghilardi, N. (2014). Homeostatic IL-23 receptor signaling limits Th17
response through IL-22-mediated containment of commensal microbiota. Proceedings of the
National Academy of Sciences of the United States of America 111, 13942-13947.

Shin, N.R., Whon, T.W., and Bae, J.W. (2015). Proteobacteria: microbial signature of dysbiosis in
gut microbiota. Trends in biotechnology 33, 496-503.

Sindrilaru, A., Peters, T., Wieschalka, S., Baican, C., Baican, A., Peter, H., Hainzl, A., Schatz, S.,
Qi, Y., Schlecht, A., et al. (2011). An unrestrained proinflammatory M1 macrophage population
induced by iron impairs wound healing in humans and mice. The Journal of clinical investigation
121, 985-997.

Sivan, A., Corrales, L., Hubert, N., Williams, J.B., Aquino-Michaels, K., Earley, Z.M., Benyamin,
F.W., Lei, Y.M., Jabri, B., Alegre, M.L., et al. (2015). Commensal Bifidobacterium promotes
antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084-1089.

Small, C.L., Reid-Yu, S.A., McPhee, J.B., and Coombes, B.K. (2013). Persistent infection with
Crohn's disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and
intestinal fibrosis. Nature communications 4, 1957.

191

Smith, C.L., Arvedson, T.L., Cooke, K.S., Dickmann, L.J., Forte, C., Li, H., Merriam, K.L., Perry,
V.K., Tran, L., Rottman, J.B., and Maxwell, J.R. (2013a). IL-22 regulates iron availability in vivo
through the induction of hepcidin. Journal of immunology (Baltimore, Md. : 1950) 191, 1845-1855.

Smith, P.D., Smythies, L.E., Shen, R., Greenwell-Wild, T., Gliozzi, M., and Wahl, S.M. (2011).
Intestinal macrophages and response to microbial encroachment. Mucosal immunology 4, 31-42.
Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly, Y.M., Glickman, J.N.,
and Garrett, W.S. (2013b). The microbial metabolites, short-chain fatty acids, regulate colonic
Treg cell homeostasis. Science 341, 569-573.

Sonnenberg, G.F., and Artis, D. (2012). Innate lymphoid cell interactions with microbiota:
implications for intestinal health and disease. Immunity 37, 601-610.

Sonnenberg, G.F., and Artis, D. (2015). Innate lymphoid cells in the initiation, regulation and
resolution of inflammation. Nature medicine 21, 698-708.

Sonnenberg, G.F., Fouser, L.A., and Artis, D. (2011). Border patrol: regulation of immunity,
inflammation and tissue homeostasis at barrier surfaces by IL-22. Nature immunology 12, 383390.

Sonnenberg, G.F., Monticelli, L.A., Alenghat, T., Fung, T.C., Hutnick, N.A., Kunisawa, J., Shibata,
N., Grunberg, S., Sinha, R., Zahm, A.M., et al. (2012). Innate lymphoid cells promote anatomical
containment of lymphoid-resident commensal bacteria. Science 336, 1321-1325.

Sonnweber, T., Theurl, I., Seifert, M., Schroll, A., Eder, S., Mayer, G., and Weiss, G. (2011).
Impact of iron treatment on immune effector function and cellular iron status of circulating

192

monocytes in dialysis patients. Nephrology, dialysis, transplantation : official publication of the
European Dialysis and Transplant Association - European Renal Association 26, 977-987.

Sorek, R., Zhu, Y., Creevey, C.J., Francino, M.P., Bork, P., and Rubin, E.M. (2007). Genomewide experimental determination of barriers to horizontal gene transfer. Science 318, 1449-1452.
Sow, F.B., Florence, W.C., Satoskar, A.R., Schlesinger, L.S., Zwilling, B.S., and Lafuse, W.P.
(2007). Expression and localization of hepcidin in macrophages: a role in host defense against
tuberculosis. Journal of leukocyte biology 82, 934-945.

Spilker, T., Vandamme, P., and Lipuma, J.J. (2013). Identification and distribution of
Achromobacter species in cystic fibrosis. Journal of cystic fibrosis : official journal of the
European Cystic Fibrosis Society 12, 298-301.

Stamatakis, A. (2006). RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with
thousands of taxa and mixed models. Bioinformatics (Oxford, England) 22, 2688-2690.

Stecher, B., Macpherson, A.J., Hapfelmeier, S., Kremer, M., Stallmach, T., and Hardt, W.D.
(2005). Comparison of Salmonella enterica serovar Typhimurium colitis in germfree mice and
mice pretreated with streptomycin. Infection and immunity 73, 3228-3241.

Stein, J., and Dignass, A.U. (2013). Management of iron deficiency anemia in inflammatory bowel
disease - a practical approach. Annals of gastroenterology : quarterly publication of the Hellenic
Society of Gastroenterology 26, 104-113.

Surana, N.K., and Kasper, D.L. (2012). The yin yang of bacterial polysaccharides: lessons
learned from B. fragilis PSA. Immunological reviews 245, 13-26.

193

Suzuki, K., Meek, B., Doi, Y., Muramatsu, M., Chiba, T., Honjo, T., and Fagarasan, S. (2004).
Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proceedings of the
National Academy of Sciences of the United States of America 101, 1981-1986.

Tang, W.H., Wang, Z., Levison, B.S., Koeth, R.A., Britt, E.B., Fu, X., Wu, Y., and Hazen, S.L.
(2013). Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. The New
England journal of medicine 368, 1575-1584.

Tatro, E.T., Purnajo, I., Richman, D.D., Smith, D.M., and Gianella, S. (2014). Antibody response
to Achromobacter xylosoxidans during HIV infection is associated with lower CD4 levels and
increased lymphocyte activation. Clinical and vaccine immunology : CVI 21, 46-50.

Turnbaugh, P.J., Ley, R.E., Hamady, M., Fraser-Liggett, C.M., Knight, R., and Gordon, J.I.
(2007). The human microbiome project. Nature 449, 804-810.

Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., and Gordon, J.I. (2006).
An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444,
1027-1031.

Ueda, Y., Kayama, H., Jeon, S.G., Kusu, T., Isaka, Y., Rakugi, H., Yamamoto, M., and Takeda,
K. (2010). Commensal microbiota induce LPS hyporesponsiveness in colonic macrophages via
the production of IL-10. International immunology 22, 953-962.

Upadhyay, V., Poroyko, V., Kim, T.J., Devkota, S., Fu, S., Liu, D., Tumanov, A.V., Koroleva, E.P.,
Deng, L., Nagler, C., et al. (2012). Lymphotoxin regulates commensal responses to enable dietinduced obesity. Nature immunology 13, 947-953.

194

Vaishnava, S., Yamamoto, M., Severson, K.M., Ruhn, K.A., Yu, X., Koren, O., Ley, R., Wakeland,
E.K., and Hooper, L.V. (2011). The antibacterial lectin RegIIIgamma promotes the spatial
segregation of microbiota and host in the intestine. Science 334, 255-258.

Valvano, M.A., Keith, K.E., and Cardona, S.T. (2005). Survival and persistence of opportunistic
Burkholderia species in host cells. Current opinion in microbiology 8, 99-105.

Van der Sluis, M., De Koning, B.A., De Bruijn, A.C., Velcich, A., Meijerink, J.P., Van Goudoever,
J.B., Buller, H.A., Dekker, J., Van Seuningen, I., Renes, I.B., and Einerhand, A.W. (2006). Muc2deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.
Gastroenterology 131, 117-129.

van Loosdregt, J., Vercoulen, Y., Guichelaar, T., Gent, Y.Y., Beekman, J.M., van Beekum, O.,
Brenkman, A.B., Hijnen, D.J., Mutis, T., Kalkhoven, E., et al. (2010). Regulation of Treg
functionality by acetylation-mediated Foxp3 protein stabilization. Blood 115, 965-974.

Varol, C., Zigmond, E., and Jung, S. (2010). Securing the immune tightrope: mononuclear
phagocytes in the intestinal lamina propria. Nature reviews. Immunology 10, 415-426.

Vetizou, M., Pitt, J.M., Daillere, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S.,
Routy, B., Roberti, M.P., Duong, C.P., et al. (2015). Anticancer immunotherapy by CTLA-4
blockade relies on the gut microbiota. Science 350, 1079-1084.

Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillere, R., Hannani, D., Enot, D.P., Pfirschke,
C., Engblom, C., Pittet, M.J., et al. (2013). The intestinal microbiota modulates the anticancer
immune effects of cyclophosphamide. Science 342, 971-976.

195

Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S., Srinivasan, S.,
Sitaraman, S.V., Knight, R., Ley, R.E., and Gewirtz, A.T. (2010). Metabolic syndrome and altered
gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228-231.

Wang, L., Harrington, L., Trebicka, E., Shi, H.N., Kagan, J.C., Hong, C.C., Lin, H.Y., Babitt, J.L.,
and Cherayil, B.J. (2009). Selective modulation of TLR4-activated inflammatory responses by
altered iron homeostasis in mice. The Journal of clinical investigation 119, 3322-3328.

Wang, L., Johnson, E.E., Shi, H.N., Walker, W.A., Wessling-Resnick, M., and Cherayil, B.J.
(2008). Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the
regulation of macrophage cytokine translation. Journal of immunology (Baltimore, Md. : 1950)
181, 2723-2731.

Wang, Z., Klipfell, E., Bennett, B.J., Koeth, R., Levison, B.S., Dugar, B., Feldstein, A.E., Britt,
E.B., Fu, X., Chung, Y.M., et al. (2011). Gut flora metabolism of phosphatidylcholine promotes
cardiovascular disease. Nature 472, 57-63.

Weaver, C.T., Elson, C.O., Fouser, L.A., and Kolls, J.K. (2013). The Th17 pathway and
inflammatory diseases of the intestines, lungs, and skin. Annual review of pathology 8, 477-512.
Wexler, H.M. (2007). Bacteroides: the good, the bad, and the nitty-gritty. Clinical microbiology
reviews 20, 593-621.

Wieland Brown, L.C., Penaranda, C., Kashyap, P.C., Williams, B.B., Clardy, J., Kronenberg, M.,
Sonnenburg, J.L., Comstock, L.E., Bluestone, J.A., and Fischbach, M.A. (2013). Production of
alpha-galactosylceramide by a prominent member of the human gut microbiota. PLoS biology 11,
e1001610.

196

Wiest, R., Lawson, M., and Geuking, M. (2014). Pathological bacterial translocation in liver
cirrhosis. Journal of hepatology 60, 197-209.

Wu, H.J., Ivanov, II, Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman, D.R., Benoist, C., and
Mathis, D. (2010). Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T
helper 17 cells. Immunity 32, 815-827.

Wu, S., Rhee, K.J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.R., Huso, D.L., Brancati, F.L.,
Wick, E., McAllister, F., et al. (2009). A human colonic commensal promotes colon tumorigenesis
via activation of T helper type 17 T cell responses. Nature medicine 15, 1016-1022.

Xu, H., Wang, X., Liu, D.X., Moroney-Rasmussen, T., Lackner, A.A., and Veazey, R.S. (2012). IL17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIVinfected macaques. Mucosal immunology 5, 658-669.

Xu, J., Mahowald, M.A., Ley, R.E., Lozupone, C.A., Hamady, M., Martens, E.C., Henrissat, B.,
Coutinho, P.M., Minx, P., Latreille, P., et al. (2007). Evolution of symbiotic bacteria in the distal
human intestine. PLoS biology 5, e156.

Yasuda, K., Oh, K., Ren, B., Tickle, T.L., Franzosa, E.A., Wachtman, L.M., Miller, A.D.,
Westmoreland, S.V., Mansfield, K.G., Vallender, E.J., et al. (2015). Biogeography of the intestinal
mucosal and lumenal microbiome in the rhesus macaque. Cell host & microbe 17, 385-391.

Zenewicz, L.A., Yin, X., Wang, G., Elinav, E., Hao, L., Zhao, L., and Flavell, R.A. (2013). IL-22
deficiency alters colonic microbiota to be transmissible and colitogenic. Journal of immunology
(Baltimore, Md. : 1950) 190, 5306-5312.

197

Zerbino, D.R., and Birney, E. (2008). Velvet: algorithms for de novo short read assembly using de
Bruijn graphs. Genome research 18, 821-829.

Zhang, D.L., Senecal, T., Ghosh, M.C., Ollivierre-Wilson, H., Tu, T., and Rouault, T.A. (2011).
Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts.
Blood 118, 2868-2877.

Zhang, H., Xiao, Y., Zhu, Z., Li, B., and Greene, M.I. (2012). Immune regulation by histone
deacetylases: a focus on the alteration of FOXP3 activity. Immunology and cell biology 90, 95100.

Zhang, Z., Cheng, L., Zhao, J., Li, G., Zhang, L., Chen, W., Nie, W., Reszka-Blanco, N.J., Wang,
F.S., and Su, L. (2015). Plasmacytoid dendritic cells promote HIV-1-induced group 3 innate
lymphoid cell depletion. The Journal of clinical investigation 125, 3692-3703.

Zhao, L. (2013). The gut microbiota and obesity: from correlation to causality. Nature reviews.
Microbiology 11, 639-647.

Zhao, N., Zhang, A.S., and Enns, C.A. (2013). Iron regulation by hepcidin. The Journal of clinical
investigation 123, 2337-2343.

Zhi, L., Ustyugova, I.V., Chen, X., Zhang, Q., and Wu, M.X. (2012). Enhanced Th17
differentiation and aggravated arthritis in IEX-1-deficient mice by mitochondrial reactive oxygen
species-mediated signaling. Journal of immunology (Baltimore, Md. : 1950) 189, 1639-1647.

Zimmermann, M.B., Chassard, C., Rohner, F., N'Goran E, K., Nindjin, C., Dostal, A., Utzinger, J.,
Ghattas, H., Lacroix, C., and Hurrell, R.F. (2010). The effects of iron fortification on the gut
198

microbiota in African children: a randomized controlled trial in Cote d'Ivoire. The American journal
of clinical nutrition 92, 1406-1415.

Zulian, A., Cancello, R., Ruocco, C., Gentilini, D., Di Blasio, A.M., Danelli, P., Micheletto, G.,
Cesana, E., and Invitti, C. (2013). Differences in visceral fat and fat bacterial colonization
between ulcerative colitis and Crohn's disease. An in vivo and in vitro study. PloS one 8, e78495.

199

